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Stellingen: 
Bij de berekening van de calorische waarde van fructooligosacchariden gaan 
Roberfroid et al. er ten onrechte van uit dat alleen bifidobacterien deze 
Oligosacchariden afbreken (Roberfroid, M.; Gibson, G.R, and Delzenne, N., Nut. Rev. 51(1993)137-146) 
De door Gibson et al. gevonden antimicrobiele werking van bifidobacterien wordt 
waarschijnlijk niet veroorzaakt door bacteriocines. (Gibson, G.R. and Wang, x., J. Appi. Bact. 
77(1994)412-420) 
Het bifidogene effect waargenomen door Bouhnik et al., wordt eerder veroorzaakt 
door de gebruikte methodiek, dan door een reele toename van bifidobacterien. 
(Bouhnik, Y.etal.; Nutr. Cancer 26(1996)21-29 en Bouhnik, Y. et al, J. Nutr. 127(1997)444-448) 
IV: 
De door Brigenthi et al. waargenomen gasvorming van 30 ml/mg inuline na het eten 
van 10 gram hiervan, moet hoogst oncomfortabel zijn geweest voor de 
proefpersonen. (Brighentietal., Hal. J. Gastroent. 27(1995)122-128) 
V : 
Door de samenstelling van het huidige huisdiervoeder, zijn honden en katten 
nauwelijks meer te beschouwen als vleeseters. 
VI : 
Door de gebrekkige regelgeving op het gebied van probiotica, zijn er een groot 
aantal producten op de markt, waarvan geen enkele werking is vastgesteld, maar 
waarvan de consument de indruk heeft dat ze gezond zijn. 
VII: 
De mate van protest tegen een verkeersbelemmerende maatregel is een goede 
maat voor de effectiviteit van de betrokken maatregel. 
VIII : 
De lage dunk die de onderzoekers op de Dreijen hebben van de bestuurders in het 
hoofdgebouw, wordt in de hand gewerkt door de geografische positie van zowel de 
Dreijen als het hoofdgebouw. 
IX: 
Groenland is groenerdan Nederland. 
X : 
Hoewel in Usland geen Eskimo's wonen, een nog veel gehoorde stelling, wonen de 
Uslanders wel in iglo's. 
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ABSTRACT 
Prebiotic effects of non-digestible oligo- and polysaccharides. 
Ph.D. thesis by Ralf Hartemink, Food Microbiology Group, Wageningen Agricultural 
University, the Netherlands 
Oligo- and polysaccharides occur naturally in many foods, mainly of vegetable origin. 
Many of these carbohydrates are not, or partially, digestible by the human upper gastro-
intestinal tract. The non-digested carbohydrates enter the large intestine, where the 
majority is degraded and fermented by the intestinal microflora. This flora is a complex 
mixture of several hundred bacterial species. These bacteria are for a considerable part 
dependent on non-digested dietary components for their growth and energy 
requirements. Some non-digestible carbohydrates are considered prebiotics, since they 
may cause changes in the bacterial composition, or the metabolic activity of the flora, 
and thus may have a positive influence on the host health. Two studies described in 
this thesis deal with the fermentation of commercial oligosaccharides by the oral flora, 
and the risk of dental caries. It is concluded that there is a potential risk for dental caries 
with one oligosaccharide preparation (fructooligosaccharides), but the other preparation 
(transgalactosyl-oligosaccharides) does not pose a risk for caries. Two additional 
studies are described that deal with the fermentation of non-digestible polysaccharides 
by the intestinal microflora and their use as sources for prebiotic oligosaccharides. It 
was concluded that the two substrates tested were fermented only by a limited number 
of species. Fermentation of several non-digestible carbohydrates was studied using 
faecal inocula. It was concluded that there are considerable differences in the faecal 
metabolic capacity in samples from different volunteers, indicating that the metabolic 
capacity is partly determined by genetic factors. Finally three studies are described that 
deal with new isolation media for two bacterial groups, lactobacilli and bifidobacteria. 
The new media were compared with other media and it is concluded that both media 
perform better than the other media tested. 
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GENERAL INTRODUCTION 
GENERAL INTRODUCTION 
The (human) gastrointestinal tract harbors a large number of bacteria, that live in 
symbiosis with the host. Especially in the large intestine, these bacteria can reach very 
high numbers per gram intestinal contents. These bacteria, commonly referred to as the 
intestinal microflora, are of great importance to the host. The bacteria degrade and 
ferment many of the food components that can not be absorbed in the small intestine. 
The fermentation results in end-products that can be absorbed through the intestinal 
wall. This results in additional energy and, possibly, add to the nutritional value of the 
food consumed. The intestinal flora also acts as a barrier against food-borne 
pathogenic bacteria. On the other hand, the intestinal microflora may produce harmful 
substances, that may be involved in the formation of intestinal cancers 
Within the intestinal microflora several hundred bacterial species may be present, 
some of these are considered beneficial for human health, others are considered as 
possible pathogens or producers of possible harmful substances. In a healthy large 
intestine an equilibrium exists between beneficial and possibly harmful bacteria. Many 
factors determine this equilibrium, one of these factors is the diet. 
The past few decades there is increasing interest in influencing the intestinal flora 
through the diet, especially to shift the equilibrium towards more beneficial bacteria. 
Two methods are being used to influence the intestinal flora, one using living bacteria 
(probiotics), another using specific growth substrates (prebiotics). 
In the concept of probiotics, live beneficial bacteria, mainly from the genera 
Lactobacillus or Bifidobacterium are used. Of several species of these genera it has 
been proven that ingestion of large quantities reduces lactose intolerance and reduces 
the effects of diarrhea. Several other beneficial effects have been claimed, but, at 
present not been proven sufficiently. Probiotics mainly act in the small intestine. 
The second concept deals with specific food components that affect the 
composition or the metabolism of the intestinal flora. Components that have a beneficial 
effect are known as prebiotics. Most prebiotics are carbohydrates that are fermented by 
a large number of intestinal bacteria and do have some effect on either the composition 
or the metabolic activity of the flora (O'Suiiivan, 1996). Prebiotics are mainly effective in 
the large intestine. 
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To have a beneficial effect prebiotics should not be digestible in the small 
intestine, they should be fermentable by the desired bacteria and have measurable 
effects. The studies described in this thesis deal with the latter two prerequisites. 
AIM AND OUTLINE OF THIS THESIS 
This thesis forms part of a larger research project on Non-Digestible Oligosaccharides 
(NDO-project), carried out at the Wageningen Agricultural University. The project was 
industry funded and carried out at four departments of the university : Food Chemistry, 
Food Microbiology, Human Nutrition and Animal Nutrition. The three main objectives of 
the project were: 
- production and characterization of oligosaccharides 
- fermentation of oligosaccharides by intestinal micro-organisms, and 
- effects of (commercial) non-digestible oligosaccharides on humans and animals 
This thesis describes the results of the studies carried out at the Food Microbiology 
group within the NDO-project. The results of the studies in Human Nutrition and Animal 
Nutrition, as well as Food Chemistry will be published in separate theses. 
In Chapter 1 of this thesis the current knowledge of fermentation of non-digestible 
oligosaccharides is reviewed as an introduction to the studies carried out within the 
Food Microbiology group. Within these studies the following topics are distinguished : 
1. fermentation of commercial and newly produced oligosaccharides by the gastro-
intestinal microflora 
a) fermentation by the oral flora 
b) fermentation by the large intestinal flora 
2. fermentation of (food) polysaccharides by the large intestinal microflora 
3. analysis of the intestinal and faecal flora of humans and piglets 
Ad 1) Several studies have been carried out on the fermentation of different 
oligosaccharides by the oral and intestinal microflora. It was observed that commercial 
fructooligosaccharides (FOS) could be degraded and fermented by members of the 
Enterobacteriaceae (Hartemink etai, 1997) as well as by the oral streptococci. The latter 
studies are presented in Chapter 2. Fermentation of the other commercial 
oligosaccharides, used at present in the Netherlands, transgalactosyl-oligosaccharides 
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(TOS), has also been studied. Fermentation by intestinal bacteria was observed, but 
fewer bacterial species were capable of fermenting TOS. These studies were carried 
out in close co-operation with the Food Chemistry group. Similarly, TOS were not 
degraded or fermented by the oral microflora, as is described in Chapter 3. 
In cooperation with Food Chemistry several plant cell wall polysaccharides were 
tested as substrates for intestinal species. Within the same studies induction and 
enrichment experiments were carried out. 
All previously mentioned studies were carried out with pure cultures of intestinal 
bacteria. Chapter 6 describes a series of batch fermentations, using faecal inocula 
from human volunteers, receiving the same diet. 
Ad 2) Two plant polysaccharides were tested as substrates for intestinal bacteria. The 
polysaccharides chosen were xyloglucan and guar gum (galactomannan). 
The results of the polysaccharide fermentation, can be used to predict fermentability of 
oligosaccharides derived from these polysaccharides. Fermentation of xyloglucan is 
described in Chapter 4, fermentation of guar in Chapter 5. 
Ad 3) Within the NDO-project, the Human and Animal Nutrition groups have carried out 
several studies with NDOs in the diet of humans and piglets. One of the main aims of 
these studies was to determine changes in the faecal or intestinal microflora. It was 
thus necessary to have reliable methods to determine changes in the bacterial and 
chemical composition of the intestinal flora. As these methods turned out to be 
unreliable, new microbiological media had to be developed. 
The main emphasis within the human and animal trials was on lactic acid bacteria, 
as these may be an indication of intestinal health. Two new isolation media were 
developed for the detection of bifidobacteria and lactobacilli, the two main genera of 
lactic acid bacteria in the intestinal flora. The development of the medium for 
bifidobacteria is described in Chapter 7, that for lactobacilli in Chapter 8. Finally, in 
Chapter 9, these two media are compared with other media used elsewhere. 
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NON-DIGESTIBLE OLIGOSACCHARIDES AND THEIR 
FERMENTATION IN THE Gl TRACT. 
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THE GASTROINTESTINAL TRACT 
The human gastrointestinal tract (Gl tract) basically is a large tube, running through the 
body and which includes the mouth, oral cavity, esophagus, stomach, small intestine 
and colon. The small intestine can be divided into duodenum, jejunum and ileum, the 
large bowel is composed of the caecum, ascending colon, transverse colon, 
descending colon, and sigmoid rectum. The proximal colon consists of the caecum and 
ascending colon whereas the distal bowel comprises the descending colon and sigmoid 
rectum. The caecum, to which the appendix is attached, is located in the right lower 
abdomen. The ascending colon continues to the right upper abdomen, where it turns at 
the hepatic flexure to form the transverse colon. Distally, the large bowel then extends 
across the splenic flexure in the left upper abdomen, which marks the beginning of the 
descending colon. In the left lower abdomen, an S-shape loop runs through the pelvis, 
and empties into the sigmoid rectum. The rectum is about 15 cm long and terminates at 
the anus. In adults, the entire length of the colon is about 150 cm (Cummings and 
Macfarlane, 1991; Macfarlane and Cummings, 1991). 
The principal functions of the Gl tract include degradation and absorption of food 
components and water. Degradation mainly takes place in the upper part of the Gl tract, 
whereas the major site of absorption are the (lower) small intestine and the large 
intestine. Degradation and absorption are enhanced by the excretion of a large number 
of digestive enzymes, such as glycosidases, lipases, peptidases and proteinases 
(Cummings and Macfarlane, 1991). 
All non-digested food compounds as well as a substantial part of the intestinal 
secretions will reach the large intestine. In the colon most products are further 
degraded by the resident intestinal microflora. Many products of bacterial fermentation 
are absorbed and thus contribute to the nutritional value of the ingested foods 
(Cummings and Macfarlane, 1991). 
The colon receives digesta from the terminal ileum approximately 5h after food 
ingestion. Thereafter, speed of passage slows progressively from the caecum towards 
the distal colon. Concurrent with this is an increase in water absorption, thus gut 
contents in the proximal colon are more or less liquid in nature but have a faeces like 
appearance distally (Cummings and Macfarlane, 1991). 
In Western populations, the average gut transit time is 60h, with a range of 
23-168h. The colon itself has a volume of approximately 500ml with about 220g 
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contents. The average stool size in Western Europe is 106 g/day, with a range of 
19-415g. In general, stool weight correlates inversely with transit time. Studies with 
healthy volunteers have indicated that speeding up colonic transit times from 67 to 25h 
results in an increase in stool weight from 148 to 285 g/day. Conversely, when transit 
times are increased, stool weight decreases from 182 to 119 g/day (Cummings and 
Macfariane, 1991; Stephen et ai. 1987). The differences are mainly due to changes in the 
water content of the faecal mass. 
The composition of faeces is highly variable. Bacteria may constitute up to 55% 
of the total solids, whilst fiber and other non-digested, non fermented compounds 
represent less than 17% of the weight of which about 24% is soluble material. Fecal 
water content may be as high as 70% of the total weight (Stephen and Cummings, 1980). 
Stool size is influenced by both dietary and endogenous factors. Endogenous factors 
mainly act through hormones on the intestinal motility. Well known are a decreased 
peristaltic movement during exercise and menstrual cycle. Dietary factors, like non-
digestible fibers and polyalcohols (sorbitol), may retain water and thus increase stool 
weight. High amounts of these factors may cause diarrhea, due to the increased 
osmotic pressure (Cummings and Macfariane, 1991; Stephen and Cummings, 1980). 
THE GASTROINTESTINAL FLORA 
The gastrointestinal flora has been described as one of the most complex bacterial 
ecosystems known. The whole Gl tract is colonized by a large number of bacteria. Each 
part of the Gl tract harbors a specific flora, adapted to the local conditions. In total over 
400 species may be present in the Gl tract of healthy humans, either as residents or in 
a transient state (Drasar and Hill, 1974). 
Total counts vary between the different regions within the Gl tract and are mainly 
dependent on the oxygen tension, pH and flow of the digesta. Due to the low pH the 
stomach generally shows the lowest number of live bacteria. The pH in the stomach of 
pigs and rats is much higher than in humans, this is reflected in the total counts, which 
are considerably higher in the stomach of these animals (Table 1.1) 
The composition of the bacterial population and the relation to carbohydrate 
metabolism will be discussed in the next chapters. 
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Table 1.1 : Approximate bacterial counts (logN/g) in different parts of the intestinal tract of 
different animal species. 
Oral cavity 
Stomach 
Jejunum 
Ileum 
Colon 
(based on Hill, 
Human 
7-8 
<3 
<3 
5 
11 
1995) 
Rat 
7-8 
7 
7 
8 
11 
Swine 
7-8 
6-7 
8 
10 
11 
Mouse 
7-8 
7 
7 
8 
11 
Rabbit 
7-8 
4 
4 
8 
11 
The oral cavity 
Ingested food material first comes into the oral cavity. The oral cavity is composed of 
different niches, each with its own microbial population. In the oral cavity bacteria are 
the main group of microorganisms, but viruses and yeasts can also be found. 
The main ecological habitats of the mouth are : 1) the mucosa of lips, cheeks and 
palate; 2) the tongue; 3) the tooth surface; 4) the saliva and 5) the tonsillar area 
(Macfarlane and Samaranayaka, 1989). The population of microorganisms is mainly 
depending on the presence of oxygen and nutrients as well as the flow rate of the 
saliva. The highest bacterial numbers can be found deep in the periodontal crevasses, 
the lowest numbers are found in the saliva (Fig. 1.1) 
The major species in the oral cavity are lactic acid bacteria of the genera 
Streptococcus, Lactobacillus and Bifidobacterium. In dental plaque and oral infections, 
many anaerobic species have been isolated, mainly Prevotella and Porphyromonas 
species. Other genera include Eubacterium, Actinomyces and Veillonella (Marsh and 
Martin, 1992). 
The main source of nutrients and energy for oral bacteria is the food. Especially 
carbohydrates are the main source of energy for the oral microflora. Due to the 
predominant presence of lactic acid bacteria, carbohydrates are rapidly metabolized to 
lactic and acetic acids. This results in a rapid drop in the pH of the saliva after ingestion 
of carbohydrates. Surplus carbohydrates can be incorporated in a large number of 
bacterial exopolysaccharides, which are used as energy storage compounds, and, on 
the other hand act as attachment factors (Marsh and Keevil, 1986; Marsh and Martin, 1992). 
10 
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Figure 1.1. Relation between bacterial species, oxygen tension and habitat in the oral cavity. 
The main effect of carbohydrate metabolism in the oral cavity related to human 
health is the process of dental caries (Fig. 1.2). Dental caries is the disease in which 
the upper protective layer of the teeth is degraded. Thereby small lesions appear, 
which may be the start of a larger cavity and, finally, dental infection. If not cured, the 
decayed tooth has to be removed. The process starts when the dental enamel (the 
upper layer of the tooth) starts to dissolve. The enamel starts to dissolve when the pH 
reaches a value of 5.5 or lower. Lactic acid is especially effective in dissolving the 
dental enamel. Formation of lactic and acetic acids from dietary carbohydrates thus is 
the main factor in the process of caries formation. The second main factor is the 
formation and presence of dental plaque. Dental plaque is the combination of bacteria 
(living and dead) and food components glued to the dental surface by 
exopolysaccharides produced by the different bacteria. Fermentation of carbohydrates 
in the dental plaque enhances caries formation as 1) the acid is produced directly on 
the dental surface, and 2) the neutralizing effect of the saliva is minimized, due to the 
protective layer of plaque (Marsh and Martin, 1992). 
Several bacterial species in the oral cavity are considered cariogenic. Among 
these Streptococcus mutans is considered the most pathogenic species as it is capable 
of rapidly fermenting carbohydrates and is present in relatively high numbers. Other 
11 
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lactic acid bacteria, such as lactobacilli, bifidobacteria and Actinomyces species, are 
also considered cariogenic (Marsh and Martin, 1992). 
All fermentable carbohydrates have a potential cariogenic risk, the risk dependent 
mainly on the fermentation rate and the final pH reached after fermentation. Sucrose, 
as it is fermented very rapidly by a large number of species, is considered the main 
cariogenic carbohydrate. Glucose and fructose are considered slightly less cariogenic 
than sucrose, whereas lactose and galactose are much less cariogenic. 
Oligosaccharides, being carbohydrates, may thus also have cariogenic properties, 
especially oligosaccharides consisting of highly cariogenic monosaccharides, such as 
glucose and fructose. 
Dental plaque 
Caries 
formiate 
succinate 
propionate 
butyrate 
Figure 1.2. Carbohydrate metabolism by the oral flora and factors related to dental caries 
formation. 
The stomach 
The human stomach generally has a very low pH, which is the main factor preventing 
bacterial growth. The normal resting gastric juice pH is below 3.0, which prevents 
practically all bacterial growth, and which is bactericidal for most transient species. 
During and shortly after a meal the pH may increase to values around 6.0. This will 
12 
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allow transient bacteria to survive and enter into the small intestine. The resident flora 
of the stomach lumen is highly acid tolerant and consists mainly of lactobacilli and 
streptococci. In the stomach mucosa the pH is much higher and bacterial populations 
may be higher. In addition to lactobacilli and streptococci, some other bacterial species 
and yeasts may be present (mil, 1995a). 
Fermentation of ingested carbohydrates in the stomach hardly occurs. 
The small intestine 
When the partly digested food enters the small intestine, it is mixed with intestinal 
secretions, such as bile, pancreatic enzymes and bicarbonate. Especially the bile has a 
strong bactericidal effect. Together with a strong fluid secretion by the intestinal 
mucosa, this prevents extensive colonization of the small intestine. Colonization mainly 
takes place in crypts and blind loops. In the lower parts of the small intestine the flow is 
somewhat reduced, the bile is diluted, the pH becomes more neutral and the oxygen 
tension drops rapidly. This favors the growth of different bacteria, initially mainly 
aerotolerant species, and in the ileum also strict anaerobes (Fig. 1.3) (Hill, 1995a; Lee, 
1985). 
Due to the flow rate and the low bacterial mass there is not much carbohydrate 
fermentation in the small intestine in healthy humans. 
In animals the conditions in the small intestine differ widely. In pigs, where the 
stomach pH is much higher, the bile secretion is less and the flow rate is lower, there is 
extensive bacterial growth in the small intestine (Russell, 1979). This also results in 
extensive fermentation of ingested carbohydrates, including oligosaccharides. 
The large intestine 
In the large intestine the flow rate of the digesta decreases considerably. In addition to 
this, the bile is even more diluted and the pH is near to neutral. Together with an 
abundance of fermentable material, this results in extensive bacterial growth. Total 
logarithmic counts may reach up to 1011 bacteria/gram contents. Higher numbers have 
been reported, but it is physically impossible to reach numbers over 1012 bacteria/gram 
faecal dry weight, taking into account the average composition of faeces and the 
dimensions of an average bacterium (Stephen and Cummings, 1980). 
13 
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Figure 1.3 Appearance of bacterial species in the small intestine. 
It is estimated that over 400 different bacterial species reside in the human large 
intestine. Of these about 200 have been validly described, but often non-identifiable 
strains are reported (Hill, 1995a; Hoideman and Moore, 1977; Benno et ai. 1989). In addition to 
the resident bacteria, transient bacteria are often isolated (mainly aerobic species). The 
flora in the large intestine is fairly stable, especially the dominant flora (like Bacteroides, 
Bifidobacterium, anaerobic cocci). Large variations occur in the less dominant species, 
especially among the facultative or aerotolerant species like E. coli and lactobacilli 
(Benno era/., 1989; Finegold etal. 1974, Hoideman era/., 1976; Hentges, 1978). The numbers Of the 
dominant species are also comparable in different populations (Fig. 1.4). Differences in 
counts are more often due to the methodology used, rather than actual differences. As 
in individuals, the counts of less dominant species differ widely between different 
populations. 
Among the dominant bacterial groups are members of the genera Bacteroides, 
Bifidobacterium, Coprococcus, Peptostreptococcus, Eubacterium and Ruminococcus. 
Members of the following genera are often isolated and are present in lower numbers : 
Fusobacterium, Streptococcus, Lactobacillus, Enterococcus, Veillonella, Megasphaera, 
Propionibacterium and Enterobacteriaceae. 
14 
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This complex microbial ecosystem has an enormous fermenting capacity. 
Practically all carbohydrates entering the colon can be fermented, either by a single 
species, or, for complex carbohydrates, by a combined action of more species. The 
main factors determining whether a specific carbohydrate is fermented and at what rate 
are the following : composition of the monomeric units, degree of polymerization (DP), 
degree of branching and solubility. In general, shorter carbohydrates are fermented 
faster than long chain carbohydrates. Similarly linear chains are fermented faster than 
branched chains and soluble carbohydrates are fermented faster than insoluble 
carbohydrates. In the next sections the fermentation of different oligo- and 
polysaccharides will be described in more detail. 
Log cfu/g faeces 
0 1 2 3 4 5 6 
Figure 1.4 Faecal bacterial counts as compared to human population figures. Reported ranges 
of bacterial groups are shaded. 
PREBIOTICS 
Prebiotics are defined as : non digestible food ingredients, that beneficially affect the 
host by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon, and thus improve host health (Gibson and Roberfroid, 1995). Most 
15 
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potential prebiotics are carbohydrates, but the definition does not exclude non 
carbohydrates to be used as a prebiotic. In theory, any antibiotic that would reduce the 
number of potentially harmful bacteria and favor health promoting bacteria or activities, 
can be considered a prebiotic. 
This definition does not emphasize a specific bacterial group. Often, however, it is 
assumed that a prebiotic should increase the number and/or activity of bifidobacteria 
and lactic acid bacteria, as these groups of bacteria are claimed to have several 
beneficial effects on the host. A product that stimulates (or claims to stimulate) 
bifidobacteria is considered a bifidogenic factor. Some prebiotics may thus also act as a 
bifidogenic factor and vice versa, but the two concepts are not identical. 
The definition also states that a change in metabolic activity may result in an 
improvement of the host health. This means that no specific group of bacteria has to be 
stimulated, but that the metabolic activity of the intestinal flora as a whole has to be 
modified. This generally means an increase in carbohydrate fermentation and a 
decrease in protein degradation and fermentation. 
DIGESTA 
I 
Polysaccharides 
Monosaccharides 
Protein 
Amino acids 
BACTERIAL 
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i i i r 
k
 Bacterial mass 
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HPS H2 C02 SCFA lactate ethanol BCFA NHa amines phenols 
I I indoles 
T 
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Figure 1.5 Schematic fermentation of protein and carbohydrates by the intestinal microflora. 
Protein and fermentation products mainly derived from protein fermentation are underlined. 
Carbohydrate fermentation generally results in harmless or even beneficial end 
products, whereas protein fermentation results in the production of potential harmful 
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products (Fig.1.5) (Hill, 1995). A change in metabolic activity does not have to correlate 
with an increase in the numbers of the possible beneficial bacterial groups. The concept 
of prebiotics thus is clear, but it is not certain that specific groups of micro-organisms, 
such as the bifidobacteria, are to be stimulated. If the aim is to stimulate bifidobacteria, 
a non-digestible carbohydrate has to be selectively fermented by bifidobacteria. If the 
aim is to modify the metabolic patterns, it is necessary to increase general 
fermentation, thus as many bacteria as possible need to be able to ferment the 
carbohydrate. 
In both cases it is necessary to determine the fermentation by individual strains, in 
faecal slurries (batch or fermentor) and finally in human studies. 
Fermentation by individual strains is often determined using three different 
methods: 
1) Determination of change in pH. This method assumes that fermentation will 
always result in a drop in pH. However, not all strains produce enough acids to reduce 
the pH considerably. Secondly, many species metabolize protein at the same time, 
which results in the formation of alkaline products. These mask a possible drop in pH. 
This method thus may result in false negative results 
2) Determination of change in optical density. This method is more reliable than 
the first method, but there is a risk for false positive results. Many species may grow on 
the carbohydrate-free medium, which results in an increase in optical density, without 
fermentation of the carbohydrate. 
3) Determination of the actual carbohydrate content using HPLC. This method 
clearly shows fermentation, regardless of changes in pH or optical density. 
Fermentation and/or degradation of each individual compound in a mixture can be 
determined. No false positives or false negatives will occur, but the method is 
expensive and time consuming. 
The differences in methods may result in different conclusions regarding the 
fermentability of a certain compound. This should be taken into consideration when 
interpreting the results in Table 1.3. 
OLIGOSACCHARIDES 
In the following paragraphs the different oligosaccharides are classified according to 
structure, not origin or production technique. Oligosaccharides in this classification are 
defined as carbohydrates or carbohydrate derivatives with a degree of polymerization 
(DP) of 2-10. Synthetic or natural oligosaccharides that are not generally present in 
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foods or feed and which have never been tested in studies aimed at fermentation by 
the intestinal flora (either in vitro or in vivo) are not included. 
Digestible oligosaccharides, like sucrose, lactose, maltose, maltodextrins, 
gentiobiose and trehalose are not included. 
Glucooligosaccharides 
Cellobiose and cellodextrins 
Cellobiose (CEL, 4-o-B-D-giucopyranosyi-D-giucose) is a non-digestible disaccharide, which 
does not normally occur in nature. It can be formed, however, by degradation of 
cellulose, either industrially or by bacterial hydrolysis in the colon. It is known that the 
human intestine harbors cellulolytic bacteria. Some of these highly cellulolytic species 
were identified as Bacteroides sp. (Betian et ai., 1977). It is not known whether these 
bacteria actually produce cellobiose but, if so, it may be used as a carbon source by 
other bacteria. Cellobiose is often used in determining carbohydrate fermentation 
patterns in the identification of bacteria. As many intestinal species are capable of 
fermenting cellobiose (Table 1.3), it is not unlikely that cellobiose may have an effect on 
either the composition or the metabolic activity of the intestinal microflora. So far there 
have not been any studies to determine such an effect. 
Cellodextrins ((4-o-6-D-giucopyranosyi)„-D-giucose), like cellobiose, can be formed by 
hydrolysis of cellulose (Russell, 1985). The degree of polymerization ranges from n=3 
(cellotriose) to n=6 (cellohexaose). No data are available on the fermentation of 
cellodextrins by intestinal microorganisms. It is, however, to be expected that cellulose 
degrading bacteria will also be able to degrade and ferment cellodextrins. Cellodextrins 
have as yet not been tested in human or animal studies as possible prebiotics. 
Cyclodextrins 
Cyclodextrins are cyclic molecules composed of oc-1-4 linked D-glucose residues, a-
cyclodextrin being a hexamer, 3-cyclodextrin a heptamer and ^cyclodextrin an octamer 
(Suzuki and Sato, 1985). 
So far cyclodextrins have not been proposed as non-digestible carbohydrates with 
functional food properties, but they are increasingly used in food and non-food 
products. Cyclodextrins readily form inclusion complexes with a number of chemicals. 
This complex formation has resulted in a large number of patents that propose the use 
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of cyclodextrins as nutritionally inert stabilizers in various food and pharmaceutical 
products (Antenucci and Palmer, 1984). 
a- And 6-cyclodextrins are quite resistant against human a- and B-amylases and 
will thus reach the colon unaltered. y-Cyclodextrin, however, is readily degraded by oc-
amylase in Vitro (Szejtli and Sebestyen, 1979; Suzuki and Sato, 1985; Antenucci and Palmer, 1984). 
In a study with B-cyclodextrin it was found that 91% of the ingested dose could be 
recovered from the effluent of ileostomy patients, but not from stools (Fiourie era/., 1993). 
Studies with labeled cyclodextrins have shown that (3-cyclodextrin is degraded rapidly 
by the intestinal flora (Szejtli et al., 1980). a-Cyclodextrin on the other hand is degraded 
very slowly if at all (Suzuki and Sato, 1985). 
Fermentation by individual strains has not been studied extensively. It has been 
shown that B-cyclodextrin can be fermented by several human faecal bacteria, 
especially the B. fragilis group, Lb. acidophilus and three species of Clostridia, among 
them CI. perfringens. The 5 species of bifidobacteria tested were not able to ferment 
this oligosaccharide. Neither did 22 other species, among them several lactobacilli and 
enterobacteha (Table 1.3)(Mitsuoka era/., 1987, Antenucci and Palmer, 1984). 
Degradation of a- or y-cyclodextrin by intestinal bacteria has not been studied in 
detail. 
It can thus be concluded that a- and B-cyclodextrins are non-digestible and, due to their 
fermentation, may have an effect on the composition or activity of the intestinal flora. 
No studies have been published yet on the influence of cyclodextrins on the intestinal 
flora of humans or animals. 
Gentiooligosaccharides 
Gentiooligosaccharides (GeOS) are a mixture of 6-1-6 linked D-glucose oligomers with 
a DP of 2-5. They are produced in Japan by transglucosylation and the commercial 
preparation is marketed as Gentose. 
GeOS are not or partly hydrolyzed in the small intestine and will be fermented in 
the colon. The only available study shows fermentation by a large number of bacteria 
(Table 1.3), among these bifidobacteria and Bacteroides spp. (Nakakuki era/., 1990). 
It is also claimed that addition of GeOS will increase the number of bifidobacteria 
and decrease the protein fermentation, resulting in lower concentrations of putrefactive 
products (Nakakuki era/., 1990; Playneand Crittenden, 1996). 
As data are scarce it can not be concluded whether GeOS have a significant effect on 
the intestinal microflora or its metabolism. 
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Glucan hydrolysates 
Glucan oligosaccharides are obtained after enzymatic hydrolysis of oat 13-glucan using 
a commercial enzyme mixture. Several lactic acid bacteria were screened for their 
hydrolyzing activity of the resulting oligosaccharide mixture. Only a single strain of Lb. 
casei was able to ferment the oligosaccharides. Three bifidobacteria and two other 
lactobacilli did not degrade the mixture (Jaskari etai., 1994). 
Glucooligosaccharides 
Glucooligosaccharides (ccGOS) are a mixture of a-D-glucose, with oligomers with a DP 
of 2-6. They are produced by transglucosidation using an oc-glucosidase from 
Leuconostoc mesenteroides, and marketed in France by BioEurope (Djouzi etai., 1995). 
Glucooligosaccharides can partly be digested by the small intestinal enzymes in 
rats (Vaiette et ai., 1993). A substantial part of the mixture will thus reach the large 
intestine. Data on fermentation by individual strains are limited, but most Bacteroides 
species, as well as some bifidobacteria and Clostridia are capable of fermenting these 
oligosaccharides. Most lactobacilli could not ferment aGOS (Djouzi etai., 1995). 
Some animal studies have shown that aGOS may influence both the metabolism 
and the composition of the intestinal microflora (Djouzi etai, 1995; Gidenne, 1995; Monsan, 
1997). As yet, data from studies with human volunteers are not available. 
Isomaltooligosaccharides 
Isomaltooligosaccharides consist mainly of linear a-1-6 linked glucose residues, some 
1-4 linkages may also occur. Examples are isomaltose (IMA, 6-O-a-D-glucopyranosyl-D-
glucose), isomaltotr iose (IMT, 6-0-a-D-glucopyranosyl-(1-6)-a-D-glucopyranosyl-D-glucose) and 
panose (PAN, 6-0-a-D-glucopyranosyl-(1 -6)-a-D-glucopyranosyl-(1 -4)-D-glucose). 
Isomaltooligosaccharides occur naturally in fermented foods as miso, soy sauce 
and sake as well as in honey (Kohmoto etai., 1992). Commercial isomaltooligosaccharides 
are prepared from starch by the combined action of oc-amylase, pullulanase and oc-
glucosidase. The resulting mixture is commercially available as lsomalto-900 in Japan 
(Kohmoto et a/., 1988). 
Isomaltooligosaccharides can be degraded by oral bacteria, among these St. 
mutans. Fermentation rates, however, are fairly low, reducing the risk of caries 
formation. Studies using rats have shown that these oligosaccharides are low 
cariogenic in vivo(Tsunehiro etai., 1997). 
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Some isomaltooligosaccharides are degraded to some extent by intestinal enzymes, 
especially isomaltase (Dahiquist etai., 1963). Degradation was further confirmed.in a study 
with 13C labeled isomaltooligosaccharides, where some of the labeled carbon could be 
recovered from the breath of the volunteers. Similarly, a rise in blood glucose was 
observed, indicating absorption of free glucose and thus intestinal degradation (Kohmoto 
etai, 1992). 
The fraction of isomaltooligosacchrides reaching the colon, will be fermented by 
the intestinal flora. A large number of intestinal bacteria is capable of fermenting 
isomaltooligosaccharides, especially the Bacteroides and Bifidobacterium species 
(Table 1.3)(Kohmoto etai., 1988). 
Trials with human volunteers have shown that ingestion of 
isomaltooligosaccharides results in a change in the composition of the intestinal flora, 
with an increase in bifidobacteria in the faeces. Bifidobacteria! numbers increased both 
in healthy adults and in hospitalized elderly people. (Table 1.2). No significant changes 
were observed in other bacterial groups (Kohmoto etai., 1988). 
Several other trials with human volunteers by the same research group have also 
shown selective increases of the number of bifidobacteria in faeces. Effects were 
already observed at a daily intake of 8.2 g/day for the commercial mixture (Kohmoto etai., 
1991), 10 g/day for the fraction with DP=2, and 5 g for the DP=3 fraction (Kaneko et a/., 
1994), which may be partly due to digestion of the DP=2 fraction in the small intestine. 
However, studies using Wistar rats did not show a significant increase in 
bifidobacteria for 12 months. In the same study only an significant increase in 
lactobacilli could be detected after 3 months. This increase was not detected after 6 or 
12 months. No significant changes could be detected in any other bacterial group 
(Kaneko et al., 1990). 
It can thus be concluded that isomaltooligosaccharides are partly non-digestible 
and potentially have an effect on the intestinal flora. Data are, however, limited to some 
(poorly documented) Japanese studies. The effects were not observed in rats, but this 
may be due to the large differences in the faecal flora between man and rats, as well as 
the differences in experimental set-up (time, dose and diet were all markedly different). 
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Table 1.2: Effect of 13.5 g/day isomaltooligosaccharides on human intestinal flora. 
A: healthy adults, B: hospitalized elderly patients 
A: healthy adults 
Bacterial group 
Total anaerobes 
bacteroides 
bifidobacteria 
enterobacteria 
day -2 
10.4(0.1) 
10.1 (0.1) 
9.5 (0.3) 
7.4 (0.8) 
dayO 
10.4(0.2) 
10.2(0.3) 
9.4 (0.7) 
7.4(1.1) 
day 7 
10.6(0.2) 
10.3(0.3) 
10.0(0.1) 
7.5 (0.8) 
day 10 
10.6(0.1) 
10.2 (0.2) 
10.0 (0.3) 
7.0 (0.9) 
B: hospitalized elderly patients 
Bacterial group 
Total anaerobes 
bacteroides 
bifidobacteria 
enterobacteria 
day -2 
9.8 (0.3) 
9.6 (0.3) 
8.3 (0.6) 
7.4 (1.9) 
dayO 
9.9 (0.3) 
9.6 (0.4) 
8.3 (0.6) 
7.1 (0.7) 
day 7 
9.9 (0.3) 
9.7 (0.3) 
8.8 (0.5) 
7.3(1.3) 
day 10 
10.1 (0.3) 
9.8 (0.4) 
9.2 (0.5) 
7.0(1.3) 
Only those groups which all volunteers harbored are shown. Data in bold differ significantly (P«0.05) from 
day=0. 
(data from Kohmoto era/., 1988) 
Leucrose 
Leucrose (5-O-a-D-glucopyranosyl-D-fructopyranoside), is a sucrose isomer, which is prepared 
by enzymatic transglucosylation. It has been found to be a by-product of microbial 
dextran production by Leuconostoc mesenteroides (Stodoia et ai., 1956) and may thus 
naturally be present in foods fermented by this bacterial species. Leucrose can be used 
as a sugar substitute, but at present there are no products available with added 
leucrose. 
Leucrose was found to be non- or very low cariogenic in vivo and in vitro (Ziesenitz 
era/., 1989a). 
Leucrose is largely digested by the human small intestinal enzymes, although 
much slower than maltose (31%) or sucrose (63%). It is therefore likely that some 
leucrose will reach the colon (Ziesenitz era/., 1989b). There are no data available on the 
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fermentation of leucrose by intestinal bacteria or its effect on the composition or activity 
of the intestinal flora. 
Leucritol 
Leucritol can be prepared from leucrose by catalytic hydrogenation. The resulting 
mixture consists of approx. 60% glucosyl-sorbitol and 40% of glucosyl-mannitol. 
Leucritol is not present in natural products and was developed as a sugar substitute. It 
is not used at present in any foods. 
Leucritol is hydrolyzed to some extent by the human small intestinal enzymes, with 
relative hydrolysation rates of 3 and 7% as compared to maltose and sucrose (Ziesenitz 
etai, 1989b). It is thus likely that a substantial amount of leucritol will reach the colon. 
There are no data available on the fermentation of leucritol by intestinal bacteria or its 
effect on the composition or activity of the intestinal flora. 
Maltitol 
Maltitol (MAT, 6-o-a-D-giucopyranosyi-D-sorbitoi) is a disaccharide alcohol which is partially 
digestible in the small intestine. Maltitol is widely used as a non-cariogenic sweetener 
and sugar substitute. Maltitol is as yet not used as a possible prebiotic. 
It has been estimated that about 50% of the ingested dose reaches the caecum 
(Nilsson and Jagerstad, 1987, Wursch et al., 1989). Undigested maltitol is fermented rapidly by 
the intestinal flora, as could be concluded from hydrogen production (Wursch etai., 1989) 
and absence of maltitol in faeces (Beaugerie etai., 1990). 
Fermentation of maltitol by individual strains of intestinal bacteria has not been 
studied extensively (Table 1.3). The available data show that maltitol can be fermented 
by species of several genera. As fermentation occurs, it is possible that maltitol has an 
effect on the composition or activity of the intestinal flora, but this has not yet been 
tested in trials using human volunteers. 
Palatinose 
Palatinose (PAL, 6-O-a-D-giucopyranosyi-D-fmctose), is a sucrose isomer. It has also been 
referred to as isomaltulose (Takazoe, 1989) or isomalturose (Mitsuoka etai., 1987). 
Palatinose has been discovered in 1957 in the beet sugar manufacturing process. 
It has also been detected in honey and cane juice (Takazoe, 1989). In Japan palatinose is 
produced on a large scale since 1984 by the a-glucosidase reaction by 
Protaminobacter rubrum (Takazoe, 1989 Fuji and Komoto, 1991). At present palatinose is 
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used in Japan as a sweetener, although its sweetness is only 42% as compared to 
sucrose. 
Palatinose is partially digestible by isomaltase at a rate of about 25-30% of that of 
isomaltose (Kaga and Mizutani, 1985, Nilsson and Jagerstad, 1987, Tewari and Goldberg, 1991). 
Some palatinose may therefore reach the colon, where it can be fermented by a large 
number of intestinal bacteria (Table 1.3). Details on fermentation rate, short chain acid 
formation and gas production are not available (Mizutani, 1989). 
In a single experiment with 6 healthy human volunteers, no statistical differences 
were observed in the faecal flora composition after ingestion of palatinose for 10 days 
(Mizutani, 1989). This single study is too limited to conclude that palatinose does not have 
an effect on the composition or activity of the intestinal microflora. 
Palatinose condensate 
Palatinose condensate (PCO), which is formed by heating palatinose under suitable 
conditions, consists of a mixture of oligosaccharides (tri- to octamers) of glucose and 
fructose. The exact composition of this melt is not known (Mizutani, 1989). 
It is not known whether all components in the condensate are non-digestible, but 
studies with human volunteers have shown effects on bacterial composition. It is thus 
likely that a substantial part of the mixture consists of non-digestible compounds. 
Fermentation of palatinose condensate has been tested with a limited number of 
bacterial species. It was observed that bifidobacteria and Bacteroides species were 
capable of fermenting the condensate to a large extent (Mizutani, 1989). 
Several studies have shown that palatinose condensate intake has an effect on 
the intestinal flora in healthy Japanese adults. An increase in bifidobacteria was 
observed, whereas all other groups remained unaffected during the test period 
(Kashimura etal., 1989; Mizutani 1989; Mizutani, 1989b). No significant changes in faecal pH and 
water content were observed during the test period, although the pH dropped from 6.3 
to 6.0 With a dose Of 24 g/day (Kashimura etal., 1989). 
A dose-response relation was observed between ingestion of palatinose 
condensate and percentage of bifidobacteria in the faeces. Without palatinose the 
percentage of bifidobacteria was around 6 %, with 2.4 g palatinose condensate per day 
this percentage increased to 10%, 4.9 g/day showed 12% bifidobacteria, whereas 10.8 
g/day increased this percentage to 22% (Mizutani, 1989b). 
It can be concluded that PCO may have a potential effect on the composition and 
the activity of the intestinal microflora. More studies are needed to prove this effect. 
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Palatinit 
Palatinit is an equimolar mixture of 6-O-a-D-glucopyranoside-D-mannitol and 6-O-a-D-
glucopyranoside-D-sorbitol (maltitol). It is prepared from palatinose by reduction of 
palatinose (Nilsson and Jagerstad, 1987). 
Palatinit is degraded slowly by human small intestinal enzymes. This indicates that 
a substantial part of the ingested palatinit will reach the colon unaltered (Nilsson and 
Jagerstad, 1987). 
Palatinit is fermented rapidly in the caecum, as can be judged from hydrogen 
production. Hydrogen production was measurable 1.5 h after digestion of 19 g palatinit. 
This value is similar to that for other polyols and lactulose (WCirsch etal., 1989). 
Stool weight and stool frequency did not change significantly after ingestion of 
palatinit (Fritz et ai., 1985). Data on fermentation by individual strains and effects on 
composition or activity of the intestinal flora, however, are not available. 
Theanderose 
Theanderose (0-a-D-glucopyranosyl-(1-6)-0-a-D-glucopyranosyl-(1-2)-B-D-fructofuranoside) is a 
naturally occurring sugar, present in honey and commercially produced using the 
fungus Mucor javanicus (Shimokawaefa/., 1995). 
It is likely that theanderose is at least partly indigestible, as in a test using human 
volunteers, it was observed that the number of bifidobacteria increased and the 
concentrations of putrefactive products (protein degradation products) was decreased 
(Shimokawa etal., 1995). 
Galactooligosaccharides 
Galactooligosaccharides are defined as oligosaccharides whose main component is 
galactose. 
Digestible galactooligosaccharides, like lactose and melibiose are not included. 
Lactitol 
Lactitol (4-O-R-D-galactopyranosyl-D-sorbitol) is a disaccharide alcohol, produced by 
hydrogenation of lactose (Booy, 1986). Lactitol is not present in nature (Harju, 1988). 
Lactitol is marketed as a non-caloric, non-cariogenic sweetener, and as a relieve agent 
against intestinal disorders, such as hepatic encephalopathy (Harju, 1988). 
Lactitol is not, or very slowly fermented by oral bacteria and does not promote 
plaque formation (Booy, 1986, chapter 3). It thus does not form a risk for caries formation. 
25 
NDOs AND INTESTINAL FLORA 
Neither is lactitol is hydrolyzed by human intestinal enzymes and thus reaches the 
caecum unaltered (Nilsson and Jagerstad, 1987, Patil et al„ 1987). Lactitol, like other sugar 
alcohols may have a laxating effect. The laxative threshold, however, is around 75 
g/day with no symptoms occurring below 40 g/day (Patil etai., 1987). 
In the colon, lactitol is rapidly fermented. Fermentation of lactitol results in the 
formation of relatively large amounts of hydrogen, higher than that of other polyols or 
lactulose. Hydrogen production from lactitol was also more rapid as compared to other 
sugaralcohols, about 1.2 h after digestion (Wursch etai, 1990, Es, van 1986, Piva etai, 1996). 
Fermentation of lactitol by individual bacterial strains has been studied by several 
research groups. It can be concluded that lactitol can be fermented by a number of 
bacterial species, from different genera, among these gas producing genera, such as 
Clostridia and enterobacteria (Kitier etai., 1992). 
Addition of lactitol to the diet of human volunteers with low initial bifidobacteria! 
counts resulted in an increase in the number of bifidobacteria as well as a reduction of 
the putrefactive products (Ballongue etai., 1997). 
The results indicate that lactitol is fermented rapidly and may thus have an effect 
on intestinal metabolism. As there are no studies with healthy volunteers available, it 
can not be concluded that lactitol has an influence on the composition of the intestinal 
microflora. 
Lactosucrose 
Lactosucrose (0-B-D-galactopyranosyl-(1 -4)-0-a-D-glucopyranosyl-(1 -2)-f3-D-fructofuranoside) or 4G-
B-D-galactosylsucrose, a raffinose isomer, is produced in Japan by action of a 
fructofuranosidase from Arthrobacter sp. on a mixture of lactose and sucrose (Terada et 
ai., 1992b). It has, as yet, not been detected in any natural food product. 
Lactosucrose is not digested by oral or intestinal enzymes to a large extent. Only 
5% hydrolysis was observed after incubation with rat intestinal acetone powder (Fujita et 
ai., 1991). Non-digestibility and fermentability of lactosucrose was confirmed by the rapid 
formation of hydrogen; increases in breath hydrogen could be observed 1-3 h after 
ingestion. Hydrogen production was similar as for maltitol or FOS (Fujita etai., 1991). 
Lactosucrose can be fermented by a number of intestinal bacteria, especially 
bifidobacteria, bacteroides and Clostridia (Fujita etai., 1991) (Table 1.3). 
Several Japanese studies have shown that lactosucrose intake in human 
volunteers may increase the number of bifidobacteria in the stools. Fujita et al. (1991) 
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used a preparation with only 55% lactosucrose and showed an increase of 
bifidobacteria in both subjects tested. 
Yoneyama et al. (1992) used a more purified preparation in 6 volunteers. In all three 
doses tested (2.0; 5.0 and 10.0 g/day) a significant increase in bifidobacteria was 
observed. No significant changes were observed in other bacterial groups, faecal pH, 
SCFA, faecal dry weight or faecal wet weight. 
Ogata et al. (1993) used a similar study design with 8 volunteers and doses of 1.0; 
2.0 and 3.0 g/day. They observed an increase in bifidobacteria with all three 
concentrations used, as well as a decrease in CI. perfringens and faecal ammonia. No 
effects could be observed on other bacterial groups, faecal wet or dry weight. Fecal pH 
had a tendency to decrease, but only at the higher dose. Fecal sulfide concentrations, 
however, increased. 
Similar results have been obtained by Ohkusa et al. (1995) in healthy volunteers, in 
several patient groups (Teramoto era/., 1996) and with animals, like cats (Terada era/., 1993), 
dogs (Terada etal., 1992b) and chickens (Terada etal., 1994). 
Even though the studies were carried out on a limited number of volunteers, the 
data suggest that lactosucrose may have an effect on either the composition or the 
metabolism of the intestinal microflora. 
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NDOs AND INTESTINAL FLORA 
Legend to Table 1.3. 
* Cel = cellobiose, MAT = maltitol, I3-CYC = B-cyclodextrin, PAL = palatinose, PCO = palatinose condensate, IMA = 
isomaltose, IMT = isomaltotriose, PAN = panose, GeOS = gentiooligosaccharides, LOL = lactitol, LAT = lactulose, 
RAF = raffinose, STC = stachyose, TOS = transgalactosyl oligosaccharides, LAS = lactosucrose, LTOS = lactitol 
oligosaccharides, GLL = galactosyllactose, FOS = fructooligosaccharides, NEP = Neosugar P (a commercial FOS 
preparation). 
** Data are compiled from a number of studies. Bacteria known to be unable to ferment any carbohydrate, but which 
have been tested, are excluded from the table. This includes the following species : CI. indolis, Eu. lentum, Eu. 
moniliforme, F. necrophorum, F. nucleatum, F. varium, P. magnus, P. micros, P. prevotii and Veilonella sp. 
+=positive fermentation in one or more studies, v=variable results in a single study, or different results between 
studies, -= no fermentation observed in any of the studies. 
Results from studies using different methodologies are compared. Studies used for the table (method of detection 
between brackets, pH = pH changes, OD = optical density at 630 or 660 nm): 
CEL : Holdeman and Moore, 1977 (GLC), CYC : Mitsuoka et at., 1987 (OD660); Antenucci and Palmer, 1984 
(pH/gas), PAL/PCO : Mizutani, 1989 (pH), IMA/IMT/PAN : Kohmoto era/., 1988 (ODeeo), GeOS : Nakakuki et al., 
1990 (pH), LOL : Kitler era/., 1992 (pH); Yanahira et al., 1995 (ODeeo), Watanabe et al., 1995 (pH), LAT : Kitler ef 
al., 1992 (pH); Ohtsuka era/., 1989 (ODeeo); Mizutani, 1989 (pH); Sahota et al., 1982 (TLC analysis) ; Kawaguchi et 
al., 1993 (gas formation), Hara et al., 1994 (pH); Watanabe et al., 1995 (pH), RAF Masai et al., 1987 (ODeso), 
Mizutani, 1989 (pH); Ohtsuka et al., 1989 (ODeeo), Holdeman and Moore, 1977 (GLC); Hara et al., 1994 (pH), : 
Masai etal., 1987 (ODeao), GLL : Ohtsuka ef al., 1989 (ODeeo); Ishikawa et al., 1995 (pH), TOS : Tanaka et al.; 1983 
(pH); Ishikawa etal., 1995 (pH), LAS Fujita etal., 1991 (ODeeo); Hara etal., 1994 (pH), LTOS : Yanahira etal., 1995 
(ODeeo), FOS : Asano etal., 1994 (pH), Hayakawa etal., 1991 (ODeeo), Wada (pH); Asano etal., 1994 (ODeeo), NEP 
: Mitsuoka etal., 1987 (ODeeo); Hara etal., 1994 (pH); Kawaguchi etal., 1993 (gas formation); Nakakuki etal., 1990 
(PH) 
Lactulose 
Lactulose (4-o-6-D-gaiactopyranosyi-D-fructose) is prepared by enzymatic or chemical 
isomerisation of lactose. Unlike lactose, lactulose is not hydrolyzed by human intestinal 
B-galactosidase and reaches the colon unaltered (Dahlquist and Gryboski, 1965). 
Lactulose is mainly marketed as a laxative and, recently, in the Netherlands in a 
product to promote intestinal health. Furthermore, lactulose is being used as a 
treatment in patients with hepatic encephalopathy and related intestinal disorders 
(Tamura etal., 1993; Terada etal., 1992a; Uribe-Esquivel, 1997). 
In the caecum lactulose is fermented rapidly, as can be concluded from hydrogen 
production. Lactulose is often used a positive marker in carbohydrate intolerance 
studies, as ingestion results in large amounts of hydrogen (Peied and Gilat, 1979; Brighenti et 
al., 1995; Kono and Nakae, 1996; Florent etal., 1985; Wursch etal., 1989; Kitler etal., 1992; Sahota ef 
al., 1982). 
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It can be concluded from a number of studies (Kitier et ai., 1992; omsuka et ai., 1989; 
Mizutani, 1989; Sahota et al., 1982; Kawaguchi et al., 1993; Hara et al., 1994; Watanabe et ai, 1995) that 
lactulose is easily fermented by the intestinal flora. It is fermented by all bifidobacteria, 
bacteroides and lactobacilli tested (Table 1.3), as well as many other bacteria. 
Gas production is relatively large on lactulose. The gas production is mainly due to 
fermentation by Clostridia (CI. butyricum, CI. paraputrificium, CI. perfringens, CI. 
sporogenes and CI. clostridioforme), as well as Kl. pneumoniae (Kawaguchi et al., 1993). 
Fermentation of lactulose in in vitro cultures by different species results in different 
end-products, mainly acetate and lactate. It was observed that a relatively large 
concentration of butyrate was produced by the faecal inoculum (Sahota et al., 1982). The 
combination of the acids indicates a fermentation in which different bacterial groups are 
involved. 
The effect of lactulose on the composition of the intestinal flora was determined 
using 8 healthy volunteers and 3 g/d of lactulose. Bacterial counts revealed an increase 
of bifidobacteria, whereas the number of bacteroides and Clostridia decreased. All other 
groups tested remained constant. Similarly indole, skatole, phenols, faecal pH, 6-
glucuronidase, nitroreductase and azoreductase activities decreased. Ammonia 
remained constant and water content increased (Terada et al., 1992a). In another study 
addition of lactulose to the diet of human volunteers with low initial bifidobacteria! 
counts resulted in an increase in the number of bifidobacteria as well as a reduction of 
the putrefactive products (Ballongue et al., 1997). 
Even though the studies are very limited, the results are an indication that 
lactulose may have an effect on both the bacterial composition and the metabolic 
activity of the intestinal flora. 
Raffinose, stachyose and other soybean oligosaccharides 
The raffinose series of oligosaccharides form a class of mixed oligosaccharides. 
Raffinose (RAF, 0-a-D-galactopyranosyl-(1-6)-a-D-glucopyranosyl-B-D-fructofuranoside), the main 
oligosaccharide in this group, is a trimer of fructose, galactose and glucose. Higher 
oligosaccharides of this group have additional galactose residues; stachyose (STC) has 
one and verbascose has two. 
As this group of oligosaccharides occur in high concentrations in nature, 
especially in legumes, they have been studied already for a long time. They play a 
major role in the flatulence problem which occurs after eating too much legumes 
(Christofaro ef al.; 1974). 
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Raffinose and its analogs are not degraded by the human digestive enzymes, and 
reach the colon unaltered. However, a small percentage of the oligosaccharides may 
be absorbed through the intestinal wall and are excreted with the urine (Christofaro et al.; 
1974, Katoefa/., 1991). 
In the colon these oligosaccharides are fermented rapidly by the intestinal flora, as can 
be judged by the formation of large amounts of hydrogen and increased flatulence, 
especially by CI. perfringens and some Bacteroides species (Myhara etai., 1988; Hayakawa, 
1990; Kono and Nakae, 1996). 
Among the species that are able to ferment raffinose and stachyose are most 
Bacteroides and Bifidobacterium species. Clostridia and other species ferment raffinose 
or stachyose, not or relatively slowly (Table 1.3) (Masai etai, 1987; Mizutani, 1989; Ohtsuka et 
al., 1989; Hoideman and Moore, 1977; Hara etai., 1994). However, data on gas formation and 
fermentation are not very consistent, which is probably due to differences in 
experimental design and variations between the strains used. Regarding B. distasonis, 
both Ohtsuka (1989) and Mizutani (1989) find positive fermentation of raffinose, whereas 
Hayakawa et al. (1990) do not find any or very limited fermentation. Both Hayakawa et 
al. (1990) as Ohtsuka (1989) use similar media and methods. Similarly, in identification 
schemes (Hoideman and Moore, 1977) several species are listed as positive in over 95% of 
the strains tested, whereas in some studies using OD or pH measurements, the same 
species is listed as negative (no fermentation) (Masai etai., 1987; Hara et a/.,1994). 
Studies with healthy Japanese volunteers have shown that ingestion of raffinose 
does increase the number of bifidobacteria in faeces, both in low (3-5 g/day) as high 
(15 g/day) doses (Benno etai., 1987; Fujisaki etai., 1994). Clostridial and bacteroides counts 
decreased significantly with the higher dose. All other bacterial groups tested remained 
unchanged. Fecal pH was somewhat reduced with the higher dose, although not 
significantly. No changes were observed in putrefactive products (Benno et al., 1987; 
Fujisaki etai., 1994). Some of the volunteers, however, initially developed diarrhea with the 
higher dose of raffinose used. The effects diminished during the study, indicating an 
adaptation of the flora (Benno etai, 1987). 
In a similar study soybean oligosaccharides were tested on 6 healthy male 
volunteers. Soybean oligosaccharides contained 23% stachyose, 7% raffinose, 44% 
sucrose and 23% other oligosaccharides. Each person ingested 10 g oligosaccharides 
per day, which corresponds with 3g raffinose and stachyose. Differences observed 
were an increase in bifidobacteria! counts and a decrease in the numbers of CI. 
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perfringens. Other bacterial groups tested remained unchanged. Similarly R-
glucuronidase and azoreductase activities decreased. No changes were observed in 
faecal moisture content and 2 of 6 volunteers showed decreased amounts of indole in 
their faeces (Masai etal., 1987, Hayakawa etal., 1990). 
Furthermore, in an in vivo study using human faecal inocula in a continuous flow 
model addition of soybean oligosaccharides resulted in an increase in bifidobacteria. Of 
the enzymatic activities tested only azoreductase was lowered significantly. 
Nitroreductase, nitrate reductase, ammonia, B-glucuronidase and 6-glucosidase were 
not changed (Saito etal., 1992). 
It can thus be concluded that ingestion of raffinose and/or raffinose containing 
soybean oligosaccharides, may have a significant effect on the composition and 
metabolic activity of the intestinal flora. 
TOS 
TOS, or transgalactosyl-oligosaccharides are produced by the action of 13-
galactosidases on lactose. The mixture consists of several di-, tri-, tetra-, penta- and 
hexasaccharides, which consist of galactose residues linked to a terminal glucose. The 
linkage may be B1-4, R1-3 or 13(1-6) (Rowland and Tanaka, 1993). Although TOS are 
produced chemically it is likely that some structures will occur in nature. TOS is being 
prepared commercially both in Japan (Oligomate, Yakult Ltd.) and in the Netherlands 
(Borculo Whey Products). The actual composition of the two preparations is very 
similar, but the relative amounts of the components differ (Van Laere, pers. comm). 
Although some minor degradation by human B-galactosidase may occur, the main 
fraction of the TOS mixture is non-digestible. The main fraction of TOS thus reaches 
the caecum, where rapid fermentation takes place, as can be judged from breath 
hydrogen increases (Tanaka et al., 1983; Ishikawa et al., 1995; Kikuchi et al., 1996; Kondo and 
Nakae, 1996; Bouhnik, 1997). 
TOS can be fermented to some extent by a number of intestinal bacteria, 
especially bifidobacteria, bacteroides, enterobacteria and lactobacilli (Table 1.3) (Tanaka 
etal., 1983; Ishikawa etal., 1995). 
Trials with Japanese volunteers have shown that ingestion of TOS, or TOS 
enriched in disaccharides increases the number of bifidobacteria in the faeces (Tanaka et 
al., 1983; Ito etal., 1990; Ito etal., 1993; Ishikawa etal., 1995). 
The increase in bifidobacteria showed a linear relation to the dose of TOS used 
(ito etal., 1990). Fecal ammonia, stool weight and stool frequency were not affected. No 
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signs of diarrhea were observed in doses of up to 10 g/day (Tanaka era/., 1983; ito etai., 
1990). Simultaneous ingestion of TOS and Bi. breve did not affect the number of 
bifidobacteria, but reduced the number of bacteroides and enterobacteria. However, in 
this case some reduction in faecal ammonia was observed (Tanaka et ai, 1983). 
Two other studies also showed an increase in bifidobacteria after administration of 
TOS, but in both cases the initial bifidobacteria! numbers were rather low (ito era/., 1993; 
Bouhnikefa/., 1997). 
Finally a well controlled study using a large number of volunteers did not show any 
effect of TOS on the bacterial composition (Alles et ai, in press). 
Effects on the intestinal metabolism were studied using specific enzymes as 
markers. Rats associated with a human faecal flora were fed a diet with 5% TOS. 
Caecal pH was reduced, as were the activities of 6-glucuronidase and nitrate 
reductase. Both enzymes are associated with toxic effects on the host. Similarly the 
conversion of the dietary carcinogen IQ to its genotoxic 7-hydroxy derivative was 
reduced. On the other hand (3-glucosidase activity was increased (Rowland and Tanaka, 
1993). 
Lactitol-oligosaccharides 
Lactitol-oligosaccharides (LTOS) are prepared by transgalactosylation using Aspergillus 
oryzae (3-galactosidase and lactitol as starting carbohydrate. The resulting mixture 
consists of several different components, all with a terminal sorbitol residue. 
LTOS are non digestible in rats, but have not yet been tested in human studies. 
LTOS can be utilized by a number of intestinal bacteria (Table 1.3) among these 
bacteria from several genera (Yananira et ai, 1995). 
Increased numbers of bifidobacteria were observed in rat faeces after feeding 1-3 
weeks of LTOS. Similarly peptococci increased, but no changes in other bacterial 
groups were observed. Concentrations of indole and cresol decreased significantly 
(Yanahira era/., 1995). 
These results indicate that LTOS may have an effect on the composition and the 
metabolic activity of the intestinal flora of rats, but data on humans are not available. 
4 '-Galactosyllactose 
Galactosyllactose (GLL, 0-D-galactopyranosyl-(1-4)-0-G-D-galactopyranosyl-(1-4)-D-glucopyranose) 
is produced in Japan by the action of Cryptococcus laurentii on lactose. The product is 
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marketed as Cup-oligo powder or syrup. This preparation also contains traces of the 
tetramer (gal)3-glu (Playne and Crittenden, 1996). 
Galactosyllactose appears to be unaffected by human intestinal enzymes as 
feeding trials with human volunteers have shown an increase in bifidobacteria in the 
faeces. 
Galactosyllactose can be fermented by a number of intestinal species (Table 1.3), 
especially bifidobacteria and bacteroides. None of the Clostridia, lactobacilli, enterococci 
or E. co//'were able to ferment galactosyllactose (Ohtsuka era/., 1989; ishikawa etal., 1995). 
Studies with 10 healthy human volunteers who received 8 g/day of GLL for 10 
days showed a significant increase in the number of bifidobacteria. No changes in other 
bacterial groups were observed. Fecal pH decreased in most subjects during the trial 
period (Ohtsuka etal., 1989). 
Although the data are rather limited, it is not unlikely that GLL may have an effect 
on either the composition or the metabolic activity of the human intestinal microflora. 
Synthetic galactooligosaccharides 
Synthetic galactooligosaccharides were prepared chemically by means of the Koenigs-
Knorr reaction (Minami et ai., 1985). Several products were prepared this way, namely 
neogalactobiose (NGB), isogalactobiose (IGB), galsucrose (GAS), three lactose 
isomers, Isolactose I (IL1) ((3-D-galactopyranosyl-B-D-glucopyranoside), Isolactose II (IL2) (R-D-
galactopyranosyl-a-D-glucopyranoside) and Isolactose III (IL3) (a-D-galactopyranosyl-B-D-
glucopyranoside) as well as a trimer, GFF (a-D-galactopyranosyl-ra-D-fructofuranosyl-(2-6)-B-D-
fructofuranoside) (Minami etal., 1983; Minami etal., 1985). 
It is not known whether these compounds are digested in the upper 
gastrointestinal tract. These products have not been tested for their influence on the 
intestinal flora in human or animal trials. 
Fermentation by individual intestinal bacteria has shown that all substrates could 
be fermented by the 5 bifidobacteria and the Klebsiella species tested. Lactobacillus 
acidophilus and enterococci were not able to ferment any of the compounds, all E. coli 
strains could utilize only NGB, but some strains also utilized IGB, IL1, IL3I and GAS 
(Minami etal., 1983; Minami etal., 1985). 
It was claimed that the use of these oligosaccharides may have some bifidogenic effect, 
even though other species grew well on these oligosaccharides. Also, these 
oligosaccharides have not yet been tested on other anaerobic species like Bacteroides 
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sp. or Clostridia. As these substrates have as yet not been tested on humans or 
animals, their actual bifidogenic effect is still unknown. 
Fructooligosaccharides 
Fructooligosaccharides (FOS) are oligosaccharides, with fructose as the major 
monomeric residue. 
Two different classes of FOS mixtures are produced commercially, based on inulin 
degradation or transfructosylation processes. As the chemical structure of the mixtures 
does not differ significantly, the two types will be discussed in one paragraph. 
FOS can be produced by degradation of inulin, or polyfructose, a polymer of D-
fructose residues linked by 13(2-1) bonds with a terminal ot(1-2) linked D-glucose. The 
degree of polymerization of inulin ranges from 10-60. Inulin can be degraded 
enzymatically or chemically to a mixture of oligosaccharides with the general structure 
Glu-(Fru)n (GFn) and Frum, (Fm), with n,m ranging from 1 to 7 (Playne and Crittenden, 
1996). This process also occurs to some extent in nature, and these oligosaccharides 
can be found in a large number of plants, especially in Jerusalem artichoke and chicory 
(Roberfroid et al., 1993; Campbell etal., 1997). This type of FOS is prepared commercially by 
Orafti Ltd., Tienen Belgium, which markets the product as Raftilose. It has also been 
referred to as oligofructose, a term which also includes pure inulin. The main 
components are kestose (GF2), nystose (GF3), fructosylnystose (GF4), bifurcose (GF3), 
inulobiose (F2), inulotriose (F3) and inulotetraose (F4). 
The second class of FOS is prepared by the transfructosylation action of a 13-
fructosidase of Aspergillus niger on sucrose. The resulting mixture has the general 
formula of GFn with n ranging from 1 to 5. Contrary to the inulin derived FOS, the 
binding is not only 6(1-2), but other linkages do occur, though in limited numbers. This 
group is produced in Japan by Meiji Seika Kaisha LTD and marketed as Meioligo, 
Neosugar, Profeed, Actilight or Nutraflora (Hidaka et al., 1986, Thiriet, 1989; Spiegel et al., 
1994). 
Some reviews have been published previously on FOS describing the production, 
functionality and nutritional effects in more detail (Fishbein et al., 1988; Hidaka et al., 1986, 
Roberfroid, 1991; Hidaka etal., 1990; Hidaka etal., 1991; Hidaka and Hirayama, 1991). 
FOS can be fermented by human oral bacteria, and can thus be considered cariogenic 
(Chapter 2). 
Human intestinal enzymes do not, or very slowly, degrade FOS. This was 
determined using rat tissue homogenates (Oku, 1984), ileostomy patients (Mies etal., 1997) 
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and human breath hydrogen measurements (Mies et ai., 1996; Mies et ai., 1997, Fujita et ai., 
1991). 
FOS are degraded and fermented rapidly by the intestinal flora. Many different 
species of intestinal bacteria are capable of fermenting FOS, among these 
bifidobacteria, lactobacilli, Clostridia, enterobacteria, bacteroides and several others 
(Tables 1.3 and 1.4) (Asano etal., 1994; Hayakawa et ai, 1991; Wada 1990.; Asano et ai, 1994; 
Mitsuoka etal., 1987; Hara etal., 1994; Kawaguchi etal., 1993; Nakakuki etal., 1990; Hartemink etal., 
1997). 
Different studies often find contradictory results regarding the fermentation of the 
different FOS-components by strains of the same species. This is most often due to the 
strains and methodology used. Bailey et ai (1991) observed no growth on FOS by 
different enterobacteria, using OD-measurements and a medium poor in nutrients, 
whereas other groups observed growth (Wang and Gibson, 1993) or fermentation (Hartemink 
et ai, 1997). Similarly, several reports show no growth on FOS by CI. perfringens 
(Mitsuoka et ai, 1987), whereas other groups observe good growth and gas formation by 
different Strains Of this Species (Wang and Gibson, 1993; Hartemink and Rombouts, 1997). 
Methodology and growth conditions thus are important in determining the possible 
fermentation of FOS by a selected strain. 
Gas formation has been observed by different groups (Wang and Gibson, 1993; 
Kawaguchi etal., 1993; Hartemink and Rombouts, 1997), as well as an increase in flatulence and 
gastrointestinal complaints (Stone-Dorshow and Levitt, 1987). Gas formation was mainly due 
to CI. sporogenes, CI. clostridioforme and Kl. pneumoniae (Kawaguchi ef ai, 1993) and CI. 
perfringens (Hartemink and Rombouts, 1997; Kolsteren, 1997). 
Studies using faecal slurries have observed production of short-chain fatty acids 
and a relatively high production of butyrate. Faecal pH was decreased in some animal 
studies. Changes in enzyme patterns have also been observed by different groups. 
Ingestion of FOS was also shown to have an effect on the microbial composition in 
humans, pigs, rats and other animals, often an increase in bifidobacteria was observed 
(Mitsuoka era/., 1987; Howard et ai, 1995; Bouhnik et ai, 1996; Gibson and Wang, 1993), whereas 
the other bacterial groups tested were unaffected. 
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Table 1.4 Specific growth rates of selected intestinal bacteria on FOS and glucose 
species 
Bi. adolescentis 
Bi. angulatum 
Bi. bifidum 
Bi. breve 
Bi. catenulatum 
Bi. infantis 
Bi. longum 
Bi. pseudolongum 
CI. perfringens 
E. coli 
FOS* 
(AOD/h) 
0.160 
0.261 
0.183 
0.204 
0.270 
0.297 
0.208 
0.303 
0.216 
0.212 
glucose* 
(AOD/h) 
0.124 
0.218 
0.180 
0.132 
0.201 
0.173 
0.215 
0.243 
0.259 
0.242 
* Data adapted from Wang and Gibson, 1993 measured as OD650 in a stirred chemostat kept at pH 7.0 in PY broth + 
0.5% carbohydrate. Measurements in triplicate on a single strain 
Even though many of the human studies have been carried out with special 
populations, like older patients (Mitsuoka etal., 1987, Mitsuoka etal., 1986), people with very 
low initial bifidobacteria counts (Bouhnik et ai., 1996) or diabetics (Sanno, 1986), the data 
indicate that addition of FOS affect the bacterial composition and the metabolic pattern 
of the intestinal microflora. 
The increase of bifidobacteria, however, is not consistent with the increase in gas 
formation (Wang and Gibson, 1993; Kawaguchi ef a/., 1993; Hartemink and Rombouts, 1997) Or 
butyrate production, as bifidobacteria produce neither gas nor butyrate (Sgorbati et ai., 
1995). FOS thus are not selectively fermented by bifidobacteria as has been stated 
previously (Roberfroid et ai., 1993). The increase in bifidobacteria may be a combined 
effect of growth by these bacteria as well as a reduced transit time with subsequent 
better recovery of bifidobacteria in faeces. 
Synthetic oligosaccharides 
These oligosaccharides are synthesized completely by chemical, non-enzymatic, 
methods. Often they do not resemble natural oligosaccharides and are synthesized as 
possible non-digestible non-caloric bulking agents. As yet none of these 
oligosaccharides have been tested on individual bacterial strains. A number of these 
38 
NDOs AND INTESTINAL FLORA 
compounds have been tested on faecal slurries and fermentation was measured by 
acid and gas production. It was found that sorbitol derivatives (like 2,3,4,6-tetra-o-G-D-
giucopyranosyi-D-sorbitoi) and other highly branched oligosaccharides could be fermented 
slowly with the production of some acid and gases. Also, all the hexoses with a 5-C-
hydroxymethyl group were found to be completely non-fermentable, suggesting a 
critical role for this group in metabolism (Mazur etai., 1993). 
As fermentation of these groups was found to be very slow, no significant effects 
on the intestinal flora will be expected. 
Xylooligosaccharides 
Xylooligosaccharides are prepared by enzymatic degradation of xylan by a xylanase 
from Trichoderma sp.. The resulting mixture consists of xylobiose, xylotriose, 
xylotetraose and xylopentaose (imaizumi et ai., 1991; Cotta, 1993). Xylobiose is naturally 
present in bamboo shoots, which are consumed in Japan and China (imaizumi et ai., 
1991). 
Xylooligosaccharides are not fermented by the human intestinal enzymes and 
reach the colon intact. In the colon, xylooligosaccharides are fermented by a number of 
species, among them most bifidobacteria, several Clostridia, Bacteroides species, E. 
CO//and some lactobacilli (Okazaki etai, 1990; Van Laere et ai, 1997). 
In a study using 5 male volunteers, it was observed that addition of 
xylooligosaccharides increased the number of bifidobacteria in the faeces. No changes 
were observed in other bacterial groups (Okazaki etai, 1990). 
Changes in the metabolic pattern of the intestinal microflora have been observed 
in rats, but as yet not in human feeding trials (Hoshi etai, 1994; imaizumi etai, 1991; Campbell 
ef ai, 1997). The results indicate that addition of xylooligosaccharides in the diet may 
have an effect on either the composition and/or the metabolic activity of the intestinal 
microflora. 
Alginate oligosaccharides 
This group consists of oligosaccharides prepared by enzymatic degradation of alginate 
and are rich in mannuronic and guluronic acid residues. The oligosaccharides tested 
could be distinguished in high mannuronate-oligosaccharides and high guluronate-
oligosaccharides. Only seven intestinal bacteria were tested for growth on these two 
groups and growth was compared with glucose. Growth was poor for Bi. infantis, Bi. 
breve, Bi. longum, Lb. acidophilus and Ec. faecalis, whereas B. thetaiotaomicron and 
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CI. perfringens were not able to use these oligosaccharides for growth (Kitamikado et at., 
1993). 
Even though these oligosaccharides are poorly fermented by bifidobacteria, a 
bifidogenic effect has been observed by Terada et al. (1995) in healthy human 
volunteers. 
Due to the limited data available, it is difficult to estimate whether alginate 
oligosaccharides have an effect on either the metabolism or the composition of the 
intestinal microflora. 
Mucin-derived oligosaccharides 
These oligosaccharides are produced in the upper intestine from the gastrointestinal 
mucosal glycoproteins. Mucin-derived oligosaccharides differ widely in structure, but 
are characterized by a complex composition, with many different monosaccharide 
building blocks, and different charged side chains. 
In the human intestine only a few Ruminococcus and Bifidobacterium strains were 
found to be the most active in degradation of human ABH blood group antigens ( a 
group of mucin-derived oligosaccharides). The 16 other bacteria tested, among them 
Bacteroides species, E. coli, Ec. faecalis and several other bifidobacteria did not 
degrade these products (Hoskins et al., 1985; Hoskins et al., 1992). These oligosaccharides 
have not yet been used in human or animal trials. 
Mannooligosaccharides 
Mannooligosaccharides are oligosaccharides, with mannose as the main component 
sugar. Two types of mannooligosaccharides can be distinguished; yeast derived 
mannooligosaccharides and guar gum hydrolysates (galactomannan hydrolysates). The 
latter will be dealt with in Chapter 5. 
Commercial mannooligosaccharides are marketed by Alltech as a crude powder, 
with less than 50% oligosaccharides. These oligosaccharides have been successfully 
used in the animal feed industry as a growth promoter (Kumprecht etai., 1997; Jacques et al., 
1997). There are no data available on the fermentation of these oligosaccharides either 
by individual bacterial strains, or from human feeding trials. 
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SUMMARY 
Fructooligosaccharides (FOS) are claimed to have a positive effect on the intestinal flora. They 
are being used in functional foods in Japan and Europe. The degradation of two commercial FOS 
preparations by oral streptococci in order to predict the cariogenicity of these products was 
studied. Both preparations could be fermented to some extent by the species of oral streptococci 
tested. 
The enzymes necessary for the degradation of FOS were inducible. Each strain showed a 
specific degradation pattern. All strains, particularly St. mutans rapidly produced acid, mainly lactic 
acid. St. mitis also produced high concentrations of acetic acid. Plaque formation by St. mutans 
was similar to the sucrose control. It is concluded that FOS are cariogenic to a similar extent as 
sucrose. 
INTRODUCTION 
Fructooligosaccharides are a group of oligosaccharides, consisting of several (3(1-2) or 
6(1-6) linked fructose residues (Fn-series), which may be linked to a glucose residue 
(GFn-series). Two FOS mixtures are available commercially, 'Profeed' and 'Raftilose'. 
Profeed is produced enzymatically from sucrose using a fungal fructosyltransferase. The 
final product consists of a mixture of linear and branched oligosaccharides of the GFn-
series. The product has been marketed as 'Neosugar', 'Meioligo1, 'Actilight' or 'Nutraflora' 
(Hidakaefa/.,1990). 
Raftilose is produced enzymatically from inulin using an endo-inulinase. The final 
product consists of a mixture of linear oligosaccharides from both the GFn-series and the 
Fn-series. This product has also been referred to as 'Oligofructose' (Roberfroid era/., 1993). 
FOS are not degraded by the human digestive enzymes and thus reach the colon 
unaltered (Hidaka era/., 1990). It has been shown for both commercial mixtures that a daily 
intake of FOS results in an increase of faecal bifidobacteria (Mitsuoka era/., 1987; Wang and 
Gibson, 1993). An increase in faecal bifidobacteria is claimed to have a beneficial effect on 
health. FOS are therefore used as a health promoting agent in 'functional foods' (Spiegel er 
a/., 1994). 
As FOS are widespread in nature, they are considered in food legislation as 
ingredients, rather than additives. In Japan this has resulted in the addition of FOS to a 
large range of products (Spiegel era/., 1994). 
As FOS are used in many food products it is likely that some product remains in the 
oral cavity after consumption. It is therefore possible that FOS are degraded by the oral 
microflora and that, consequently, they may be cariogenic. It is well known that oral 
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streptococci produce several fructanases, which can degrade inulin and other fructans 
(Hamada and Slade, 1980; Walker etal., 1983; Takahasi etal., 1985; Burne etal., 1987). 
Nystose (GF3), one of the components in both Raftilose as Profeed, has been 
shown to be non-cariogenic (Hirasawa etal., 1984; ikeda etal., 1990), however, Ziesenitz and 
Siebert (1987) came to the opposite conclusion. Neosugar (Profeed) has been shown to 
be non-cariogenic, although some acid is produced by oral streptococci (Hirasawa et al., 
1984). 
Among the genera present in the oral cavity, the streptococci are considered to be 
the main cariogenic group of bacteria. We have therefore tested the degradation of FOS 
by members of this group, mainly St. mutans to predict the cariogenicity of this group of 
oligosaccharides. 
MATERIALS AND METHODS 
Bacteria 
The following strains of oral streptococci were obtained from Dr. F.H.M. Mikx, Dept. of 
Oral Microbiology, Catholic University of Nijmegen, The Netherlands: St. mutans 44 (Nijm. 
591), St. oralis 45 (Nijm. 592), St. mitis biovar I 46 (Nijm. 593), St. sanguis biovar I 43 
(Nijm. 594) and St. gordonii biovar II 42 (Nijm. 595). In addition St. mutans 36 (DSM 
20523) was used. For the induction studies a Streptococcus strain was isolated from 
saliva of a human volunteer. It was identified as St. salivarius, using the Rapid ID 32 
Strep and the APILAB identification program (Bio-Merieux, Marcy-l'Etoile, France). 
Oligosaccharides 
Raftilose P95 was obtained from Orafti (Tienen, Belgium). Profeed P95 was obtained 
from Nutreco (Boxmeer, The Netherlands). Both preparations consisted of at least 95% 
(P95) oligosaccharides according to the manufacturers. The remaining part consists of 
glucose, fructose and sucrose. 
Screening 
FOS agar was used to screen for growth and acid formation of oral isolates. FOS agar 
consisted of Buffered Peptone Water (Oxoid) to which were added (gl1): Raftilose P95 
15, agar technical (Oxoid) 15, yeast extract (Oxoid) 5 and chlorophenol red (Merck) 0.05. 
Only Raftilose P95 was used, as most components of Profeed P95 are present in 
Raftilose P95 as well. Appropriate dilutions of the strains, pre-grown in Peptone-Yeast 
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extract broth supplemented with glucose (PY-G) were applied to FOS agar plates. PY-G 
was prepared according to Holdeman and Moore (1977). Growth was considered positive 
when the colony size was over one mm diameter. Acid production was considered 
positive when a yellow zone was formed around the colony. Raftilose P95 contains some 
fermentable mono- and disaccharides. Acid formation due to fermentation of these 
compounds was neutralized by the buffer in the medium. Any yellow discoloration is 
therefore due to fermentation of oligosaccharides. The plates were incubated at 37EC 
anaerobically, using an atmosphere of 80% nitrogen, 10% hydrogen and 10% carbon 
dioxide (HoekLoos, Rotterdam, The Netherlands). 
Induction 
Induction was studied using a St. salivarius strain which showed slow growth and slow 
acid production on FOS agar (i.e. no yellow zone within 24 h). The strain was cultured in 
25 ml PY-G. After 24 h 100 uJ was inoculated into 25 ml PY-broth with 0.5% Raftilose P95 
(PY-Raf). This strain was subsequently subcultured daily in PY-Raf for 7 days. 
Growth curves were determined by adding 25 ul of a 24 h PY-G culture to 250 |il 
PY-G and PY-Raf, respectively, in a microtiter plate. Similarly 25 uJ of a 24 h old culture of 
St. salivarius subcultured 7 times on PY-Raf was added to PY-Raf. Growth curves were 
determined by measuring the absorbance at 620 nm every 15 minutes for 11 hours in a 
microtiterplate reader (EAR 400, SLT Instruments, Groedig, Austria). 
Acid formation 
Acid formation was studied by culturing the following strains in HPLC-broth : St. /nutans 
36, St. mutans 44, St. oralis 45, St. mitis 46, St. sanguis 43 and St. gordonii 42. HPLC 
broth is a medium which minimizes interference on the HPLC, it consists of (gf1): 
neutralized bacterial peptone (Difco) 5, yeast nitrogen base (Difco) 6, dipotassium 
hydrogen phosphate (anhydrous, Merck) 13, Raftilose P95 or Profeed P95 5. The pH was 
adjusted to 7.0 using 3 moll"1 sodium hydroxide before sterilization for 15 min at 121°C. 
The strains were pre-cultured on PY-G for 16 h. All strains were grown anaerobically for 
60 h at 37°C. Samples were taken at 12 h intervals for St. mutans 36 and after 60 h for 
the other strains. 
The samples were centrifuged for 15 min at 10.000 rpm to precipitate the cells. 
Lactic and acetic acids were determined using HPLC with an Aminex HPX-87H column 
and 0.01 mol I"1 sulfuric acid as the mobile phase (voragen etai., 1986). 
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Rapid acidification 
For the rapid acidification experiments St. mutans 36 was precultured for 16 h in PY-G. 
Cells were harvested by centrifuging 100 ml culture and washed twice with reduced 
peptone physiological salt solution (RPFS). RPFS consisted of (gl"1): neutralized bacterial 
peptone (Difco) 1.0, sodium chloride (Merck) 8.5 and cysteine.HCI (Sigma) 0.5. The pH 
was adjusted before sterilisation to 6.7 with 3 mol I"1 potassium hydroxide. After the 
second washing the cells were resuspended in 5 ml RPFS. For acidification tests 500 JLLI 
carbohydrate or carbohydrate/RPFS mixture was added to 5 ml RPFS. The mixture was 
placed in an incubator and the pH was measured continuously. When the pH was 
stabilized 500 nJ cell suspension was added and the pH was measured continuously for 
at least 30 min. 
Fermentation patterns 
Fermentation patterns were determined by growing all strains anaerobically at 37°C in 
HPLC-broth supplemented with 20 gl"1 of Raftilose P95 for 60 h. Profeed P95 was not 
used in this experiment, as most components of Profeed P95 are present in Raftilose 
P95. After 60 h a sample (one ml) was taken and centrifuged at 10.000 rpm to precipitate 
the cells. Residual Raftilose P95 was analysed using High Performance Anion Exchange 
Chromatography (HPAEC). HPAEC was performed using a BIO-LC system (Sunnyvale, 
California, USA), equipped with a Dionex Carbopac PA-100 (4x250 mm) column and a 
Dionex pulsed electrochemical detector in the pulsed amperometric detection method 
(Voragen etai., 1986). The oligosaccharides were analyzed using a gradient of 0 to 1.0 mol I" 
1
 sodium acetate in 100 mmol I"1 sodium hydroxide. 
Artificial plaque formation 
Plaque formation was studied using St. mutans 36. The strain was pre-cultured 
anaerobically at 37°C for 24 h in PY-G broth. Plaque formation was determined using the 
procedure described by Hirasawa et al. (1984). PY supplemented with 10% Profeed, 
Raftilose or sucrose was used. In a second experiment 0.1 mol I"1 potassium dihydrogen 
phosphate was added and the pH adjusted to 7.0 using 3 mol I"1 sodium hydroxide. 
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RESULTS 
Screening 
All oral streptococci were able to grow on FOS agar. Good growth was observed within 24 
h for all strains except St. sanguis 43, which showed good growth only after 48 h (Table 
2.1). Acid production started within 24 h for St. mutans 36 and St. mitis. All strains 
showed acid production after 3 days, except for St. oralis which showed only weak acid 
production. 
Similarly, FOS agar plates inoculated with samples of saliva from 40 healthy 
volunteers and 4 healthy piglets, all showed acid production and good growth within 48 h. 
Induction 
The induction experiments with a slow-growing St. salivarius strain showed that the 
production of FOS-degrading enzymes is inducible. Fig 2.1 shows that the main effect is 
a reduced lag-phase, indicating the induction of the necessary enzymes. The growth rate 
was unaffected by induction. 
Table 2.1 : Growth of oral streptococci on FOS agar, containing 1.5% Raftilose P95. 
Strain 
St. gordonii 42 
St. mitis 46 
St. mutans 36 
St. mutans 44 
St. oralis 45 
St. sanguis 43 
growth 
++ 
++ 
++ 
++ 
+-
-
day 1 
acid 
+ 
+ 
+ 
+ 
-
-
growth and acid production after 
day 2 
growth 
++ 
++ 
++ 
++ 
++ 
++ 
acid 
++ 
++ 
++ 
+ 
-
+ 
day 3 
growth 
++ 
++ 
++ 
++ 
++ 
++ 
acid 
++ 
++ 
++ 
++ 
+ 
+ 
: growth ++ colony size over 1 mm diameter, + colonies small but clearly visible, +- colonies barely visible, 
- no visible colonies 
acid ++ yellow zone around colonies, + orange to yellow zone, - no zone around colonies 
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Acid formation 
All strains showed production of both lactic and acetic acids (Table 2.2). Lactic acid was 
generally present in higher concentrations than acetic acid. Most acid was produced by 
St. gordonii, St. mutans 36 and 44 and St. mitis. These strains also showed the fastest 
production of acid in the screening experiment. St. mitis also produced a relatively high 
concentration of acetic acid, indicating heterofermentative fermentation. 
St. mutans 36 showed slower growth on Profeed, which resulted in lower concentrations 
of acid after 60 h. St. mutans 36 produced similar amounts of acid on Raftilose as on 
sucrose, indicating a similar and rapid fermentation. 
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Fig. 2.1 : Induction of growth of St. salivarius on Raftilose P95. 
St. salivarius was grown on PY-G. After 24 h the strain was subcultured in PY-Raf. This procedure was 
repeated every 24 h. Growth of the following cultures in PY-Raf was measured in a microtiter reader with 
absorbance at 620 nm : pre-grown on PY-G only (open rectangles), subcultured once on PY-Raf (crosses), 
subcultured twice on PY-Raf (triangle), subcultured three times on PY-Raf (line only) and four times of PY-
Raf (closed rectangles) 
Rapid acidification 
Acid formation was very rapid as could be concluded from this experiment. A critical pH 
for dental caries of 5.5 was reached within 15 minutes for glucose as well as both FOS 
preparations (Fig 2.2). With a lower concentration of Raftilose (2.3 mmol I"1) the critical pH 
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was reached within 30 minutes. No acid was produced in the absence of a fermentable 
carbohydrate. 
Table 2.2 : Acid formation on 0.5 % Raftilose P95 and Profeed P95 by oral streptococci in HPLC 
broth. 
Strain 
St. gordonii42 
St. mitis 46 
St. mutans 36 
St. mutans 44 
St. oralis 45 
St. sanguis 43 
time of 
incubation (h) 
60 
60 
12 
24 
36 
48 
60 
60 
60 
60 
lactic acid 
(mmol I'1) 
107.0 
49.6 
1.1 
58.4 
105.3 
115.4 
123.7 
124 
38.2 
41.2 
acetic acid 
(mmol I"1) 
6.9 
38.4 
9.7 
13.6 
12.9 
12.4 
10.3 
8.9 
10.3 
11.8 
Acid production was determined using HPLC. See Materials and Methods section for details. 
Fermentation patterns 
The fermentation patterns of the different strains are shown in Figure 2.3. It is clear that 
the strains degrade the FOS mixture differently. The only common factor is a complete 
fermentation of sucrose (GF, at 11.5 minutes). St. mutans 44, St. gordonii and St. mitis 
showed the most extensive degradation. This is in accordance with both the screening 
and the acid formation experiments. 
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20 30 
Time in minutes 
Figure 2.2 : Rapid acidification by St. mutans 36. 
Cells of St. mutans 36 pregrown in PY-G for 16 h were washed twice with RPFS and added to 500 nl RPFS 
containing 23 mol 11 carbon sources : (rectangles) no carbon source added, (crosses) glucose, (circles) 
Raftilose and (triangles) 2.3 mol I"1 Raftilose. 
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Figure 2.3: Change in composit ion of Rafti lose upon fermentat ion by oral streptococci. 
Composition patterns were determined by HPLC. For experimental conditions see Materials and Methods 
section. Lower line: Raftilose, Middle line: Raftilose after fermentation by St. gordonii 42, Upper line: Raftilose 
after fermentation by St. mitis 46. 
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St. gordonii degraded the higher oligosaccharides, both Fn and GFn series (Table 
2.3), thereby producing fructose, F2 and GF2. The intermediate structures F3 and GF3 
seemed to be unaffected, or their degradation and formation rates are in equilibrium. 
Similarly, glucose levels seemed to be unaffected. This may also be due to a preference 
for fructose by St. gordonii. 
St. sanguis showed only limited degradation of Raftilose. Only GF5 and F4 were 
degraded completely. In contrast to St. gordonii, no fructose accumulation was observed. 
On the other hand an accumulation of F3 was observed, probably due to hydrolysis of a 
fructose residue from F4. 
St. mutans 44 showed no production of GF2, which may be due to a better, more 
extensive degradation. Similarly no glucose could be detected. Large amounts of fructose 
and F2 were detected. 
The degradation with time by St. mutans 36 differed from the pattern of strain 44, in 
that GF3 was degraded as rapidly as the other components. Similarly no increase in F3 
was observed. From the data (Table 2.4) it can be seen that all components were 
degraded rapidly, the Fn series somewhat faster. Increases in fructose and glucose were 
only observed after 36 hours. St. oralis showed very limited degradation. Only glucose, 
sucrose and GF2 were degraded. Surprisingly no changes in fructose were observed. 
St. mitis showed again extensive degradation. In contrast to St. gordonii and St. 
mutans 44 no degradation of GF3 or higher was observed. All linear fructose oligomers (F 
to F4) were degraded completely, as were sucrose and GF2. No accumulation of fructose 
could be detected. Glucose concentrations remained unaffected, similarly as in St. 
gordonii. 
Artificial plaque formation 
Plaque formation was determined using St. mutans 36. The results (Table 2.5) show that 
Raftilose induces the formation of plaque as rapidly as does sucrose. Growth and 
formation of plaque on Profeed was considerably slower. However, after three days of 
incubation, the difference was negligible. Use of a phosphate buffer, which was added to 
imitate the conditions in the mouth more accurately, clearly influenced the formation of 
plaque. The amount of plaque formed with Raftilose as a substrate even surpassed the 
amount formed with sucrose. 
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Table 2.3 : Changes in carbohydrate-pattern after incubation of 2% Raftilose P95 by oral 
streptococci. 
Strain 
St. gordoniiAZ 
St. sanguis 43 
St. mutans 44 
St. oralis 45 
St. mitis 46 
G 
/** 
/ 
-
-
— 
GF 
... 
... 
-
... 
... 
GF2 
+ 
/ 
-
-
/ 
GF3 
/ 
/ 
/ 
/ 
-
Compound* 
GF4 
-
/ 
-
/ 
/ 
GF5 
--
-
--
/ 
/ 
F 
+++ 
-
+++ 
/ 
+ 
F2 
++ 
/ 
++ 
/ 
... 
F3 
/ 
+ 
/ 
/ 
-
F4 
-
-
--
/ 
-
Fn 
-
/ 
-
/ 
/ 
* G = glucose unit, Fx = number (x) of fructose units, n = more than 4 fructose units 
**/: no visible changes, - some degradation (<20%), - degradation (20-75%), — : complete degradation, + 
slight increase (<20%), ++ clear increase (20-100%), +++ considerable increase (>100%) 
Increases are due to degradation of larger oligosaccharides and incomplete fermentation. 
Table 2.4: Changes in carbohydrate pattern after incubation of 2% Raftilose P95 by St. mutans 
36. 
component 
G* (glucose) 
F (fructose) 
GF (sucrose) 
GF2 (kestose) 
F2 
GF3 
F3 
GF4 
F4 
GF5 
0 
100 
100 
100 
100 
100 
100 
100 
100 
100 
100 
24 
0 
0 
0 
19 
0 
23 
0 
24 
0 
27 
time (h) 
36 
133 
1409 
6 
29 
0 
4 
0 
1 
0 
0 
42 
100 
200 
0 
0 
0 
0 
0 
0 
0 
0 
* G = glucose units, Fx = number (x) of fructose units 
Values were determined using HPLC. For experimental details see Materials and Methods section. Values 
are relative percentages as compared to T=0. 
Increases are due to degradation of larger oligosaccharides and incomplete fermentation. 
51 
FOS AND ORAL FLORA 
Table 2.5 Artificial plaque formation by St. mutans 36. Values are average of duplicate 
measurements. 
Carbon source 
(10%) 
sucrose 
sucrose + buffer" 
Raftilose P95 
Raftilose P95 + buffer 
Profeed P95 
day 1 
(mg plaque) 
11 
15 
12 
18 
8 
day 2 
(mg) 
14 
16 
10 
22 
5 
day 3 
(mg) 
16 
25 
18 
34 
13 
: buffer was 0.1 mol I KH2P04, pH adjusted to 7.0. 
Plaque formation was determined by growing St. mutans 36 on the carbon source in pre-weighed plastic 
tubes. After growth the tubes were emptied, dried and weighed again. 
DISCUSSION 
Fermentation of fructooligosaccharides is very common among oral streptococci as can 
be concluded from our experiments. The presence of FOS fermenting streptococci is 
widespread among the population, as saliva of 40 volunteers and 4 piglets contained 
strains which were able to degrade FOS (data not shown). None of the volunteers or the 
piglets had ever consumed commercial FOS, as at the moment of the trial no products 
with added FOS were on the Dutch market. It has been shown previously (Walker et 
a/.,1983) that oral streptococci possess fructanases. These fructanases are able to 
degrade levan- as well as inulin-type fructans. As the main fraction of FOS are oligomers 
of the inulin-type, it is not surprising that all the strains tested were able to degrade FOS. 
The FOS-degrading enzymes may be inducible, as was shown for a strain of St. 
salivarius. This has also been demonstrated previously for St. mutans using D-fructans as 
a substrate (Burne era/., 1987). 
Various streptococci degraded FOS in a different way. Especially St. mutans and St. 
gordonii showed extensive degradation of all oligomers. St. mitis, however, showed 
mainly degradation of the Fn series, and hardly any degradation of the GFn series. This 
was surprising, as in a previous study no strains of St. mitis seemed to produce a 
fructanase, when pre-grown on glucose (Walker et ai., 1983). However, the latter studied 
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only extracellular fructanases using fructan as a substrate. It is possible that fructanases 
are not able to degrade oligosaccharides. It is possible that the FOS-degrading enzymes 
are not necessarily extracellular. Finally, it is also possible that the enzymes are inducible, 
and may be suppressed by pre-culturing on glucose. 
The GF3 compound, nystose, seems to be relatively stable towards degradation by 
most strains. Only St. mutans 36 rapidly degraded nystose. St. mutans 44 degraded 
nearly all substrates except nystose. This would also explain the results obtained by 
other researchers. Ikeda et al. (1990) showed that nystose was slowly degraded or 
fermented by 5 strains of St. mutans, among them St. mutans NCTC 10449, which is the 
same as our strain 36. On the other hand Ziesenitz and Siebert (1987) showed that 
nystose was degraded rapidly by their strain of St. mutans NCTC 10449 and also with 
human mixed dental plaque bacteria. Walker et al. (1983) reported that fructanase 
activities ranged from 0 to 944 units per liter. In the same study they showed that the 
production of fructanase was dependent on pre-cultivation as well as medium conditions. 
Finally, fructanases produced by different strains showed different preferences towards 
fructans (Walker et al., 1983). These factors may have contributed to the observed 
differences towards degradation of nystose. 
All species produced acid from FOS, both from Raftilose and from Profeed. Acid 
production on Raftilose was similar to that on sucrose, about 0.11 mol I"1. Profeed 
apparently is a less suitable substrate for St. mutans 36, as could be determined from the 
lower acid production and slower growth rate. 
Rapid acidification studies with St. mutans 36 showed that acidification is as rapid 
on glucose as on FOS. The critical pH for dental caries (5.5-5.7) was reached within 15 
minutes with 23 mmol I"1 FOS as substrate. This is somewhat longer than found with 
mixed dental plaque (Ziesenitz and Siebert, 1987), which is probably due to the lower cell 
concentration in our experiments. Even with a reduced concentration of Raftilose (2.3 
mmol I'1) the critical pH was reached within half an hour. 
Artificial plaque formation was similar on Raftilose and on sucrose, around 17 mg 
was formed after 3 days. Plaque formation on Profeed was somewhat less, 13 mg after 3 
days. This data is in contrast with the results of Hirasawa et al. (1984), who could not 
detect any plaque after 3 days incubation with Neosugar (Profeed). Even if only the 
sucrose unit of the GFn series would be utilized in plaque formation, it is to be expected 
that Neosugar, which consists entirely of the GFn series, would be a good substrate for 
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plaque formation. The slower production of plaque on Profeed may again be due to the 
slower growth rate of St. mutans 36 on Profeed. 
Addition of buffer increased the plaque formation considerably to around 30 mg. 
Surprisingly plaque formation on Raftilose surpassed plaque formation on sucrose. As 
sucrose is the preferred substrate for St. mutans glycosyltransferases (Hamada and siade, 
1980) it is unlikely that Raftilose would be a better substrate. However, it has been 
described that oligosaccharides may act as a primer for St. mutans glycosyltransferase 
(Hamada and siade, 1980) and this may be the explanation for the increased plaque 
formation. As growth and acid production on Profeed was slower than on Raftilose, it is 
likely that the Fn series are degraded more rapidly by the streptococci. This was 
confirmed with the degradation experiments. St. mutans 36 degraded the Fn series faster 
than the GFn series, and after 60 h considerably more degradation of the Fn series could 
be detected with the other strains. 
As all strains grow and produce acid rapidly from Fn as GFn oligosaccharides, it can 
be concluded that both substrates are cariogenic, unless proven otherwise in animal 
studies on cariogenesis. Furthermore, artificial plaque formation occurs and this will 
enhance cariogenicity. 
Comparison of both fructooligosaccharide preparations would lead to the conclusion that 
Raftilose is somewhat more cariogenic than Profeed, due to the slower growth rate and 
acid formation by the most cariogenic species, St. mutans, on Profeed. 
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SUMMARY 
Transgalactosyl-oligosaccharides (TOS) are a class of oligosaccharides produced by 
transgalactosylation of lactose. TOS are used as bifidogenic factors in human and animal 
nutrition. TOS can be present in the oral cavity and form a risk for caries. 
All oral bacteria tested were able to degrade and ferment both TOS and galactosyllactose 
(GLL), one of its components. Growth was improved as compared to carbohydrate-free media 
and acid was produced after 24 h incubation of the bacteria with TOS and GLL. Degradation 
patterns, using HPAEC, showed degradation of most components. Galactosyllactose was 
degraded only partially. Rapid acidification was only observed for Streptococcus mutans, 
resulting in a pH of 5.4 within 30 minutes. All other strains fermented TOS and GLL only slowly. 
Plaque formation could not be detected on both substrates. 
It can be concluded that TOS and GLL possess only a small risk for caries formation, 
unless proven otherwise in animal studies. 
INTRODUCTION 
Transgalactosyl oligosaccharides (TOS) are a class of oligosaccharides produced from 
lactose using 13-galactosidase (EC 3.2.1.23). Several (3-galactosidases are known to 
possess transgalactosylation properties. These enzymes may be of fungal or bacterial 
origin (Smart, 1993, Zarate and Lopez-Leiva, 1990; Toba etal., 1981; Toba era/., 1985; Asp era/., 1980; 
Dumortier er a/., 1990). Commercial TOS is produced using B-galactosidases from St. 
thermophilus (Greenberg and Mahoney, 1983), Cryptococcus laurentii or Aspergillus oryzae 
(Fujii and Komoto, 1991). 
The composition of the resulting mixture is dependent on the enzyme and process 
conditions, like pH, temperature, salt and substrate concentration (Zarate and Lopez-
Leiva, 1990). 
Several commercial TOS mixtures are available, both in Japan and in Europe. The 
general structure of the oligosaccharides in these mixtures is (gal)n-glu, with n ranging 
from 1 to 4. The glucosidic linkage between the residues may be (3-1,3, (3-1,4 or 6-1,6. 
This results in a large number of oligosaccharides in some of these mixtures (Tanaka er 
al. 1983; Smart, 1993). 
TOS are marketed in Japan as bifidogenic factors. Several studies have shown 
that ingestion of TOS may result in an increase in bifidobacteria! counts in the faeces in 
humans (Tanaka etal., 1983; Ohtsuka etal., 1989; Ito etal., 1990; Fujita etal., 1991; Yoneyama etal., 
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1992; Ito etal., 1993a,b; Ogata et al., 1993) and animals (Terada et al., 1992; Rowland and Tanaka, 
1993; Terada etal., 1993; Terada etal., 1994). 
Practically none of the oligosaccharides in the TOS mixtures can be digested by 
human intestinal lactase (B-galactosidase). They are, however, rapidly degraded by the 
intestinal flora (Tanaka etal., 1983; Fujita et al., 1991). This implicates that many bacterial 
species have B-galactosidases that are able to degrade this class of oligosaccharides. 
As these compounds are applied in food products, it may be possible that some part 
remains in the oral cavity. Many of the oral streptococci and lactobacilli are able to 
ferment lactose and thus possess B-galactosidases (Zarate and Lopez-Leiva, 1990). These 
enzymes may also degrade B-galactooligosaccharides and fermentation of the resulting 
monomers may contribute to caries formation. 
As little is known about the fermentation of these compounds by oral bacteria we 
determined their possibility to contribute to caries. 
MATERIALS AND METHODS 
Oligosaccharides 
Galactosyl lactose (GLL, Cup Oligo syrup) was a gift from Nissin Sugar Co., (Tokyo, 
Japan). This syrup also contains about 25% mono- and dimeric sugars (glucose, 
galactose and lactose) as well as traces of larger components as stated by the 
manufacturer. 
TOS was obtained from Borculo Whey Products, Borculo Holland. This mixture 
contained less than 5% lactose and no monomeric sugars as stated by the 
manufacturer. 
Strains 
Oral bacteria used were the same as described previously (Hartemink etal., 1995). These 
strains were : St. mutans 44 and St. mutans 36 (DSM 20523), St. oralis 45, St. mitis 
biovar I 46, St. sanguis biovar I 43 and St. gordonii biovar II 42. In addition a strain of Lb. 
rhamnosus, isolated from a human volunteer, was used. 
Growth characteristics 
Growth characteristics were determined by growing the strains in Peptone-yeast extract 
(PY) broth supplemented with 100 mmol I-1 phosphate buffer, pH 6.8 +/- 0.1, and 1% 
(w/v) of the test sugar. PY-broth was prepared according to Holdeman and Moore 
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(1977). Carbohydrates were sterilized separately at 121°C for 15 minutes and added 
before use. 
Strains were cultured in 5 ml sugar-free PY or PY supplemented with lactose (PY-
lac), galactosyl-lactose (PY-gll) or TOS (PY-tos) for 24 h at 37°C. After incubation 50 ul 
was added to 5 ml of the same medium. In addition 50 pi of the PY, PY-lac and PY-tos 
cultures were added to 5 ml of PY, PY-lac, PY-gll and PY-tos. This was done to 
determine induction by pre-culturing on lactose or TOS. From these tubes 250 pi was 
pipetted in triplicate in a microtiter plate. Growth was determined by measuring the 
optical density every 15 minutes for 20 h in a microtiter reader (SLT-240 ATCC, SLT 
Instruments, Groedig, Austria). From the resulting curves Vmax and DOD were 
determined using the EasyKin software supplied with the reader. 
Acidification studies 
Acidification was determined by measuring the pH after 24 h incubation at 37°C in the 
media as described above. 
Rapid acidification was determined by pre-growing St. mutans 36, St. gordonii, St. 
oralis and Lb. rhamnosus in 400 ml PY supplemented with 1 % (w/v) sucrose for 24 h at 
37°C. Cells were removed by centrifugation and washed twice with 400 ml reduced 
physiological saline solution (RPS). RPS consisted of (g I"1) sodium chloride 8.5, 
cysteine.HCI 0.5 and bacto-peptone 1.0, pH was adjusted to 6.8 +/- 0.1 using 3 mol I"1 
NaOH. 
After the washing steps the pellet was dissolved in 7 ml RPS and stored at 7°C 
until use. To 5 ml pre-heated RPS or RPS supplemented with 1% (w/v) carbohydrate, 1 
ml of the cell suspension was added. The tube was immediately placed in an incubator 
at 37°C and a pH electrode was added. The pH was measured continuously for 60 
minutes. In another experiment the cell suspension was replaced by saliva. The saliva 
was a mixture of saliva of three healthy volunteers. 
Carbohydrate analysis 
After incubation as described previously, samples were taken for carbohydrate analysis 
and stored at -80°C. Carbohydrate analysis was performed to determine which 
compounds were degraded by the bacteria. 
Carbohydrates were determined using a HPAEC (High Performance Anion 
Exchange Chromatography) system. HPAEC was performed using a BIO-LC system 
(Sunnyvale, California, USA), equipped with a Dionex Carbopac PA-100 (4x250 mm) 
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column and a Dionex pulsed electrochemical detector in the pulsed amperometric 
detection method as described previously (Hartemink etai., 1995). 
Acid analysis 
After incubation as described above, samples were taken from the acidified tubes for 
acid analysis. Samples were stored at -80°C before analysis. Lactic and acetic acids 
were determined using HPLC with an Aminex HPX-87H column and 0.01 mol I"1 sulfuric 
acid as the mobile phase as described previously (Hartemink etai., 1995). 
Plaque formation 
Plaque formation on TOS and GLL was determined as described previously (Hartemink et 
al., 1995), using St. mutans 36 as the test strain. 
RESULTS 
Growth characteristics 
All strains showed higher final optical density and increased growth rates with PY-lac, 
PY-gll and PY-tos as compared with the carbohydrate free PY, indicating fermentation 
of the carbohydrates. 
Acidification studies 
A final pH more than 0.5 units below the carbohydrate-free PY was considered positive 
for fermentation. All strains showed a clear decrease in pH in PY-lac, PY-gll and PY-
tos, indicating fermentation of all substrates (Table 3.1). It should, however, be taken in 
consideration that significant concentrations of lactose are present in PY-gll. 
Rapid acidification studies showed no rapid pH decrease for saliva, Lb. 
rhamnosus, St. gordonii and St. oralis. St. mutans fermented TOS rapidly, resulting in a 
final pH of 5.4 after 30 minutes. 
Acid analysis 
Acid analysis showed production of lactic and acetic acids from all substrates, 
indicating extensive fermentation (Table 3.1). Lactic acid was the major acid produced 
after fermentation of both GLL and TOS by all strains. Acetic acid production was 
higher for all strains on TOS as a substrate, as compared to GLL as a substrate. Total 
acid production on GLL ranged from 33.1 to 87.6 mmol I"1 and from 58.9 to 80.7 with 
TOS as the substrate. Ac. naeslundii, Lb. rhamnosus and St. sanguis produced similar 
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amounts of acid on both substrates. St. gordonii and St. mutans 44 produced more acid 
on GLL, whereas the other strains produced more acid on TOS as a substrate. 
Especially St. mitis produced only limited amounts of acid on GLL, but 80.7 mmol 1-1 on 
TOS. 
Table 3.1: Acid formation by oral bacteria after 24h incubation at 37°C on buffered PY medium 
supplemented with 1% (w/v) of the carbohydrate tested. The strains were precultured for 24h at 
37°C in the same medium. 
Species Strain 
pH* 
PY 
lactic** 
acid 
acetic 
acid 
pH 
PY-lac 
lactic acetic 
acid acid 
PH 
PY-gll 
lactic 
acid 
acetic 
acid 
PY-tos 
pH lactic 
acid 
acetic 
acid 
Ac. naeslundii 
Lb. rhamnosus 
St. gordonii 
St. mitis 
St. mutans 
St. mutans 
St. oralis 
St. sanguis 
41 
42 
46 
36 
44 
45 
43 
n.t. 
n.t. 
n.t. 
n.t. 
5.7 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
6.8 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
56.2 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
n.t. 
5.1 
n.t. 
n.t. 
n.t. 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
1 between 5.0 and 6.0 
57.6 
63.7 
67.6 
21.5 
43.2 
57.9 
50.5 
57.0 
8.8 
7.8 
21.0 
11.6 
7.5 
12.6 
7.7 
8.5 
++ pH below 5.0 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
55.2 
61.3 
64.1 
56.8 
48.7 
57.8 
51.9 
56.3 
12.7 
9.3 
13.6 
23.9 
10.2 
8.9 
19.9 
8.6 
' acid in mmol M n.t.: not tested 
< 
D. 
Time 
Figure 3.1: Carbohydrate degradation pattern of PY-tos after incubation with St. oralis 45 for 
24h at 37°C; A : HPAEC pattern of PY-tos before incubation with St. oralis 45; B : HPAEC 
pattern of PY-tos after 24 h incubation at 37°C with St. oralis 45 
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Carbohydrate analysis 
HPAEC analysis showed degradation of all major components of the TOS mixtures by 
all strains. Degradation was nearly complete for St. oralis (Fig 3.1) and St. mitis. The 
other species degraded mainly the higher components. Galactosyllactose in the TOS 
mixture was degraded only partially by most strains. Pure galactosyllactose was 
degraded slowly by all strains (Fig 3.2). No complete degradation was observed. 
< 
o. 
Time 
Figure 3.2: Carbohydrate degradation pattern of PY-gll after incubation with St. gordonii 42 for 
24h at 37°C; A : HPAEC pattern of PY-gll before incubation with St. gordonii 42; B : HPAEC pattern of 
PY-gll after 24 h incubation at 37°C with St. gordonii 42 
Plaque formation 
No plaque could be detected on any of the substrates tested after 3 days of incubation. 
DISCUSSION 
It has been shown that all oral bacteria tested were able to grow on both TOS and GLL. 
Growth was enhanced and final cell yield, as judged by optical density, increased. 
All strains were able to produce acid from TOS and GLL. As all strains are able to 
grow on lactose, they possess intra- or extracellular B-galactosidases. It is therefore not 
surprising that several components from the TOS mixture are degraded. Most strains 
produced lactic as well as acetic acid, indicating heterofermentative fermentation. Total 
acid production was somewhat higher on TOS than on GLL. This is in according with 
the degradation patterns obtained using HPAEC. Galactosyllactose was fermented 
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slowly by all the strains. Similarly GLL present in the TOS mixtures was not or not 
completely degraded. The reason for this is not known. 
Rapid acidification showed that only St. mutans 36 was able to acidify the medium 
within 30 minutes to pH 5.4. The other strains degraded and fermented TOS and GLL 
too slow to show any significant pH drop within 90 minutes. Preculturing on TOS or GLL 
did not increase the acidification rate (data not shown). As St. mutans is the main 
cariogenic species, the rapid acidification may be a risk factor for caries. The other 
bacteria do not form a risk for caries formation, due to the slow acidification rate. Saliva 
has a buffering capacity that will neutralize the acid produced. This was confirmed by 
the test with saliva, where no rapid acidification could be detected. 
Plaque formation was absent for St. mutans. Together with rapid acidification, 
plaque formation is a risk factor for caries formation. Plaque consists mainly of bacterial 
polysaccharides. These polysaccharides are both glucans and levans. As TOS and 
GLL are mainly composed of galactose, transglycosylation to plaque polysaccharides is 
unlikely (Schemmei et ai, 1982). These results are in accordance with Balekjian et al. 
(1977), who did not observe plaque formation on lactose. However, lactose was found to 
be cariogenic in rats (Schemmei et ai., 1982) and humans (Koulourides etal., 1976). 
It can therefore be concluded that oral bacteria are able to degrade and ferment 
TOS and GLL. Acid is produced, but, with the exception of St. mutans, the fermentation 
process is relatively slow. In addition plaque is not formed, which decreases the 
cariogenicity of these substances. The risk of caries formation from TOS and GLL can 
therefore be considered rather low. As acid is produced, the risk is not absent. Studies 
using animal models should be undertaken to determine the actual risk in vivo. 
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SUMMARY 
Xyloglucan, a cell wall polysaccharide and part of the dietary fiber fraction of the diet, can be 
degraded by the intestinal microflora. Degradation is not common among intestinal bacterial 
species. Of 138 strains (representing 75 species) only nine strains were able to degrade 
xyloglucan polymer. These strains, seven Clostridia, one bifidobacterium and one bacteroides, 
all produced apparent extracellular enzymes, which degraded the glucan backbone. Gas 
production was detected with faecal slurries and the individual Clostridia. The other two strains 
did not produce any gas. Selective elimination of bacterial groups from faecal slurries indicated 
that Clostridia are the main group of intestinal bacteria responsible for degradation of xyloglucan 
polymer. In addition to the polymer-degrading strains, some other strains were able to degrade 
and ferment oligosaccharides produced from tamarind seed xyloglucan with a fungal endo-f3-
glucanase. HPAEC analysis showed that the fungal oligosaccharides were identical to the 
oligosaccharides produced by the polymer-degrading species suggesting the presence of an 
endo-B-glucanase in these bacteria. It is proposed that xyloglucan is degraded in vivo by endo-
B-glucanases produced mainly by Clostridia, followed by fermentation of the oligosaccharides 
by a larger group of bacteria. 
INTRODUCTION 
Non-digested polysaccharides from the diet can be separated in three different groups; 
resistant starch, hemicelluloses and cellulose. All three groups are fermented to some 
extent by the intestinal microflora to short chain fatty acids, hydrogen and carbon 
dioxide (Hill, 1995). 
The hemicelluloses are a diverse group of plant cell wall polysaccharides, 
including galactomannans, arabinoxylans, pectic substances and many more. One of 
the lesser studied polysaccharides from cell wall material is xyloglucan. Xyloglucan 
consists of a B-1-4 glucosidic backbone, with side chains made up of xylose, galactose 
and, Occasionally, fucose (Belitz and Grosch, 1987; Maclachlan, 1987; York et al., 1993). 
Xyloglucans are present in cell walls of many plants, like rice (Shibuya and Misaki, 1978), 
cotton (Hayashia and Delmer, 1988), mung beans (Kato and Matsuda, 1980a), peas, potatoes 
and wheat (Maclachlan, 1987). Xyloglucans are generally present in relatively small 
quantities. In tamarind (Tamarindus indica) seeds, however, xyloglucan is the 
predominant polysaccharide. This xyloglucan can be obtained rather easily, and is 
commercially available in large quantities (Beiitzand Grosch, 1987). It lacks the fucose side 
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chains and consists of a glucan backbone with xylose-galactose side-chains attached at 
regular intervals (Fig 4.1) (York era/., 1993). 
Xyloglucan from tamarind seed is used as pectin substitute in the production of 
jellies and marmalades. Xyloglucan can also be used as a thickening agent and 
stabilizer in ice cream and mayonnaise (Beiitzand Grosch, 1987). 
It can thus reasonably be assumed that xyloglucans form a part of the daily intake 
of dietary fiber. Xyloglucans cannot be digested by the human small intestinal enzymes 
(Sone era/., 1992). Xyloglucans thus reach the colon unaltered. It is to be expected that 
xyloglucans, like other hemicelluloses, can be degraded and fermented by the intestinal 
bacteria. Whereas no published data are available on fermentation of xyloglucan by 
bacteria, degradation and fermentation by other micro-organisms, such as fungi, have 
been studied in detail (Kato and Matsuda, 1980a,b). 
B-D-Glc-(1~>4)- B-D-Glc-(1^"4)-B-D-Glc-(1 ->4)-B-D-Glc 
6 
t 
a-D-Xyl 
6 
f 
a-D-Xyl 
6 
t 
a-D-Xyl 
R1 R2 
1. R1=R2=B-D-Gal 
2. R1=H, R2=B-D-Gal 
3. R1=B-D-Gal, R2=H 
4. R1=R2=H 
Fig 4.1 : Structure of xyloglucan-oligomers (York etal., 1993). 
Several mechanisms of xyloglucan degradation can be postulated. In the first 
mechanism the side-chains are degraded and fermented before the backbone is 
degraded. The second mechanism assumes degradation of the backbone into smaller 
oligosaccharides with the side chains still attached. In the third mechanism both 
processes occur simultaneously. 
It is well known that intestinal bacteria possess a large number of cell-associated 
or extracellular enzymes, which are able to degrade polysaccharides. Polysaccharide 
degradation by intestinal bacteria has been reported for Bacteroides spp., 
Bifidobacterium spp. and Clostridium spp.(Salyers etal., 1977; Crociani etal., 1994; Englyst et 
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ai, 1987). As several of these enzymes might be of commercial interest, we determined 
the ability of intestinal bacteria to degrade xyloglucan from tamarind seed. 
MATERIALS AND METHODS 
Xyloglucan 
Xyloglucan polymer (XYG-P) from tamarind seed was obtained from Dainippon 
Pharmaceutical, Osaka, Japan. It was essentially free of oligosaccharides and 
monosaccharides as was judged by high-performance anion exchange chromatography 
(HPAEC). 
Xyloglucan oligomers (XYG-O) were prepared from the polymer by enzymatic 
hydrolysis, using an endo-B-glucanase obtained from Trichoderma viride (Beldman et ai, 
1985). The resulting mixture consisted of four oligosaccharides and no monomeric 
carbohydrates could be detected using HPAEC (Vincken et ai, 1995). These 
oligosaccharides were used as standards for the products obtained after liquefaction. 
Strains 
All strains were from the culture collection from our Department. Most strains were of 
human origin, some strains originated from porcine faeces. A total of 135 strains was 
tested for XYG-P liquefaction: 10 strains of the Bacteroides fragilis group (5 species), 
21 bifidobacteria (6 species), 37 Clostridia (21 species), Eubacterium limosum, 7 
lactobacilli (3 species), 12 enterococci (3 species), 28 enterobacteria (19 species or 
serotypes), 5 fusobacteria (3 species), 4 Actinomyces sp. (3 species), 2 Prevotella 
species, 6 streptococci (5 species) and two species of peptostreptococci. 
Previously unidentified strains were characterized using the API 50CH system 
(BioMerieux, France) for carbohydrate fermentation combined with Gram staining, gas 
formation and spore formation (plating after heating for 15 min at 80°C) (Hoideman and 
Moore, 1977). 
Liquefaction 
Screening for xyloglucan degradation was done by liquefaction of a XYG-P gel. A 5% 
(w/v) XYG-P gel was prepared in PY broth. PY broth was prepared as described 
previously (Hoideman and Moore, 1977). This mixture was boiled to dissolve all XYG-P and, 
while still hot, poured in screw-capped test tubes. These were sterilized and kept closed 
at room temperature until use. Strains or faecal slurries were pre-grown in carbohydrate 
66 
FERMENTATION OFXYLOGLUCAN 
free thioglycollate broth, or PY broth supplemented with 1% glucose (PYG) 
anaerobically at 37°C for 24-48 hour. XYG-P tubes were inoculated using sterile tooth 
picks, each pure culture was inoculated in triplicate, faecal slurries in duplicate. The 
inoculated tubes were incubated anaerobically at 37°C for 24-96 hours. Liquefaction 
indicated degradation of the polymeric xyloglucan. Syringes were attached to the tubes 
to determine gas production. 
Table 4.1 : Treatment of faecal slurries for elimination of specific bacterial groups. 
Treatment 
A 
B 
C 
D 
E 
F 
G 
H 
I 
Medium 
RCM 
RCM 
RCM 
RCM 
RCM 
RCM 
RCM 
RCM 
RB 
Conditions/additions 
none 
10min80°C 
10 min80°C, aerobic 
aerobic 
vancomycin 2 mg/ml 
cefpirome 200 mg/l2 
D, E and F combined 
1 ml acetic acid 96%, pH 5.2 
pH5.9 
Number of 
subcultures 
-
1 
1 
2 
2 
2 
2 
2 
2 
Selected group 
all faecal bacteria 
sporeformers 
bacilli 
aerobes 
Gram-negative 
bacteria 
resistant 
anaerobes 
resistant aerobes 
lactic acid bacteria 
bifidobacteria 
Reference 
Chow and Cheng, 
1988 
Katoefa/., 1993 
Scriverefa/., 1992 
Hartemink et al., 
1996 
1 : Vancomycin was obtained from Eli-Lilly, 2 : Cefpirome sulfate was obtained from Roussel-Uclaf. 
Faecal studies 
To determine whether faecal slurries were able to degrade XYG-P and XYG-O, 
liquefaction tests were performed. Faecal slurries were prepared by mixing fresh human 
faeces from several healthy volunteers with anaerobic storage medium (Crowther, 1971) in 
an anaerobic cabinet. Slurries were kept at -80°C before use. To determine which 
groups of micro-organisms were able to degrade XYG-P, faecal slurries were prepared 
in which certain groups were eliminated as follows: Three faecal slurries (3 ml each) 
were diluted in 80 ml Reinforced Clostridial Medium (RCM, Oxoid, Basingstoke, UK). 
From these mixtures 1 ml samples were transferred into 80 ml RCM supplemented with 
antibiotics (vancomycin, obtained from Eli Lilly, and cefpirome sulfate, obtained from 
Roussel-Uclaf) or in RB-medium (Hartemink et al., 1996), according to Table 4.1. For some 
of the options this procedure was repeated after 24h incubation. After another 24h 
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incubation one ml was used to inoculate a 20 ml XYG-P gel. Liquefaction was 
determined as described above. 
Oligosaccharide fermentation 
Eighteen strains, both negative and positive in the liquefaction test, were further 
screened for XYG-O degradation and fermentation. Strains pre-grown in PYG or 
thioglycollate broth were subcultured in triplicate in PY broth supplemented with 1% 
XYG-0 and 0.01% bromocresol purple as pH indicator. After anaerobic incubation for 
24, 48 and 72 hours at 37 °C, pH was measured and a final pH of 1.0 pH unit below a 
control (non-supplemented PY) tube was considered positive. Strains were checked for 
morphology before and after the incubation. 
HPAEC 
Oligosaccharides produced from XYG-P by fungal endo-B-glucanase and bacterial 
incubation were separated using HPAEC. The HPAEC system consisted of a CarboPac 
PA-100 column, with a 1 M acetic acid (A) in 100 mM NaOH (B) gradient and PAD 
detection. The gradient conditions were as follows: T=0 min : A 100 %, T=5 min A 
97%, B 3%, T=45 min A 92%, B 8%, T=55 min A 80% B 20%, T=60 min B 100%, T=65 
min B 100%, T=66 min A 100% (Vincken etal., 1995). 
Enzyme location 
Strains positive for XYG-P liquefaction were used to determine whether the liquefying 
enzymes were extracellular. Strains were cultured in PYG broth at 37°C for 24-48 h. 
The culture was centrifuged 15 min at 10.000 rpm to precipitate the cells. The 
supernatant was added to a sterile test tube containing a 5% gel of XYG-P in water, 
prepared as described above. Liquefaction was monitored after incubation at 37°C for 
24, 48, 72 and 96 h. Degradation was confirmed using HPAEC as described above. 
RESULTS 
Faecal studies 
The results of incubation of XYG-P gels with faecal slurries are summarized in Table 
4.2. All three untreated faecal slurries (A) liquefied XYG-P gels completely. Gas could 
be detected. Phase contrast microscopic analysis showed the presence of different 
types of cocci and rods. Heat treatment, which selectively isolates spores, resulted in 
complete liquefaction with gas production for the anaerobic samples (B). 
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Only one of the three heat-treated aerobic samples (C-3) showed complete 
liquefaction with gas formation. One other sample (C-1) showed some liquefaction 
without gas. Microscopy showed only short rods in samples C-1 and C-2, but also some 
streptococci in sample C-3. 
Aerobic incubation of faecal slurries (D) resulted in good growth after two days of 
pre-incubation. Many different bacterial groups were present as could be judged by 
microscopy. However, no liquefaction was observed. Only in sample D-2 some limited 
liquefaction occurred, the sample was somewhat fluid but far from liquefied. No gas 
was detectable. 
Treatment with antibiotics (E-G) resulted in good growth in all samples after the 
second subculturing step, but did not result in any liquefaction. No gas was detected in 
any sample. In the vancomycin-treated samples (E) mainly long rods were visible with 
some streptococci. In sample E-3 the streptococci were more abundant than the rods. 
In the cefpirome-treated samples (F) predominantly streptococci were visible. 
Combination of the antibiotics with aerobiosis did not result in any growth after 96h of 
incubation. Growth of lactic acid bacteria was favored by acidification of the medium 
(H). In all three samples long and short rods were visible, with some bifidobacteria in 
sample H-3. Some liquefaction was detectable in all three samples. Gas production 
was absent. Pre-incubation in RB medium (I) resulted in predominantly bifidobacteria, 
with some straight rods in samples I-2 and I-3. Only samples 1-1 and I-2 showed some 
liquefaction, without gas formation. 
Liquefaction 
Only 9 strains of 135 showed liquefaction of the XYG-P gel after 96 h of incubation. 
These strains are shown in Table 3. Gas was produced by all Clostridia, especially CI. 
beijerinckii CI-7, CI. novyi CI-8, CI. butyricum CI-26 and CI. sartagoforme CI-27. The two 
other strains, Bi. infantis Bi-223 and B. ovatus B-1 did not produce significant amounts 
of gas. 
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Table 4.3 : Strains positive in the liquefaction of XYG-P, with the final pH reached after 
liquefaction. 
Species 
Bacteroides ovatus 
Bifidobacterium infantis 
Clostridium beijerinckii 
CI. beijerinckii 
CI. butyricum 
CI. clostridioforme 
CI. novyi 
CI. sartagoforme 
CI. sordelli 
strain 
B-1 
Bi-223 
CI-7 
CI-30 
CI-26 
CI-3 
CI-8 
CI-27 
CI-9 
origin 
ATCC 8483 (type) 
DSM 20223 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
ATCC 9714 
final pH 
5.3 
4.4 
4.7 
5.9 
5.0 
4.7 
4.8 
5.3 
5.3 
30 
elutbn time Cm in) 
Figure 4.2 : Degradation of xyloglucan polymer and formation of oligomers after incubation of a 
xyloglucan polymer gel with and CI. sartagoforme CI-27. 
A: Blank sample of tamarind seed xyloglucan polymer, B: Sample after incubation with CI. sartagoforme 
CI-27 The numbers refer to the structures as shown in Fig 4.1. 
HPAEC revealed production of oligosaccharides from the XYG-P gel. The degradation 
patterns of CI. butyricum CI-26 and CI. sartagoforme CI-27 are shown in Fig 4.2. The 4 
major peaks co-eluted with the four peaks that were present after incubation of XYG-P 
with fungal endo-B-glucanase. The structures of these oligosaccharides are shown in 
Fig 4.1 (York etat., 1993). 
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0.00 5.00 10.00 15.00 20.00 25.00 30.CD 35.00 40.00 45.00 50.00 
eiution time Cm in) 
Fig 4.3 : Degradation of xyloglucan oligomers after incubation with Lb. acidophilus 128 
A: Sample of xyloglucan oligomers as obtained after degradation of xyloglucan polymer from Tamarind 
seed by endoglucanase from Trichoderma viride after incubation with Lb. acidophilus 128. B: Blank 
sample. 
Table 4.4 Ability of selected faecal bacteria to degrade* and ferment XYG-O. 
Species 
- (blank) 
B. fragilis 
B. ovatus 
B. 
thetaiotaomicron 
B. vulgatus 
Bi. adolescentis 
Bi. breve 
Bi. infantis 
Bi. longum 
CI. beijerinckii 
CI. 
clostridioforme 
origin 
ATCC 25285 
ATCC 8483 
ATCC 29741 
ATCC 8482 
DSM 20083 
DSM15700 
DSM 20088 
DSM 20219 
human faeces 
human faeces 
final 
PH 
7.2 
6.9 
6.3 
5.8 
6.0 
5.7 
6.9 
6.4 
5.1 
7.5 
6.0 
degra-
dation 
-
-
-
-
-
-
-
-
-
++ 
++ 
Species 
CI. perfringens 
CI. ramosum 
CI. sartagoforme 
CI. sporogenes 
E. coli 
E. coli 
Kl. pneumoniae 
Lb. acidophilus 
Lb. casei 
Lb. fermentum 
R. productus 
origin 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
swine faeces 
Yakult 
swine faeces 
ATCC 35244 
final 
PH 
6.8 
7.9 
7.6 
7.8 
7.6 
6.6 
6.9 
7.0 
5.7 
6.1 
5.5 
degra-
dation 
-
-
+ 
-
-
+ 
++ 
+ 
-
-
-
pH values shown in bold are considered positive for fermentation. 
* -: no clear degradation or fermentation, + : some degradation, ++ : complete degradation 
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Oligosaccharide fermentation 
The results of the degradation of XYG-0 are summarized in Table 4.4. Of the 18 strains 
tested only 8 were able to ferment XYG-0 as was judged by a drop in pH. However, 
HPAEC analysis revealed that not all these strains were able to degrade the 
oligosaccharides. Complete fermentation could only be observed with three strains: CI. 
butyricum CI-26, CI. clostridioforme CI-3 and Kl. pneumoniae 119. Partial degradation 
was observed with E. coll 103 and Lb. acidophilus 128 (Fig 4.3). 
Enzyme location 
All strains that were positive in the liquefaction test (Table 3) produced extracellular 
enzymes as was judged by liquefaction of an aqueous XYG-P gel. HPAEC analysis of 
the resulting fluid revealed the presence of the same oligosaccharides as could be 
produced with the fungal endo-B-glucanase. In addition some small unidentified 
oligomeric structures and larger oligosaccharides could be detected. No monomeric 
sugars could be detected. 
DISCUSSION 
Xyloglucan can be fermented rapidly by the human intestinal microflora as was shown 
with faecal inocula. Selective elimination of specific groups from faecal slurries 
indicated a major role for Clostridia. Samples were heated at 80°C to eliminate all 
vegetative cells. To distinguish between Clostridia and bacilli, a series of heat-treated 
samples was incubated aerobically. All three anaerobic samples showed complete 
liquefaction and production of gas. Microscopic analysis revealed the presence of 
streptococci in two samples. This was also reflected in a lower final pH (Table 4.2). 
Further purification of these strains and subsequent liquefaction showed that the 
streptococci were not able to degrade XYG-P, whereas the rods liquefied the gel and 
produced gas (data not shown). The liquefaction in all samples was therefore due to 
the rod shaped bacteria. As aerobic incubation showed much less or no liquefaction, it 
can be concluded that in the anaerobic samples liquefaction was due to anaerobic 
spore-forming gas producing Gram-positive rods. This strongly indicates Clostridium 
species. The presence of streptococci in two samples indicates that the heating 
procedure was not sufficiently long for these samples. As some liquefaction occurred 
under aerobic conditions it can be concluded that aerotolerant Clostridium species or 
Bacillus species may be responsible for liquefaction. It is known that some Clostridium 
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species are aerotolerant (CI. perfringens) or able to grow under aerobic conditions (CI. 
tertium) (Cato etal., 1986). 
The use of vancomycin against Gram-positives (Chow and Cheng., 1988; Hoiiiman and 
Bone, 1988; Green etal., 1991) did not result in liquefaction. It can be concluded that the 
strains responsible for liquefaction are probably Gram-positive. 
Literature data on cefpirome are limited, but indicate resistance to the 
concentrations used for Bacteroides sp., Fusobacterium sp. and CI. difficile. Aerobes 
are susceptible (Kato etal., 1993; Scriver etal., 1992). It can be concluded that the strains 
responsible for liquefaction are susceptible to cefpirome, which excludes most 
Bacteroides sp., Fusobacterium sp. and CI. difficile. 
Combination of antibiotics and aerobic treatment resulted in complete absence of 
growth. This indicated that the resistant organisms were anaerobic. 
Selective isolation of lactic acid bacteria (Lactobacillus, Bifidobacterium, 
Enterococcus and Streptococcus species) was carried out using acetic acid and a low 
pH. After two subculturing steps only rods were observed. In the third sample some 
bifidobacteria were present. As most other rods in faeces (Clostridia, bacteroides, 
fusobacteria, enterobacteria) fail to grow in the presence of acetic acid at these low pH 
values (Cato et al., 1993) the rods present were considered Lactobacillus species. No 
complete liquefaction was observed, although the gel was somewhat fluid. Gas was not 
produced. It is concluded that lactobacilli are not responsible for the liquefaction in 
faecal slurries. 
Bifidobacteria can selectively be isolated using RB medium (Hartemink etal., 1996). 
After two subculturing steps only bifidobacteria were present in the samples. In samples 
2 and 3 some rods were present, most likely unbranched bifidobacteria. Liquefaction 
did not occur, gas was not produced. It is concluded that bifidobacteria are not 
responsible for the liquefaction in faecal slurries. 
The results mentioned above indicate that the strains responsible for liquefaction 
are anaerobic and Gram-positive. Bifidobacteria, enterococci, streptococci and 
lactobacilli could be excluded. Heat treatment did not affect liquefaction. These results 
strongly suggest that Clostridia are the main group of bacteria responsible for the 
liquefaction of xyloglucan. 
To test whether pure strains of intestinal bacteria were able to degrade XYG-P 
135 strains were tested, representing 75 species. Of these only 9 were able to degrade 
the polymer and liquefy the sample. Seven of these strains were Clostridia and all 
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produced gas. Both other strains, Bi. infantis Bi-223 and B. ovatus B-1, did not produce 
any gas. Liquefaction with the latter two strains was also slower than with the Clostridia. 
These data are consistent with the data observed with the faecal slurries, indicating 
strongly the role of Clostridia in the degradation of xyloglucan. 
Degradation of XYG-P gels resulted in formation of oligosaccharides. These 
oligosaccharides were similar to oligosaccharides produced with a fungal endo-B-
glucanase. This result suggests the presence of an endo-B-glucanase in the positive 
strains. It was also very likely that the endo-(3-glucanase was excreted, although it can 
not be excluded that the enzyme originates from dead cells. No other degradation 
products could be observed in large amounts using culture supematants. This result 
indicates that other enzymes necessary for degradation are cell-bound or intracellular. It 
also implies that degradation of xyloglucan with endo-B-glucanase results in 
oligosaccharides that may be available for all other bacteria. This conclusion confirms 
the results with faecal slurry studies, where many other bacteria were present in 
liquefied samples that were not precultured. Similarly, in heat-treated samples where 
streptococci were present, the final pH was lowered, possibly indicating growth on 
degradation products of xyloglucan. 
We therefore tested the degradation of XYG-0 with a selection of intestinal 
bacteria. XYG-0 was produced as described previously, which resulted in a mixture that 
is similar to the oligosaccharide mixture produced by the different Clostridia. It was 
shown that some other intestinal bacteria, which were not able to liquefy the 
polysaccharide, were able to ferment the oligosaccharides completely. Not all species 
that were able to liquefy the gel were able to degrade and ferment the oligosaccharides. 
This may be due to two factors, either the strains possess an endo-B-glucosidase, but 
not the enzymes for further degradation, or the growth medium alone supported growth 
and the necessary enzymes for degradation were not induced. As liquefaction of the gel 
results in a low final pH and gas production, it is unlikely that the strains do not possess 
the other enzymes. It can thus be concluded that the oligosaccharides are a 'difficult' 
substrate for many species and complete degradation will only occur under substrate-
limiting conditions. 
It was also noted (Table 4.4) that a decrease in pH did not always correspond with 
degradation of the oligomers and vice-versa. This may be due to the presence of other 
fermentable material in the XYG-0 preparation. On the other hand, some species (CI. 
beijerinckii) may ferment the oligosaccharides slowly. Simultaneous protein 
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degradation, which results in an increase in pH, thus masks the oligosaccharide 
fermentation. It is therefore necessary for substrates that are fermented slowly to 
determine degradation using HPLC. 
In conclusion we propose the following model for xyloglucan degradation by the 
intestinal microflora. Xyloglucan is degraded by endo-6-glucanases, mainly produced 
by Clostridium species, to oligosaccharides. These oligosaccharides are further 
degraded both by some of the same species, as well as some other bacteria. The 
complete mechanism of this latter degradation remains to be elucidated. Contrary to 
many Other plant Cell wall polysaccharides (Salyers etal., 1977; Salyers etal., 1978; Degnan and 
Macfariane, 1995), xyloglucan is degraded mainly by Clostridia, not by bacteroides or 
bifidobacteria. This may result in a relatively large production of gas after ingestion of 
this polysaccharide. 
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SUMMARY 
Guar gum is widely used in the food industry as a thickening agent. Guar and other 
galactomannans are ingested as a normal part of the human diet. Guar is completely degraded 
in the large intestine. Often large amounts of gas are produced. It was observed that only a 
limited number of species is able to degrade and ferment guar. Guar degrading species are 
present in faeces in numbers over 108/g and in saliva in numbers over 105/g. Guar degrading 
strains could be isolated from faecal samples of all volunteers and in 90% of the saliva of 
volunteers. 
The main species isolated from humans were Bi. dentium and CI. butyricum. From 
several samples of animal faeces St. bovis could be isolated. In addition some strains of 
Bacteroides ovatus were able to degrade guar to a limited extent. 
Fermentation resulted in the production of short-chain fatty acids and, when CI. butyricum 
was present, in a large gas production. Competition experiments showed that CI. butyricum 
degrades guar faster than both other species under simulated physiological conditions. 
INTRODUCTION 
Guar gum consists of a (1->4)-f3-linked D-mannan backbone which carries single unit 
(1 -»6)-ot-linked D-galactose-residues with a mannose-galactose ratio of 1:2 (Figure 
5.1). It is obtained from the seeds of the guar plant or cluster bean (Cyamopsis 
tetragonoloba), a leguminous tree. Guar gum is widely used in many food applications 
(Table 5.1) (Reid and Edwards, 1991). The annual world production of guar exceeds 
100.000 tons, mainly produced in India, Pakistan and the USA (Gierschner, 1986). It can 
thus be stated that guar is often ingested as part of a Western-style diet. 
Guar gum can not be degraded by the human small intestinal enzymes and thus 
reaches the colon unaltered. Although it has been widely observed that guar is 
degraded completely by the intestinal microflora (Nyman and Asp, 1982; Tomlin era/., 1986; 
Nyman etal., 1986; Bourquin era/., 1996), very little is known which species are involved in 
degradation and fermentation of guar and related galactomannans. 
Fermentation of guar has been described for B. ovatus (about 25% of the strains 
tested), Bi. adolescentis (1 strain), Bi. dentium (all strains), an unidentified Bacteroides 
species and R. albus (all strains) (Okubo etai, 1994; Salyers et al., 1977; Balascio era/., 1981; 
Crociani et al., 1994). Only for B. ovatus the fermentation has been characterized in more 
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detail. In addition to this, fermentation of partially hydrolyzed guar gum (PHGG) has 
been tested by Japanese researchers (Okubo et ai, 1994). They observed a bifidogenic 
effect of the PHGG in humans, but none of the 16 bifidobacteria! strains tested, was 
able to ferment PHGG. They did not, however, test Bi. dentium, which is mainly an oral 
species, although some strains have been isolated from intestinal contents. In addition, 
they tested 67 other intestinal bacteria. Of these only CI. butyricum, CI. coccoides, B. 
ovatus and ft productus were able to ferment the PHGG to some extent (Okubo et ai., 
1994). 
Galactose unit 
CH,OH 
°Vi>x 
OH\ 
OH <pH,OH_ 
HO-\^—-A 
O OH \ 
CH.OH 
Figure 5.1: structure of guar. 
CHjOH OH 
Mannose chain 
Table 5.1 : Use of guar and other galactomannans in food and consumer products. 
Product group 
Bakery products 
Beverages 
Dairy 
Desserts 
Diabetic products 
Instant products 
Pharmaceuticals 
Seasonings 
Function and application 
thickener 
thickener 
thickener, stabilizer, fat substitute 
thickener 
thickener 
thickener 
thickener, stabilizer 
thickener 
Food products 
icings, bread 
chocolate milk 
ice cream, milk desserts, cheese 
jellies 
coffee whiteners, infant formula 
desserts, hot milk puddings 
tooth paste 
sauces 
Adapted from Reid and Edwards (1991) and Gierschner (1986) 
Fermentation of guar results, as is the case with most undigestible carbohydrates, in 
the production of short chain fatty acids and gases. It has been noted in several studies 
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that the fermentation of guar results in relatively large amounts of butyrate. However, 
none of the species known to ferment guar produces butyrate as a major fermentation 
end product. B. ovatus produces mainly acetate and propionate, bifidobacteria produce 
only acetate and lactate. Only Ft. albus produces small amounts of butyrate, but mainly 
acetate (Hoideman and Moore, 1977). It is not likely that butyrate is formed from either 
lactate, propionate or acetate. Of the PHGG fermenting strains, only CI. butyricum 
produces butyrate, CI. coccoides and R. productus produce succinate and acetate as 
main end products, respectively (Hoideman and Moore, 1977; Kaneuchi etal., 1976). 
Fermentation of guar often, but not always, results in gas production. Trials using 
human volunteers have shown increased intestinal pressure and flatulence, as well as 
hydrogen and methane excretion in the breath (Robb, et at., 1991; Wolever and Robb, 1992; 
Cummings etal., 1978; Todd era/., 1990). As with the formation of butyrate, no hydrogen is 
produced in large amounts by the strains known to ferment guar. Some B. ovatus 
strains produce large amounts of carbon dioxide, only the three PHGG fermenting 
species may produce hydrogen (Hoideman and Moore, 1977). 
To answer some of the discrepancies mentioned above, we decided to study the 
fermentation of guar by the intestinal flora in more detail. 
MATERIALS AND METHODS 
Galactomannans 
The guar used was a commercial product, intended for use in foods (Vellinga Food 
Ingredients, Oudewater, The Netherlands). Other galactomannans, with a galactose-
mannose ratio of 1:1, 1:3 and 1:4 were obtained from Diamalt (Diamalt, Munich, 
Germany). Pure mannan from yeasts was obtained from Sigma (M 7504, Sigma, Saint 
Louis, USA). 
Strains 
The strains used for the screening experiment were either type strains or isolates from 
human or swine faeces. Strains used for the initial screening included Ac. species (3 
strains), B. fragilis group (49), bifidobacteria (17), Clostridia (27), Eu. limosum, F. 
necrophorum (2), lactobacilli (29), Me. e/scfen//'(5), anaerobic cocci (3), propionibacteria 
(3), enterobacteria (6), streptococci (3) and 22 unidentified faecal isolates. 
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Liquefaction 
Degradation of guar was determined by liquefaction. A 1.5% guar solution was 
prepared in carbohydrate free thioglycollate broth. This broth was prepared from the 
ingredients of thioglycollate broth (Oxoid CM 391). In addition 0.1% cysteine.HCI 
(Sigma, C 7880) was added. The pH was adjusted to 6.7 +/- 0.1, unless otherwise 
stated. The guar was dissolved by mixing the guar slowly into the broth, while stirring 
rapidly. This highly viscous solution was rapidly poured into test tubes (10-15 ml/tube) 
and sterilized 15 min at 121°C. After sterilisation the tubes were placed in an anaerobic 
chamber for at least 16h before use. The anaerobic atmosphere consisted of: nitrogen 
80%, carbon dioxide 10% and hydrogen 10% (SHK050H, HoekLoos, Rotterdam, The 
Netherlands). Tubes were inoculated with either culture medium (0.1-1 ml) or test 
material using sterile loops. The tubes were incubated up to 5 days anaerobically at 
37°C. Guar degradation was considered positive when the tubes were completely 
liquefied. 
HPGPC 
In some samples checking for liquefaction was combined with degradation 
measurements using High-Performance Gel Permeation Chromatography (HPGPC). 
The HPGPC system consisted of three combined (linear) Biogel TSK columns, 40XL, 
30XL and 20XL, each column being 300 x 7.5 mm. The columns were eluted using 0.4 
M sodium acetate buffer at pH 3.0 and a flow rate of 0.8 ml/min. Detection was by 
refraction index measurements, using a Shodex SE-61 detector. The column was kept 
at 30 °C and the injection volume was 20 uJ. 
Isolation of guar degrading strains 
Guar degrading strains were isolated from faeces or saliva of healthy human volunteers 
or faecal samples obtained from different animals. Guar tubes were inoculated with 
different serial dilutions of the samples. After liquefaction 100 pi of the liquid was 
transferred into new guar tubes. This procedure was repeated twice. After the third 
liquefaction 5 pi of the liquid was plated onto agar plates with Reinforced Clostridial 
Agar (RCA, Oxoid CM 151). These plates were incubated anaerobically and colonies 
were purified, using the same medium. Purified colonies were tested for guar 
liquefaction. Strains positive in the liquefaction test were characterized using 
morphology, spore formation, aerobic growth, catalase and oxidase tests, as well as a 
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API 50CH test (BioMerieux, France). For identification the procedure described by 
Holdeman and Moore was used (Hoideman and Moore, 1977). 
As only a limited number of species could be isolated, the procedure was changed 
to improve isolation of other species. To improve isolation of lactic acid bacteria the pH 
of the guar tubes was decreased to 5.0. To isolate lactobacilli tubes with pH 5.0 and 
vancomycin (20 mg/l) were used (Hartemink et al., 1997). To isolate Gram-negative 
bacteria vancomycin was added. To isolate aerobes the whole procedure was carried 
out aerobically and cysteine was omitted from the guar tubes. 
In addition it was tried to isolate guar degrading strains using solid media. The 
media used were MRS, Raffinose Bifidobacterium Agar (RB) (Hartemink et al., 1996), 
Kanamycin Azide Agar (KAA, Oxoid CM 591), Bacteroides Bile Esculin Agar (BBE) 
(Summanen et al., 1993), which were prepared from the ingredients, replacing glucose by 
0.25% guar. Samples were plated on these media and colonies were purified and 
tested for guar degradation using the liquefaction procedure. 
Gas measurements 
Gas produced by fermentation of guar was determined with a pressure meter. Strains 
or faecal samples were grown in 50 ml screw-capped glass bottles, with a butyl-rubber 
gas-tight septum. A maximum of 30 ml culture medium was added to the bottles. Gas 
was measured using a needle attached to a three-way valve, which was connected to 
the pressure meter and a syringe. The needle was pierced through the septum and the 
pressure was read. The pressure was reduced to zero by pulling the syringe. The 
volume of gas produced was read from the syringe. 
Faecal inocula 
Fermentation of guar was determined using faecal inocula. Faecal inocula were 
prepared from fresh faeces in buffered peptone water with cysteine. HCI (0.5 g/l) in 
approximately 10-fold dilution. In an anaerobic chamber a 1 ml sample of this dilution 
was transferred into a screw-capped bottle with 25 ml of the following medium (Medium 
1): yeast extract 5 g/l (Oxoid L21), hemin solution 5 ml/l (Sigma H 2250), salts solution 
40 ml/l, LabLemco powder 5 g/l (Oxoid L29), potassium phosphate buffer 25 mmol/l 
(Merck 1.05104), sodium thioglycollate 0.5 g/l (Sigma T 0632), guar 5 g/l and 
cysteine.HCI 0.5 g/l. The pH was adjusted to 6.7 +/- 0.1 using a 6 N NaOH solution. 
The bottles were sterilized by autoclaving 15 min at 121°C. After inoculation the bottles 
were incubated at 37°C for 36 h. The gas production was measured as described 
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above at three different time intervals. Final pH was measured after 36h. Some 
samples were frozen at -80 °C and stored for later analysis of short-chain fatty acid 
profile (acetate, propionate, butyrate) and lactate concentrations using HPLC (Lee, 1990). 
Faecal inocula were prepared from 10 volunteers. Use was made of faecal 
samples obtained in a large nutrition trial. During this trial, which was not related to our 
experiments, the volunteers received a completely controlled diet. The diet was 
essentially free of guar and other galactomannans. All volunteers received the same 
diet. Faeces was sampled twice in the third week as well as twice in the sixth week of 
the trial, resulting in 40 faecal inocula. All volunteers were of good health. The bacterial 
counts of all the samples were within a 7% range for the following bacterial groups: total 
anaerobes, total aerobes, bifidobacteria, E. coli, Clostridia and lactobacilli (unpublished 
data). 
Competition experiments 
Strains used for the competition experiments were CI. butyricum G-13 (isolated from 
human faeces), Bi. dentium DSM 20484T and St. bovis G-2 (obtained from ID-DLO, 
Lelystad, The Netherlands). Clostridium butyricum G-13 was chosen as it produced the 
highest amount of gas, compared to the other Clostridium isolates (data not shown). 
The other two strains were chosen as these also liquefied guar rapidly, and were well 
characterized strains. 
Competition was determined using gas measurements as described above. The 
strains were pre-cultured overnight in carbohydrate free RCM broth (made from the 
ingredients according to the RCM broth (Oxoid CM 149)), with 0.25% glucose or guar 
added. In addition the pH of the RCM medium was adjusted to pH 5.5, 6.0, 6.5 or 7.0 
using 1 M HO and 1 M NaOH. 
After incubation 1 ml of the overnight culture, or appropriate dilution in reduced 
physiological salt solution, was added to 25 ml of the same medium in a screw-capped 
glass bottle. Either single cultures or combinations of the test strains were added. 
All dilutions and inoculations were performed in an anaerobic chamber to maintain 
anaerobic conditions. 
After inoculation the bottles were incubated at 37°C for 120h. Gas was measured 
at regular time intervals and after 120h the final pH was determined. 
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RESULTS 
Screening and isolation. 
None of the identified strains tested in the initial screening experiment was able to 
liquefy guar, with the exception of the Bi. dentium type strain and one strain of B. 
ovatus (WAU B-203). Samples of human or animal faeces as well as saliva liquefied 
guar within 24 hours, most often even within 12 hours. 
From human faecal samples only two types of guar-degrading bacteria could be 
isolated. These were identified as strains of CI. butyricum and Bi. dentium/adolescentis. 
The latter were identified as Bi. dentium on their ability to degrade guar (Crociani et ai., 
1994), carbohydrate fermentation pattern (Hoideman and Moore, 1977) and presence of 13-
glucuronidase (Roy and Ward, 1992). Identification was further confirmed, as known strains 
of these species from culture collections were also capable of degrading guar. 
Fermentation of guar by strains of Bi. dentium resulted in a final pH of 4.2-4.6, 
whereas the final pH of the CI. butyricum strains was between 5.0 and 5.6. All CI. 
butyricum strains fermented guar with the production of large amounts of gas, none of 
the bifidobacteria produced any gas. 
In addition to the human strains some guar-degrading strains were isolated from 
animal faeces. Strains were isolated from the following species : pig (Sus scrota), 
pekari (Tayassu tajacu), kudu (Tragelaphus strepsiceros), wallaby (Wallabia sp), 
watussi (Bos taurus), giraffe {Giraffa camelopardia), cheetah (Acinonyx jubatus), camel 
(Camelus bactrianus), water antelope (Kobus ellipsiprymus), yak (Bos grunniens), 
elephant (Elephant maximus), oryx (Taurotagus oryx), lama (Llama glama) and bison 
(Bison bison). With the exception of three strains, all strains were streptococci. The 
strains were identified as St. bovis using the API-strep system (BioMerieux, France). 
The identity was again further confirmed by testing known strains of Strep bovis (type 
strain and strains obtained from pigs and cows at the ID-DLO institute, Lelystad, The 
Netherlands) for guar degradation. No gas was produced by any of the strains, the final 
pH was between 4.5 and 5.0. The three non-streptococci, isolated from pigs and 
cheetah, were identified as CI. butyricum. These strains produced large amounts of 
gas. 
Selective isolation from faecal samples using specific media, selective agents, 
aeration or antibiotics did not result in any additional species, neither from human nor 
from animal samples. 
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In addition to the faecal isolates we could isolate Bi. dentium from the saliva of 37 
out of 40 volunteers as well as from 10 out of 10 samples of dental plaque (obtained 
using dental floss). No other guar degrading strains could be isolated from the oral 
cavity. 
Faecal inocula 
Fermentation of guar by 40 faecal inocula resulted in the production of gas and short-
chain fatty acids. Gas production was between 7 and 50 ml, with an average of 26 ml. 
The final pH was between 4.4 and 6.6 with an average of 5.25 (Figure 5.2). Only 8 
samples had a pH below 5.0. Incubation of the same faecal inocula in the same 
medium without carbohydrate resulted in a gas formation of less than 5 ml and a pH of 
6.5+/-0.1. 
Short chain fatty acids and lactate were determined in 12 samples. The total acid 
concentration was between 24.5 and 69.8 mmol/l, with an average of 54.9 mmol/l 
(Table 5.2). The major acid produced was acetate, followed by butyrate, propionate and 
lactate. The average percentage of butyrate, expressed as percentage of all acids, was 
28%. 
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Figure 5.2 : Gas produced and final pH after fermentation of guar by faecal inocula. 
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Table 5.2 : Final pH, gas, lactate and short-chain fatty acids after batch fermentation of guar 
with faecal inocula from 12 healthy human volunteers. 
sample 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
average 
SD 
L= lactate 
ml gas 
35 
42 
31 
49.5 
34.5 
7 
22 
35.5 
7.5 
11 
11.5 
17 
25.29 
13.86 
, A = acet 
final 
PH 
concentration (mmol/l)* 
4.9 
5.2 
5.4 
5.0 
5.4 
6.6 
5.3 
5.2 
5.6 
5.6 
5.7 
5.2 
5.43 
0.42 
ate, B= 
L 
12.55 
4.73 
2.58 
11.40 
4.06 
10.26 
1.59 
5.29 
5.45 
2.14 
2.66 
4.02 
5.56 
3.60 
bi jtyrate, P 
A 
29.55 
18.56 
20.94 
21.07 
18.15 
7.94 
24.05 
20.04 
22.78 
27.75 
29.76 
33.83 
22.87 
6.56 
P 
9.37 
3.27 
10.74 
8.06 
6.93 
2.72 
17.74 
8.88 
12.36 
12.28 
25.07 
14.63 
11.00 
5.92 
= propionate 
B 
18.32 
17.71 
17.00 
25.95 
21.34 
3.53 
17.19 
23.99 
9.78 
14.23 
6.62 
9.95 
15.47 
6.59 
total 
(mmol/1) 
69.79 
44.26 
51.26 
66.48 
50.48 
24.45 
60.57 
58.20 
50.37 
56.40 
64.11 
62.43 
54.90 
11.68 
relative 
L 
17.99 
10.69 
5.03 
17.15 
8.05 
41.97 
2.62 
9.09 
10.82 
3.80 
4.14 
6.44 
11.48 
10.33 
percentage 
A 
42.34 
41.93 
40.85 
31.69 
35.95 
32.46 
39.71 
34.43 
45.22 
49.20 
46.42 
54.19 
41.20 
6.59 
P 
13.43 
7.38 
20.96 
12.13 
13.73 
11.14 
29.29 
15.26 
24.53 
21.77 
39.11 
23.43 
19.35 
8.60 
B 
26.25 
40.00 
33.16 
39.03 
42.27 
14.43 
28.38 
41.22 
19.43 
25.23 
10.33 
15.93 
27.97 
10.79 
HPGPC 
The degradation of guar was determined by HPGPC for seven strains, one B. ovatus 
(WAU B-203), three strains of St. bovis, one strain of CI. butyricum and two strains of 
Bi. dentium. After 24h incubation all guar gels were completely liquefied. Gas was 
produced by the CI. butyricum strain. The HPGPC patterns showed that the 
degradation was very limited for the B. ovatus strain (Figure 5.3). Both the St bovis and 
Bi. dentium strains degraded the guar to smaller compounds and monomers. It was 
impossible to obtain a degradation pattern from the CI. butyricum strain, the reason for 
this is unknown. 
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All strains tested also liquefied gels made with galactomannans with other 
mannose-galactose ratios. Final pH values were similar as obtained with guar. Final pH 
on pure mannan generally was higher, indicating less fermentation (data not shown). 
25 
Time (min) 
Figure 5.3. HPGPC Elution pattern of guar incubated 24 h with the following strains: A Blank 
guar, B B. ovatus WAU B-203, C Bi. dentium G-6, D St. bovis G 41. B. ovatus WAU B-203 was 
obtained from a local hospital, Bi. dentium G-6 was obtained from saliva of a human volunteer, 
St. bovis G 41 was isolated from pig faeces. 
Competition experiments 
The competition experiments between CI. butyricum G-13 and the Bi. dentium (type) 
showed that guar is fermented faster by Bi. dentium than by the Clostridium strain 
tested (Table 5.3). Gas production was around 27 ml for the CI. butyricum strain alone. 
Addition of Bi. dentium reduced the gas production, indicating fermentation by Bi. 
dentium. In a ratio 1:100 {Bi dentium vs. CI .butyricum) Bi. dentium reduced the overall 
gas production by 20-40%, the strongest at the lower pH values. When equal amounts 
of both strains were added, gas production was reduced by half for pH 6.5 and 7.0 and 
by 80% for the two lower pH values. In a ratio of 10:1 {Bi. dentium vs. CI. butyricum) 
gas production was practically zero at the lower pH values and reduced by 70-80% at 
pH 6.5 and 7.0. 
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Table 5.3. Competition experiments between CI. butyricum G-13 (C) and Bi. dentium type (B)). 
Total gas production and final pH after 120h incubation at 37°C at four different initial pH 
values. Guar concentration 0.25%. Initial cell counts were 3*108/ml +/- 2*108/ml. Data are mean 
of three different bottles. 
Inoculation level Initial pH of media 
5.5 6.0 6.5 7.0 
Initial pH of media 
5.5 6.0 6.5 7.0 
mIC 
1 
1 
1 
0.1 
0 
mlB 
0 
0.01 
1 
1 
1 
Total gas produced 
26.7 27.3 
15.3 14.3 
4.3 5.7 
0.7 1.7 
0.7 n.d. 
27.3 
23.7 
17.3 
5.7 
0.7 
27.3 
20.7 
12.3 
8.0 
n.d. 
Final pH 
5.9 
5.3 
5.1 
4.9 
4.9 
5.8 
5.6 
5.1 
4.9 
4.8 
6.0 
5.9 
5.4 
5.1 
5.0 
5.9 
5.8 
5.6 
5.1 
4.9 
-C onty 
-B0O1 
B1 
Figure 5.4 : Effect of initial inoculum of Bi. dentium on the gas production resulting from the 
fermentation of guar in the presence of a fixed inoculum of 108/25 ml CI. butyricum at pH 5.5. C 
only is no Bi. dentium added, B 0.01 is 0.01 ml Bi. dentium added, B1 is 1 ml Bi. dentium 
added. Concentration of Bi. dentium was 3.108/ml. 
Final pH values also showed a similar trend, indicating fermentation of guar by Bi. 
dentium. 
Gas production was relatively slow, probably due to the low concentration of guar 
(Figure 5.4). The maximum amount of gas produced was not reached within 3 days of 
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incubation. The influence of Bi. dentium became noticeable directly when equal 
amounts of both strains were added, but only after 40h when added in the ratio 100:1 
(Bi. dentium vs. CI. butyricum). At higher pH values growth and gas production was 
faster, reaching a maximum already after 50 h at pH 6.5. 
The competition between CI. butyricum G-13 and St. bovis G-2 showed a different 
pattern (Figure 5.5). No effect of St. bovis on the gas formation could be observed at 
pH 6.5 or 7.0, not even at the initial ratio of 100:1 (St. bovis vs. CI. butyricum). At pH 6.0 
the gas production was reduced by 20% at a ratio of 1:1 or 10:1 and by 75% at a ratio 
100:1. At pH 5.5 gas production was clearly reduced, even at a 1:1 ratio, final gas 
production was reduced by 75% under these conditions. 
30.0 
0 0.01 0.1 1 
rrl a Clostridium culture added 
Figure 5.5 : Effect of initial inoculum of CI. butyricum on the gas production resulting from the 
fermentation of guar in the presence of a fixed inoculum (1 ml) of St. bovis at different pH 
values: 5.5; 6.0; 6.5 and 7.0. Concentration of CI. butyricum was 2.5*108/ml, that of St. bovis 
was7*108/ml. 
DISCUSSION 
The results show that guar can only be degraded by a limited number of individual 
bacterial species from the intestinal contents. We have only been able to isolate strains 
from three species, Bi. dentium, St. bovis and CI. butyricum that are able to degrade 
and ferment guar. In addition, some strains of B. ovatus were able to liquefy guar, but 
probably did not completely ferment the mannose chain. Besides B. ovatus and Bi. 
dentium, only R. albus has been isolated previously. In addition to this, CI. coccoides 
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and R. productus have been found to be able to degrade PHGG. None of the latter two 
strains, however has been isolated previously as a guar fermenting species from 
human or animal faeces. Even though we have found only a limited number of guar 
degrading strains, it is not unlikely that a combination of strains from different species 
are able to degrade and ferment guar and galactomannans in vivo. 
The strain most frequently isolated from human faecal samples was CI. butyricum. 
The numbers of CI. butyricum were found to be around or over 109/g faeces in most 
samples. Although this species has been isolated previously from human faeces in 
similar numbers, we have isolated this species from most humans. Previous results did 
only show a low frequency of isolation, probably due to the presence of other clostridial 
species. CI. butyricum has not been isolated previously as a guar degrading strain, but 
it was found to be able to degrade PHGG (Okubo etal., 1994) and glucomannan (Nakajima 
and Matsuura, 1997). 
The presence of Bi. dentium in faeces has been described previously (Crociani etal., 
1994). Literature results indicate that Bi. dentium is present in relatively small numbers 
compared to other bifidobacteria! species. The isolation of Bi. dentium from faeces 
therefore requires selective techniques. Also, Bi. dentium is difficult to differentiate from 
Bi. adolescentis and Bi. catenulatum, which are both more common in faeces (Hoideman 
and Moore, 1977). It is thus likely that some Bi. dentium isolates have previously 
misidentified as Bi. adolescentis or Bi. catenulatum. The two selective tests to 
differentiate between the species are the presence of 13-glucuronidase and guar 
fermentation, both of which are positive for Bi. dentium (Crociani etal., 1994; Roy and Ward, 
1992). 
Bi. dentium is normally associated with dental caries. We have shown, using guar 
degradation, that this species was present in saliva in higher incidence than observed 
previously (Scardovi and Crociani, 1974). 
St. bovis has not previously been isolated as a guar degrading species. We 
isolated strains of St. bovis from most samples of animal faeces. St. bovis has been 
isolated previously from many animals, but also from human faeces (Hardie and Whiley, 
1995). As all our isolates grew aerobically, they could not be misidentified with R. 
productus or R. albus, two anaerobic species that were associated with guar 
fermentation in previous studies. Also, the type strain of St. bovis, as well as strains that 
we obtained from other institutes, were capable of degrading and fermenting guar. 
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In contrast to previous research we failed to isolate guar degrading B. ovatus 
strains. The reason for this is unknown. It was shown in previous studies that about 
25% of all strains of B. ovatus were capable of degrading and fermenting guar (Saiyers et 
ai, 1977). The average log counts of B. fragilis group organisms in the tested faecal 
inocula was generally above 1010/g, indicating that the conditions were not inhibiting to 
B. ovatus. Even with the addition of vancomycin to suppress the Gram-positive species, 
no liquefaction of guar gels was observed. In a similar technique as Bayliss and 
Houston (1984), using Bacteroides Bile Esculin Agar with guar as the only carbohydrate 
source, we isolated many Gram-negative rods, none of which liquefied guar in 
subsequent tests. B. ovatus is not present in faeces of all humans. Finegold et al. (1974) 
isolated B. ovatus only in 8 out of 18 persons on a Western style diet. Similarly B. 
ovatus was isolated only in 9 out of 70 samples of infant faeces (Benno et ai, 1984), 13 
out of 30 samples of older persons (Benno et ai., 1989), 4 out of 13 samples of healthy 
vegetarian adults and 3 out of 14 non-vegetarian adults (Finegold et at., 1977). It is 
unknown whether B. ovatus is common in healthy Dutch adults and/or our donors. B. 
ovatus is also rarely isolated from intestinal or faecal samples in general hospitals in the 
Netherlands [pers comm]. 
Guar fermentation by faecal inocula resulted in the production of gas and butyrate 
as a major short-chain fatty acid. Some lactate was produced as well. This is in 
agreement with other studies (Tomiin et at., 1986; Bourquin et ai, 1996). The data presented 
in Table 5.2 include SCFA and lactate produced from the medium components. 
However, the total concentration of acids produced from the medium without 
carbohydrate source was less than 15 mmol/l, indicating that most acids were produced 
from the carbohydrate (unpublished data). Butyrate is formed by direct fermentation of 
carbohydrates, it is not formed from other acids, such as acetate or lactate by faecal 
bacteria. Of all guar fermenting species isolated in our or previous studies, only CI. 
butyricum produces butyrate. 
Gas production varied between the samples (Figure 5.2), but was always present. 
In vivo studies have also shown production of considerable amounts of gases, resulting 
in intestinal bloating, flatulence and hydrogen excretion (Robb era/., 1991; Woleverand Robb, 
1992; Cummings er a/.,i978; Todd et ai, 1990). Of all species isolated in our or previous 
studies only CI. butyricum, CI. coccoides and ft productus produce hydrogen, some of 
the B. ovatus strains are reported to produce carbon dioxide (Hoideman and Moore, 1977). 
As we failed to isolate the latter three species, it can be concluded that CI. butyricum is 
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the species responsible for the gas production. Gas may also be produced as a 
secondary metabolite from lactate by Me. elsdenii or Veillonella species (Hoideman and 
Moore, 1977). This would result in high concentrations of acetate and propionate. 
Similarly, the B. ovatus strains do not produce hydrogen, nor butyrate (Hoideman and 
Moore, 1977). The presence of large concentrations of butyrate, therefore, emphasizes 
the role of CI. butyricum. Some secondary fermentation yielding butyrate may, 
however, not be excluded, neither in vivo nor in vitro. 
The final pH of guar fermentation by faecal inocula was relatively high as 
compared with other substrates (unpublished data). With a few exceptions, the final pH 
was above 5.0. This further emphasizes the role of CI. butyricum in many samples, as 
this strain does not acidify below 5.0, whereas the two other species can acidify below 
5.0. 
The B. ovatus strain tested did not completely degrade guar, but probably only 
removed the galactose units. The molecular mass was slightly less than that of the 
original guar, but the sample was completely liquefied. Removing of the galactose 
results in liquefaction of the gel, as mannan does not form gels. This B. ovatus strain 
thus was positive in the liquefaction test, but does not completely ferment guar. The two 
necessary enzymes for guar degradation (a-galactosidase and mannanase), have been 
described for B. ovatus. Two different a-galactosidases have been described, both of 
which are not active on intact guar gum. a-Galactosidase I is only active on partially 
degraded guar gum (Gherardini et ai., 1985). In another study it was shown that oc-
galactosidase activity is induced by guar gum and that these enzymes are acting 
towards guar (Macfarlane et ai, 1990). A mannanase has been described, but not 
purified (Gherardini et ai., 1985). Whether both enzymes are present in all strains is not 
known. 
Repeated incubation and storage (over 1 year) in non-guar containing media 
(cooked meat medium) or at -80°C with subsequent inoculation of guar tubes, did not 
result in the loss of the guar degrading capacity for the isolated strains (data not 
shown). Similarly, the culture collection strains, which were most likely never tested on 
guar degradation, as it is normally not included in identification schemes, did liquefy 
guar rapidly. These data indicate that the enzymes are constitutive and not, or very 
rapidly, induced by guar. 
The competition experiments showed that Bi. dentium was capable of influencing 
the gas production by CI. butyricum at all pH values tested. The strongest inhibition was 
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observed at the lower initial pH values. This influence was also reflected in lower final 
pH values. As Bi. dentium grows faster than CI. butyricum at physiological conditions 
(pH 6.5-6.8), isolation of Bi. dentium using guar degradation should occur, when both 
species are initially present in equal amounts, or even when CI. butyricum outnumbers 
Bi. dentium by a factor 10-100. However, we could not detect Bi. dentium in liquefied 
guar gels using faecal samples. This indicates that Bi. dentium is present in much lower 
numbers than CI. butyricum. It is therefore unlikely that Bi. dentium is responsible for 
the bifidogenic effect of PHGG as has been reported previously (Okubo etai., 1994). The 
addition of PHGG to the diet of volunteers increased the numbers of bifidobacteria from 
(log counts) 9.9 to 10.3. As only Bi. dentium is capable of fermenting guar and Bi. 
dentium in our results is present only in (log) numbers below 6, the increase observed 
by this study would indicate an (unlikely) increase in numbers by 4 log units. It is not 
expected that the (Japanese) population tested has a much higher faecal count of Bi. 
dentium than our volunteers, as the presence of this species has not been reported 
previously by Japanese researchers in high numbers in faeces (Benno etai, 1984; Benno ef 
a/., 1989). Therefore the bifidogenic effect of PHGG as described by Okubo et al. (1994) 
can not readily be explained. 
Competition experiments between St. bovis and CI. butyricum indicated that St. 
bovis has no influence on the gas production by CI. butyricum under physiological 
conditions, not even when St. bovis outnumbers CI. butyricum with a factor 100. Only at 
pH 6.0 gas production was reduced. It can thus be concluded that in human faeces it is 
not likely to isolate St. bovis using guar gel liquefaction when CI. butyricum is present. 
As we isolated all our strains from animals it can be concluded that, in these samples, 
CI. butyricum was present in much lower numbers than St. bovis. 
The fermentation of guar results in the formation of relatively large concentrations 
of butyrate (Tomlin etai., 1986; Bourquin era/.,1996). Formation of butyrate is considered to 
have a beneficial effect in the intestine (Brebech Mortensen and Rye Clausen, 1996). Guar 
does not directly stimulate the growth of beneficial bacteria such as bifidobacteria and 
lactobacilli, with the exception of Bi. dentium. On the contrary, guar seems to stimulate 
mainly CI. butyricum, and the stimulation of Clostridia is not considered beneficial. The 
effects of guar on intestinal health are thus difficult to determine. 
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SUMMARY 
The fermentation of 9 different carbohydrates (lactose, lactulose, lactitol, raffinose, guar gum, 
fructooligosaccharides (FOS), transgalactosyl-oligosaccharides (TOS), xyloglucan and inulin) 
was studied in a batch system using faecal samples from 10 volunteers. The volunteers all 
received the same controlled diet for six weeks, with an addition of TOS during the last three 
weeks. Two samples were taken both in the third and sixth week of the study. Carbohydrates 
were fermented for 48h and after incubation, final pH, gas production, lactate and short-chain 
fatty acids were determined. Gas production and pH differed widely between the substrates. 
Our batch fermentation results indicate extensive fermentation by Clostridia of guar and 
xyloglucan. Lactose, raffinose, FOS and lactulose were probably fermented to a large extent by 
lactic acid bacteria, most likely bifidobacteria. Fermentation of TOS, lactitol and inulin could not 
be attributed to one or two specific bacterial groups. 
Butyrate production in our system was highly correlated with gas production, indicating that gas 
measurements are a cheaper and faster method to screen for butyrate producing substrates. 
The overall metabolic pattern was highly dependent of the volunteer donating the sample, as 
different samples from a single volunteer resulted in a similar profile. Results from different 
volunteers, consuming the same diet for 6 weeks, were markedly different, indicating that host 
factors are important for the metabolic capacity of the flora. 
INTRODUCTION 
Dietary carbohydrates can be divided in digestible and non-digestible carbohydrates. 
Components of the latter group will enter the colon unaltered and may act as a 
substrate for the colonic microflora. The non-digestible carbohydrates may be divided in 
the classical dietary fibres (mainly polysaccharides), resistant starch and non-digestible 
oligosaccharides. 
Fermentation of carbohydrates by the colonic microflora results in the production 
of microbial mass, short-chain fatty acids (SCFA), lactate and the gases carbon dioxide 
and hydrogen. Subsequent metabolism of these compounds results in the formation of 
secondary products, such as methane (Hill, 1995). 
Different carbohydrates are fermented by different subgroups of the bacterial 
population, due to structural changes of the carbohydrates and the (specific) enzymes 
necessary for degradation, which are not present in all bacterial species. Some 
carbohydrates are claimed to be selectively fermented by specific bacterial groups, 
such as fructooligosaccharides by bifidobacteria (Gibson and Wang, 1993; Bouhnik et al., 
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1996). Other carbohydrates may be degraded and fermented by many different species 
from different genera (Table 1.3, Chapter 1). Complex carbohydrates, such as mucins, can 
only be degraded and fermented by different bacteria acting together (Hoskins etal., 1992). 
During the last decades many studies have been carried out on the fermentation 
of different carbohydrates, dietary fibres and crude substrates by the intestinal 
microflora. Studies have been performed using individual bacterial species (Chapter 1) as 
well as in batch and continuous fermentations using faecal inocula (McBurney and 
Thompson, 1987; Englyst and MacFarlane, 1987; Bourquin et al., 1996). Due to the large 
differences in experimental setup the different studies are difficult to compare. 
Fermentations are often carried out using a single faecal sample or a mixture 
of faecal inocula from different volunteers. As it is generally considered necessary to 
use a fresh faecal inoculum to avoid damage due to freezing or oxygen damage (Aiies, 
1998), repetition of the results may be difficult. Similarly, as the bacterial composition of 
the faeces may be dependent of the diet (Hentges, 1980; Edwards, 1993), faecal inocula, 
even when taken from the same donor, may be considerably different due to dietary 
changes. 
To determine the variation in fermentative characteristics between faecal inocula 
of the same donor as well as the variation between inocula of different donors the 
present study was carried out. 
Volunteers participating in a large nutritional trial that was aimed to determine the 
effects of transgalactosyl-oligosaccharides (TOS) on the intestinal microflora of healthy 
adults (Alles, et al., 1999), provided the faecal samples. All volunteers received a 
controlled diet for the six weeks of study. During the last three weeks the volunteers 
received either the same diet (placebo) or the diet supplemented with two different 
doses of TOS. 
The fermentation of nine different carbohydrates was investigated. With the 
exception of lactose, all carbohydrates tested are non-digestible. Lactose, lactulose and 
lactitol were used to compare chemical structure and fermentation products. Raffinose 
was used as it is supposed to be involved in the flatulence due to the digestion of 
legumes. Fructooligosaccharides and inulin were used to determine differences due to 
chain length. TOS was used to determine adaptation due to addition of TOS to the diet. 
Finally xyloglucan and guar gum were used as these are more complex 
polysaccharides, which have been found to be fermented mainly by Clostridia (Chapters 4 
and 5). 
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MATERIALS AND METHODS 
Medium 
The medium used for the batch fermentation consisted of : yeast extract 5.0 g/l, Lab 
Lemco powder (Oxoid) 5.0 g/l, sodium thioglycollate 0.5 g/l, cystein.HCI 0.5 g/l, hemin 
solution 5 ml/1 (Holdeman and Moore, 1977), salts solution 40 ml/I (Holdeman and Moore, 1977) 
in 25 mM potassium phosphate buffer. The pH was adjusted to 6.6 +/- 0.1 using 1 M 
NaOH or 1 M HCI solutions. The pH was not affected after addition of the test 
carbohydrates or sterilisation. The medium was supplemented with the selected 
carbohydrates to a concentration of 5 g/l. The medium was then distributed in 25 ml 
screw-capped gas tight bottles, with a butyl rubber piercable septum. The bottles were 
sterilized 15 min at 121°C and kept at refrigeration temperatures until use. Prior to use, 
the bottles were kept overnight at 37°C in an anaerobic chamber to check sterility, to 
remove oxygen from the headspace and to avoid a temperature shock to the faecal 
inoculum. 
The following carbohydrates were used : blank (no carbohydrate added), lactose 
(Merck, Darmstadt, Germany), lactulose (Pharmachemie, Haarlem, the Netherlands), 
lactitol (Purac, Gorinchem, the Netherlands), transgalactosyl-oligosaccharides (TOS, 
Borculo Whey Products (now Borculo Domo Ingredients), Borculo, the Netherlands), 
raffinose (Sigma, St. Louis, USA), fructooligosaccharides (FOS, Raftilose P95, Orafti, 
Tienen, Belgium), inulin (Raftiline LS, Orafti), guar gum (Vellinga Food Ingredients, 
Oudewater, the Netherlands) and xyloglucan (Dainippon Pharmaceutical, Osaka, 
Japan). Except for TOS, which contained up to 15% lactose and monomeric sugars, all 
carbohydrates contained less than 2% impurities. 
Faecal inocula 
Faecal inocula were obtained during a large experiment carried out in collaboration 
between the Human Nutrition and Food Microbiology groups at the Wageningen 
Agricultural University. This study has been described in detail by Alles et al. (1999, in 
press). In short, all volunteers received the same controlled diet, which was low in fibre 
and relatively high in protein content. During the first three weeks all volunteers 
received the same diet, the second three weeks of the study the diet was supplemented 
with a placebo, a low or a high dose of TOS. Faecal inocula were taken from 10 
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volunteers, selected at random from the subgroups, 5 of which received a high dose of 
TOS (15 g/d), 5 received a low dose of TOS (7.5 g/d). Faecal inocula were taken twice 
in the third week of the study (no addition of TOS to the diet), and twice in the sixth 
week (after 3 weeks of TOS supplementation). None of the volunteers had taken 
antibiotics or other medicine at least 6 months prior to the study date. None of the 
volunteers was lactose intolerant. 
Volunteers defaecated in a special toilet near the laboratory. Faecal samples were 
transferred immediately into an anaerobic chamber. The whole procedure between 
defaecation and transfer into the chamber took less than 5 minutes. Within the 
anaerobic chamber (atmosphere 80% N2, 10% C02 and 10%H2, SHK 050H, HoekLoos, 
Rotterdam, the Netherlands), the samples were homogenized using an Ultra-Turrax 
mixer and diluted 100 fold with reduced physiological peptone solution (rps, peptone 1 
g/l, NaCI 8.5 g/l, cysteine.HCI 0.5 g/l, pH 6.7 +/- 0.1). One milliliter of these dilutions was 
added to the medium containing the test carbohydrates. The bottles were then closed 
and transferred from the anaerobic chamber to be incubated for 48h at 37°C. 
Gas measurements 
Gas was measured using a needle attached to a three-way valve, which was connected 
to the pressure meter and a syringe. The needle was pierced through the septum and 
the pressure was read. The pressure was reduced to zero by pulling the syringe. The 
volume of gas produced was read from the syringe. Gas was measured after 24 and 
48h of incubation at 37°C. 
Analysis of acids 
After 48h of incubation as described above, final pH was measured and samples were 
taken from the acidified tubes for acid analysis. To 5 ml sample 100 JLXI 50% sulfuric acid 
was added to kill all bacteria and stop the fermentation reactions. Acidified samples 
were immediately stored at -80°C before analysis. Prior to HPLC analysis 1 ml samples 
were centrifuged for 15 minutes in an Eppendorf centrifuge to remove all bacterial cells 
and insoluble material. Short chain fatty acids (SCFA, acetate, propionate and butyrate) 
and lactate were determined using HPLC with an Aminex HPX-87H column and 0.01 mol 
I'1 sulfuric acid as the mobile phase. 
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RESULTS 
Gas production 
Gas production differed widely between the substrates (Table 6.1, Fig. 6.1). The blank 
samples produced less than 10 ml of gas, with an average of 5.4 ml from faecal inocula 
taken from volunteers before and 6.6 ml from faecal inocula during the intervention of 
TOS. The highest average gas production was observed on guar gum (33.8 ml) in 
faecal inocula from the low-TOS group before the intervention. 
The addition of TOS, in either dose, to the diet did not have any effect on the 
blank gas production, or on the gas production on inulin, lactose, lactulose, lactitol, 
raffinose, guar gum or xyloglucan. The gas production, however, was reduced in both 
the high-TOS and low-TOS intervention on FOS as a substrate. 
Gas production differed widely between the faecal inocula of the same person as 
well as between persons (Fig 6.2). Large variation between individuals was observed 
for the polysaccharides guar gum and xyloglucan, lactitol and FOS. Variations were 
generally small for lactose, lactulose and TOS. 
Table 6.1 : Gas produced on the different substrates by different faecal inocula derived from the two 
groups of volunteers before and during the intervention with high- or low TOS. 
substrate 
bla 
fos 
gua 
inu 
lac 
lat 
lol 
raf 
tos 
xyg 
before intervention with 
low TOS 
mean 
6.3 
13.4 
33.8 
12.6 
6.2 
7.1 
14.6 
11.9 
7.7 
24.8 
SD 
1.6 
6.7 
12.7 
3.7 
2.7 
3.5 
4.7 
4.0 
2.9 
12.0 
hiah TOS 
mean 
4.8 
9.3 
21.5 
11.0 
5.9 
5.9 
13.7 
9.0 
7.2 
17.1 
SD 
1.6 
4.3 
12.5 
3.0 
2.3 
1.5 
7.2 
3.8 
2.2 
9.8 
after intervention with 
low TOS 
mean 
6.8 
9.5 
22.1 
14.1 
6.2 
8.4 
13.9 
10.1 
9.4 
17.2 
SD 
1.2 
2.1 
5.1 
6.2 
1.3 
2.4 
4.4 
2.9 
3.2 
5.3 
hiah TOS 
mean 
6.4 
6.7 
21.1 
11.5 
5.0 
8.0 
13.3 
6.3 
7.0 
16.0 
SD 
0.6 
2.7 
11.2 
6.1 
1.3 
3.1 
3.9 
2.2 
3.2 
7.5 
bla = blank sample (no carbohydrates added), fos = fructooligosaccharides, gua = guar gum, inu = Inulin, 
lac = lactose, lat = lactulose, lol = lactitol, raf = raffinose, tos = transgalactosyl-oligosaccharides, xyg = 
xyloglucan. 
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PH 
The final pH differed widely between the substrates (Fig. 6.1 C, 6.1 D, Table 6.2). The 
final pH was practically unchanged for the blank samples, due to the presence of the 
buffer in the medium. A drop in pH was thus considered to be due to fermentation of 
the test carbohydrates. The final pH was on average below 5.0 for lactose, raffinose 
and FOS. Fermentation of all other substrates, except xyloglucan, resulted in an 
average final pH between 5.0 and 5.5. 
Table 6.2 : Final pH after fermentation of a test carbohydrate with different faecal inocula the two groups 
of volunteers before and during the intervention with high- or low TOS. 
substrate 
bla 
fos 
gua 
inu 
lac 
lat 
lol 
raf 
tos 
xyg 
before intervention with 
low TOS 
mean 
6.55 
4.85 
5.15 
4.93 
4.58 
5.56 
5.20 
4.78 
5.49 
5.44 
SD 
0.60 
0.28 
0.26 
0.28 
0.34 
0.37 
0.34 
0.25 
0.24 
0.26 
hiah TOS 
mean 
6.63 
4.66 
5.51 
5.08 
4.51 
5.50 
5.35 
4.72 
5.41 
5.72 
SD 
0.15 
0.16 
0.42 
0.13 
0.10 
0.27 
0.63 
0.15 
0.33 
0.35 
after intervention with 
low TOS 
mean 
6.61 
4.76 
5.28 
5.11 
4.56 
5.80 
4.99 
4.86 
5.64 
5.48 
SD 
0.09 
0.19 
0.26 
0.27 
0.12 
0.33 
0.14 
0.18 
0.39 
0.21 
hiah TOS 
mean 
6.61 
4.64 
5.06 
4.96 
4.47 
5.77 
5.10 
4.69 
5.50 
5.67 
SD 
0.10 
0.22 
0.29 
0.37 
0.08 
0.32 
0.34 
0.22 
0.37 
0.31 
bla = blank sample (no carbohydrates added), fos = fructooligosaccharides, gua = guar gum, inu = inulin, 
lac = lactose, lat = lactulose, lol = lactitol, raf = raffinose, tos = transgalactosyl-oligosaccharides, xyg = 
xyloglucan. 
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Gas production versus pH 
There was no relation between gas production and final pH when all data were plotted 
(Fig 6.3A). For some substrates, however, there was a clear relation between the 
amount of gas produced and the final pH. This correlation was high for TOS (1^=0.86, 
Fig 6.3B) and lactulose (1^=0.84), weak for FOS (1^=0.55) and raffinose (r^O.45, Fig 
6.3D). Other substrates did not show any correlation, an example is given in Fig 6.3C 
for lactitol (r^O.01). 
SCFA and lactate 
It was observed that the production of short-chain fatty acids and lactate varied widely 
between and within substrates (Table 6.3). Acetate was the main short-chain fatty acid 
produced, but for four substrates lactate was produced in higher concentrations. 
Lactate concentrations were especially high after fermentation of lactose, raffinose 
and FOS. Fermentation of guar, xyloglucan and lactitol on the other hand, resulted in a 
very low concentration of lactate, but high percentages of butyrate and propionate. 
Table 6.3 : Short-chain fatty acids and lactate produced after 48h of fermentation by different faecal 
inocula for all volunteers on the different substrates shown as relative percentages of total production (in 
mol%). 
substrate 
fos 
gua 
inu 
lac 
lat 
lol 
raf 
tos 
xyg 
Lactate 
% 
47.2 
11.5 
37.5 
55.3 
40.9 
15.1 
50.4 
26.5 
9.5 
SD 
12.7 
10.3 
12.2 
9.8 
9.1 
9.3 
10.1 
12.8 
7.8 
Acetate 
% 
34.5 
41.2 
45.1 
35.1 
37.7 
49.8 
36.0 
48.6 
44.4 
SD 
8.5 
6.6 
11.4 
9.4 
11.6 
9.2 
8.6 
7.9 
4.8 
Propionate 
% 
9.9 
19.4 
12.1 
6.6 
13.0 
17.2 
8.7 
10.6 
21.8 
SD 
4.6 
8.6 
3.3 
1.9 
5.4 
8.6 
1.6 
4.8 
9.7 
Butyrate 
% 
8.3 
28.0 
14.5 
3.1 
8.5 
17.9 
4.9 
14.3 
24.3 
SD 
9.0 
10.8 
9.0 
2.3 
8.3 
12.2 
3.3 
15.2 
10.9 
fos = fructooligosaccharides, gua = guar gum, inu = inulin, lac = lactose, lat = lactulose, lol = lactitol, raf = 
raffinose, tos = transgalactosyl-oligosaccharides, xyg = xyloglucan. 
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Most volunteers showed similar relative proportions of SCFA and lactate in all samples 
(Fig 6.4, volunteers G,H,I), whereas other volunteers showed large variations in the 
relative proportions of acids between samples (Fig 6.4, volunteer F). 
There was no correlation between the production of any of the acids with the final 
pH for any of the substrates tested, although samples with high lactate concentrations 
generally had a low pH, and samples with high butyrate generally showed a relatively 
high pH. There was no correlation between the production of acetate or propionate with 
the formation of gas. For butyrate, however, there was a relatively strong correlation 
(r^O.78, Fig 6.5A), the more gas produced, the larger the proportion of butyrate. An 
opposite relation was observed between lactate and gas formation. A relatively large 
concentration of lactate corresponds with a low gas production (Fig 6.5B). 
DISCUSSION 
All different substrates were fermented completely, as analysis of carbohydrates in a 
random series of fermentation bottles did not show residual carbohydrates (data not 
shown). 
Fermentation resulted generally in a reduction of pH as well as production of acids 
and gases. Large differences were observed both between the different substrates as 
the different faecal inocula. 
Gas production was highest for xyloglucan and guar gum. This was expected as 
both substrates are fermented mainly by Clostridia (Chapter 4 and 5). Clostridia generally 
produce large amounts of gas. Production of hydrogen has also often been reported 
after the ingestion of guar by human volunteers (Robb, era/., 1991; Wolever and Robb, 1992; 
Cummings etal., 1978; Todd et ai, 1990). Similarly, fermentation of these two substrates also 
resulted in a relatively high final pH, and in the production of much propionate and 
butyrate and a small amount of lactate. These findings confirm the fermentation by 
Clostridia. Guar is known to be fermented nearly exclusively by CI. butyricum, which 
does produce large amounts of butyrate and very little lactate (chapter 5, Hoideman and 
Moore, 1977). The final pH of a CI. butyricum fermentation hardly ever reaches values 
below 5.5. 
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Fermentation of raffinose, which has often been implicated in the flatulence 
observed after the ingestion of beans and related products (Christofaro etai., 1974), did not 
result in the formation of much gas in the inoculum of any of the volunteers. This may 
either be due to differences between in vivo studies and our in vitro fermentations, or 
raffinose may not be the main flatulence factor in beans. The final pH after the 
fermentation with raffinose was low, with a high percentage of lactate among the acids 
produced, and small amounts of propionate and butyrate. Raffinose can be fermented 
by a large number of intestinal bacteria (Table 1.3, chapter 1). Raffinose has been 
proposed as a bifidogenic factor (Benno et ai, 1987; Fujisaki et at., 1994) and as a selective 
agent in a medium for bifidobacteria (Chapter 7). Our in vitro batch fermentation results 
also indicate that bifidobacteria may play an important role in the fermentation, as 
bifidobacteria do not produce gas, butyrate or propionate, but they do produce acetate 
and lactate (Bezkorovainy and Miller-Catchpole, 1989). 
Fermentation of FOS and inulin, which share a similar chemical composition, only 
differing in chain length, also resulted in relatively large gas production. On the other 
hand, the final pH after fermentation was relatively low for both substrates. 
Fermentation of FOS resulted in slightly more lactate and less propionate and butyrate 
than fermentation of inulin. Ingestion of FOS is known to result in an increase in breath 
hydrogen as well as increased flatulence (Wang and Gibson, 1993; Kawaguchi et ai, 1993; 
Hartemink and Rombouts, 1997; Stone-Dorshow and Levitt, 1987; Alles etai., 1996; Alles etai, 1997, 
Fujita etai, 1991). Some gas formation was thus to be expected. The differences between 
the low gas production in our system and the reported increased flatulence in vivo can 
be explained by a rapid acidification due to fermentation by bifidobacteria. A low pH 
inhibits gas producing organisms, such as Clostridia. In vivo the intestinal contents are 
highly buffered and the acids are rapidly absorbed (Hill, 1995). The pH will thus not drop 
as rapidly as in our system and some substrate will be fermented by gas producing 
organisms. 
Both FOS and inulin can be fermented by a large number of intestinal bacterial 
species (Table 1.3), and have been proposed as bifidogenic factors (Mitsuoka etai, 1987; 
Howard et ai, 1995; Bouhnik et ai, 1996; Gibson and Wang, 1993). As with raffinose, 
bifidobacteria seem to play an important role in the fermentation of FOS in our system, 
as can be seen from the large percentage of lactate. The effect of a larger chain length 
was reflected in the production of a little more butyrate and propionate. Inulin is 
fermented more slowly by bifidobacteria than FOS (Hopkins et ai, 1998), resulting in a 
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slower acidification rate. As discussed above, a slower acidification rate will result in 
increased fermentation of the substrate by other bacteria, including butyrate and 
propionate producing organisms. Our data from gas, butyrate and lactate production, 
indicate a more mixed fermentation for inulin than for FOS. This has also been shown 
previously in rats, where fermentation of inulin resulted in relatively large amounts of 
propionate and butyrate (Levrat etal., 1991). 
Lactitol fermentation resulted in the highest butyrate and propionate 
concentrations of the three galactosyl disaccharides, as well as relatively much gas. 
Very little lactate was formed from lactitol. The relatively high concentration of butyrate 
formed from lactitol, is probably due to the fermentation of the sorbitol residue of 
lactitol. Sorbitol fermentation was shown to result in the production of butyrate and 
propionate (Brebech-Mortensen et ai, 1988). Lactitol has been proposed as a bifidogenic 
factor (Baiiongue et ai, 1997), but our data do not indicate extensive fermentation by 
bifidobacteria, which would have resulted in large concentrations of lactate and little 
butyrate. In accordance with our results is the observation that most bifidobacteria 
cannot ferment sorbitol (Hoideman and Moore, 1977, Table 1.3). Which genera are 
responsible for the fermentation of lactitol cannot be deduced from the data or table 
1.3. 
Lactose and lactulose did, unlike lactitol, not give rise to much gas. Lactose 
fermentation resulted in the lowest average final pH and the largest percentage of 
lactate. Practically no butyrate and propionate were formed. Lactose 
(galactosylglucose) and lactulose (galactosylfructose) differ only slightly chemically, but 
lactulose fermentation resulted in a higher final pH. Lactose normally does not reach 
the large intestine, except in lactose-intolerant persons. In lactose-intolerant persons 
large amounts of gas are formed, causing flatulence and cramps. Considerable gas 
production on lactose was thus to be expected. The high lactate concentrations indicate 
fermentation by lactic acid bacteria, in faeces most likely bifidobacteria. Rapid 
fermentation and subsequent lowering of the pH, may have prevented gas production 
by other bacterial groups, such as Clostridia. 
Lactulose is known to be fermented rapidly with the formation of gas, as can be 
deducted from breath hydrogen studies (Peled and Gilat, 1979; Brighenti et ai, 1995; Kono and 
Nakae, 1996; Florent ef ai, 1985; Wursch et ai, 1989; Kitler et ai, 1992; Sahota ef ai, 1982). It has 
also been proposed as a bifidogenic factor (Terada et ai, 1992a). Many different bacterial 
species can ferment lactulose (Table 1.3). Our data indicate a mixed fermentation, 
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which is in accordance with the observed gas production in vivo as well as the 
bifidogenic effects. From our data the fermentation can not be attributed to any specific 
group of intestinal bacteria. 
Fermentation of TOS resulted in a low gas production, and a similar final pH as 
lactulose. Slightly more propionate and butyrate were formed as compared to lactulose, 
and more as compared to lactose. On the other hand, little lactate was produced. No 
differences were observed in the two groups of volunteers. TOS is considered a 
bifidogenic factor, and it is supposedly fermented preferentially by bifidobacteria (Tanaka 
etal., 1983; Ito et al., 1990; Ito et al., 1993; Ishikawa et al., 1995 Bouhnik et al., 1997). Fermentation 
by bifidobacteria would have resulted in a large percentage of lactate, as with lactose, 
FOS and raffinose. On the other hand not much gas was formed either, which should 
have indicated clostridial fermentation. It can thus not be concluded which bacterial 
groups are mainly involved in fermentation of TOS in our system. 
Lactate was still present in most of the samples after 48h of fermentation. 
Presence of lactate was correlated with a low pH in our studies. Lactate may be further 
metabolized to butyrate, propionate, acetate and gas by different bacterial species. This 
further metabolism may be prevented by a low pH, which may (partly) explain the 
correlation between low pH and lactate. In a continuous, pH controlled system, as well 
as in vivo, lactate may be further metabolized. A low pH and high lactate concentration 
may thus indicate rapid fermentation, as lactate would have been further metabolized, 
before a critical low pH was reached. Similarly, when the pH does not drop rapidly, 
lactate may be formed, but not detected, due to subsequent fermentation. 
It was observed that butyrate production correlates highly with the production of 
gases. The measurement of gases may thus be used as a simple and cheaper 
screening method for butyrate production. Butyrate can be produced directly from 
carbohydrates by many different intestinal species, especially Clostridia. Similarly, some 
Clostridium species can further metabolize lactate to butyrate, carbon dioxide and water 
(Schiegei, 1993). To our knowledge, no other intestinal species is capable of this reaction. 
In conclusion it can be stated that a high concentration of butyrate indicates substantial 
fermentation by Clostridium species, either directly from the carbohydrates, or through 
lactate. 
An interesting observation from this study is that samples from several volunteers 
showed a similar pattern of end products over a six-week period. Similarly, there were 
marked differences between the different volunteers, even though all volunteers had 
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received the same diet for six weeks. It can thus be concluded that factors other than 
diet (including TOS intervention) determine for a large part the metabolic capacity of a 
specific faecal flora in an in vitro batch system. This has been shown previously, but 
only for a single volunteer (McBurney and Thompson, 1987). Recent studies using molecular 
techniques have also shown that genetic factors determine the composition and 
metabolic activity of the intestinal flora in vivo, which is remarkably stable in time 
(McCartney et at., 1996; Zoetendal et al, 1998). 
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SUMMARY 
A new selective medium for the detection of bifidobacteria was developed. The medium owns 
its selectivity to the presence of propionate (15 g/l) and lithium chloride (3 g/l) as inhibitory 
agents, and raffinose (7.5 g/l) as a selective carbon source. In addition casein (5 g/l) is used as 
a protein source, which results in a zone of precipitation around the colonies of bifidobacteria. 
The medium, Raffinose-Bifidobacterium (RB) Agar is free of antibiotics and easy to prepare. 
Bifidobacteria growing on RB agar, show a yellow colony with yellow halo and precipitation zone 
around the colony. All human and dairy bifidobacteria grew well on RB-agar, except for some 
Bi. bifidum strains. Some uncommon or animal species, Bi. gallicum, Bi. asteroides, Bi. 
animalis, Bi. pullorum,, and some Bi. bifidum did either not grow or did not show the 
characteristic reactions. No non bifidobacteria! strains used in dairy products grow with the 
distinctive characteristics. Some faecal strains showed good growth and acid production, 
resulting in characteristic reactions. These strains were Actinomyces species, a CI. perfringens 
strain and some lactobacilli from animal origin. Comparison with other media indicated that RB 
agar is more selective than other media used. 
INTRODUCTION 
Bifidobacteria are Gram-positive anaerobic branched or pleomorphic rods. 
Bifidobacteria can be isolated from a number of sources, mainly faeces, but also 
sewage and from the oral cavity. Their main habitat is the large intestine of humans and 
animals. Bifidobacteria are one of the major groups of intestinal bacteria. At present 
about 25 species of bifidobacteria are recognized. Bifidobacteria can be distinguished 
from other genera by the presence of fructose-6-phosphate phosphoketolase (F6PPK), 
a key enzyme in the 'bifidus pathway' (Scardovi, 1986; Bezkorovainy and Miller-Catchpole, 1989). 
The main species present in humans are Bi. adolescentis, Bi. bifidum, Bi. infantis, 
Bi. breve and Bi. longum in the colon and Bi. dentium in the oral cavity. Five more 
species have been isolated from human sources, Bi. catenulatum, Bi. 
pseudocatenulatum, Bi. angulatum and Bi. gallicum (Scardovi, 1986; Bezkorovainy and Miller-
Catchpole, 1989; Lauer, 1990). 
It is claimed that a high number of bifidobacteria in the colon is positive for human 
health. A high number of bifidobacteria may prevent colonization of pathogens, and 
may have positive effects on intestinal peristalsis, the immunesystem, cancer 
prevention, cholesterol metabolism and carbohydrate metabolism in the colon (Mitsuoka, 
1990; ishibashi and Shimamura, 1993). For these reasons bifidobacteria are added as 
probiotics, especially in dairy products (Tamime era/.; 1995). To stimulate the growth of 
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bifidobacteria specific carbon sources, oligosaccharides, are used as bifidogenic factors 
(Modier, 1994). It is assumed that these carbohydrates are selectively fermented by 
bifidobacteria. Among oligosaccharides with bifidogenic activity are: lactulose, 
transgalactosyl-oligosaccharides (TOS), fructooligosaccharides (FOS), 
isomaltooligosaccharides, raffinose and soybean oligosaccharides (Terada etai; 1992; ito 
etal., 1993; Mitsuoka etal., 1987; Kohmoto etai, 1988; Hayakawa etal., 1990). 
As there is growing interest in using bifidobacteria as probiotics as well as in the 
use of bifidogenic factors, it is necessary to have a rapid, reliable and relatively 
inexpensive method to determine bifidobacteria in both faeces and food products. 
To detect bifidobacteria in faeces or dairy products several methods could be 
applied, like plate count methods, DNA-based methods (ito et ai., 1992) or enzymatic 
methods (Scardovi, 1986). For quality control measurements in dairy products, or for a 
large number of samples in faecal flora studies, plate count methods are still preferable. 
It is therefore necessary to have a medium that selectively promotes the growth of 
bifidobacteria, whereas other bacteria are suppressed. 
Many different media for bifidobacteria have been described (Table 7.1). As it is known 
that several of these media are not selective for bifidobacteria (ishibashi and Shimamura, 
1993) and as previous results showed a large number of other species growing on the 
media we used for the isolation of bifidobacteria, it was decided to develop a new 
medium for the selective detection of bifidobacteria. 
The medium should enhance the growth of (most) bifidobacteria, inhibit the growth 
of (most) other faecal and dairy isolates, lactobacilli and streptococci. As there is very 
little known about the sensitivity and resistance to antibiotics in bifidobacteria, 
lactobacilli and other non-pathogenic intestinal bacteria (Sozzi et ai., 1990; Pacner and 
Kneifel, 1996; Lim etai, 1993) as well as emerging resistance patterns, the medium should 
preferably be free of antibiotics. Furthermore, Pacher and Kneifel (1996) observed that 
the three media containing antibiotics tested in their survey (NPNL ,MPN and MSB) 
showed lower growth rates for bifidobacteria than media without antibiotics. As 
bifidobacteria need carbohydrates for growth (Bezkorovainy and Miiier-Catchpoie, 1989) and 
ferment many oligosaccharides (Terada et ai; 1992; ito et ai, 1993; Mitsuoka et ai, 1987; 
Kohmoto etai, 1988; Hayakawa etai, 1990; Yazawa and Tamura, 1978; Yazawa etai, 1978) it was 
decided to use an oligosaccharide as a carbon source. From the literature it was known 
that most bifidobacteria possess the enzyme a-galactosidase and are able to ferment 
raffinose (Scardovi, 1986; Bezkorovainy and Miller-Catchpole, 1989; Holdeman and Moore, 1977). 
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Table 7.1 : Selection of media used for the enumeration of bifidobacteria from faeces and dairy 
products. 
Medium 
AL-agar 
AMC-agar 
BBM-agar 
BiBI-agar 
Bif-medium 
BIM-25 
BS-agar 
CB-agar 
GL-agar 
LCL-agar 
LP-agar 
MPN-agar 
MRS-LP-agar 
NPNL-agar 
propionate agar 
RCM (modified) 
RCM + stain 
Rogosa 
Rogosa (mod) 
Rogosa-N 
TCPY-agar 
(basic) 
TOS-agar 
(basic) 
TOS-agar 
(mod) 
TPYd-agar 
TTC-agar 
VF Agar (mod) 
YN-6 
Selectivity based on* 
lactose, acetylglucosamine 
nal, polymyxin B, kan, iac, TTC, LiCI, 
prop 
nal, rifampicine, raffinose 
aniline blue, blood 
human whey, nal, paro, aztreonam, 
netilmycin 
kan, nal, iac, neo, polymyxin B 
LiCI, neo, paro, prop 
specific color of china blue 
galactose, LiCI 
lactose, liver infusion 
LiCI, prop, lactose 
lactose, nal 
prop, LiCI 
LiCI, nal, neo, paro, prop 
propA, pH 5.0 
low pH 
Loeffler's methylene blue stain 
low pH 
neo, paro, prop, LiCI 
low pH, nal 
tomato juice 
TOS 
TOS, nal, neo, paro 
dicloxacillin 
TTC 
LiCI, prop, neo, sodium lauryl sulfate 
lactose, nal, neo, bromocresol green 
Used for 
faeces 
Bi. longum 
faeces 
faeces, pharmaceutics 
dairy products 
sewage 
faeces 
faeces 
dairy products 
faeces 
dairy products 
faeces 
dairy products 
faeces, dairy products 
faeces 
dairy products 
dairy products 
dairy products, faeces 
dairy products 
faeces 
faeces 
faeces, dairy products 
dairy products 
dairy products 
faecal contamination 
dairy products 
faeces, sewage 
references 
Yazawaera/., 1984 
Arroyo era/., 1995 
Cole and Fuller, 1989 
Rasig, 1990 
Pacher and Kneifel, 
1996 
Muhoa and Pares, 1988 
Rasig, 1990 
Mevissen-Verhage et 
ai, 1987 
Iwanaefa/., 1993 
Rasig, 1990 
Lapierreefa/., 1992 
Tanaka and Mutai, 1980 
Gomes etal., 1995 
Teraguchi etal., 1978 
Beerens, 1990 
Rasig, 1990 
Rasig, 1990 
Rasig, 1990 
Rasig, 1990 
Rasig, 1990 
Rasig, 1990 
Sonoike, 1986 
Wijsman etal., 1989 
Sozziefa/., 1990 
Gyllenberg and Niemela, 
1957 
Calicchia ef a/., 1993 
Resnickand Levin, 1981 
* iac = iodoacetic acid, kan = kanamycin, LiCI = lithiumchloride, nal = nalidixic acid, neo = neomycin, paro 
= paromomycin, prop = propionate, propA = propionic acid, TOS = transgalactosyl oligosaccharides, TTC 
= 2,3,5-triphenyl-tetrazoliumchloride. 
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In addition raffinose is available in large quantities and high purity. 
Bromocresolpurple was used as a pH indicator to determine fermentation. 
Bifidobacteria may be stimulated by short-chain fatty acids, like propionate and 
butyrate (Kaneko etai., 1994). Several other media also use propionate either alone or in 
combination of lithium chloride (Table 7.1). Kaneko et al. (1994) still observed good 
growth of bifidobacteria at concentrations of propionate, that are higher than the 
concentrations used in these media. Therefore it was decided to add propionate in a 
high concentration in combination with lithium chloride. 
Casein was chosen as a protein source. Bifidobacteria are able to utilize casein 
and may be stimulated by specific casein fractions (Bezkorovainy and Milier-Catchpole, 1989). 
This report describes the selectivity of the newly developed Raffinose-
Bifidobacterium (RB) medium as compared to other media. 
MATERIALS AND METHODS 
Raffinose Bifidobacterium (RB)-medium 
The RB-medium has the following composition (g/l or ml/l): 
Agar bacteriological No 1 (OXOID, Haarlem, The Netherlands) 18.0; D(+)-raffinose 
(Sigma, St. Louis, USA) 7.5; sodium caseinate (Sigma C0376) 5.0; yeast extract 
(OXOID) 5.0; lithiumchloride (Merck, Darmstadt, Germany) 3.0; sodium propionate 
(Verdugt, Tiel, The Netherlands) 15.0; L-cysteine.HCI (Sigma) 0.5; sodium thioglycollate 
(Sigma) 0.5; bromocresolpurple 1% solution (Merck) 15 ml and salts-solution 40 ml. 
The salts solution contained (g/l): MgS04 0.2; CaCI2 0.2; K2HP04 1.0; KH2P04 1.0; 
NaHC03 10.0 and NaCI 2.0. The final pH of the medium was adjusted to 6.7 +/- 0.1, 
using 4N NaOH or HCI. 
Other media 
The following media were prepared according to the instructions by the authors: AL 
(Yazawa et al., 1984), Bifidus Blood Agar, BiBI (Rasi?, 1990), BIM-25 (Munoa and Pares, 1988), 
China Blue Agar, CB (Mevissen-Verhage, 1987), Galactose Lactate Agar, GL (iwana et al., 
1993), LCL (Rasi?, 1990), Lithium chloride - sodium Propionate agar, LP (Lapierre et al., 
1992), NPNL (Teraguchi et al., 1978; Laroia and Martin, 1991), Propionate agar, prop (Beerens, 
1990), TCPY (basic) (RasiQ, 1990), TOS (basic) (Wijsman era/., 1989) and TTC (Gyllenberg and 
117 
RB MEDIUM 
Niemeia, 1957). Agar was omitted from these media when used as broths. Thioglycollate 
medium, thio, (OXOID CM 173) with or without agar (12.0 g/l) was used as a non-
selective control medium. These media were chosen on the basis that they were either 
free of antibiotics or used by several research groups. Media which were essentially 
similar to one of the media chosen were omitted, as were known non-selective media 
(f.e. Rogosa) or media requiring laborious determinations (BBM). 
Strains 
The strains used are listed in Table 7.2, as well as over 100 unidentified faecal isolates 
of lactic acid bacteria, bifidobacteria and streptococci. The strains were obtained from 
culture collections, dairy starters, our departmental strain collection as well as from 
hospitals in the Netherlands. All species tested may be present in faeces or dairy 
products. 
All the unidentified faecal strains were isolated from human and swine faeces 
using media other than RB-agar and were characterized on the basis of cell 
morphology, aerobic and anaerobic growth, katalase and oxidase tests, Gram stain and 
acid tolerance (growth at pH 5.0). 
All strains were kept as stock solutions at -80°C in thioglycollate medium with 30% 
(v/v) glycerol. 
Growth on RB medium 
All strains were pre-cultured from the stock cultures in thioglycollate broth for 24-48h 
anaerobically at 37°C. After incubation RB-agar plates were inoculated with these 
cultures using the surface streak method and incubated 72 h anaerobically at 37°C 
(80% N2, 10% CO2,10% H2, HoekLoos, Rotterdam, The Netherlands). Growth (colony 
size) and colony morphology were determined visually. 
Comparison of RB with other media 
Broth media were prepared according to the literature without the agar. It was decided 
to use broth cultures in the screening for practical purposes. Media (Table 7.1) used 
were AL, BiBI, CB, GL, LCL, LP, prop, TCPY, TOS, TTC and RB. The media were all 
free of antibiotics. A selection of strains (6 bifidobacteria and 26 non-bifidobacteria) 
were precultured in thioglycollate broth for 24-48 h anaerobically at 37°C. Screw 
capped tubes containing 7 ml medium were inoculated with 500 \i\ of these cultures. 
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The tubes were closed and incubated for 72 h (120 h for the prop medium) 
anaerobically at 37°C. Fresh thioglycollate tubes were inoculated with the same 
Table 7.2 : Strains used in this study 
Species 
Ac. israelii 
Ac. naeslundii 
Ac. naeslundii 
Ac. viscosus 
Ac. viscosus 
B. fragilis 
B. ovatus 
B. thetaiotaomicron 
B. vulgatus 
Bi. adolescentis 
Bi. angulatum 
Bi. animalis 
Bi. asteroides 
Bi. bifidum 
Bi. bourn 
Bi. breve 
Bi. catenulatum 
Bi. dentium 
Bi. gallicum 
Bi. infantis 
Bi. infantis 
Bi. longum 
Bi. longum 
Bi. 
pseudocatenulatum 
Bi. pseudolongum 
ssp pseudolongum 
Bi. pullorum 
Bi. subtile 
Bi. suis 
Bi. suis 
Bi. thermophilum 
Bifidobacterium sp. 
Bifidobacterium sp. 
Bifidobacterium sp. 
Bifidobacterium sp. 
CI. beijerinckii 
CI. bifermentans 
CI. butyricum 
CI. clostridioforme 
CI. difficile 
Strains 
Ac-1 
Ac-2 
041 
040 
Ac-3 
ATCC 25285 
ATCC 8483 
ATCC 29714 
ATCC 8482 
ATCC 15703, 
15704, 15705 
ATCC 27535 
ATCC 25527 
ATCC 25910 
ATCC 29521, 
35917, DSM 20082, 
20215, NCIMB 8810 
ATCC 27917 
ATCC 15698, 15700 
ATCC 25739 
ATCC 27534 
ATCC 49850 
ATCC 15697,25962 
BBI 
NCFB 2259, ATCC 
15707 
BBL 
ATCC 27919 
ATCC 25526 
ATCC 27685 
ATCC 27537 
ATCC 27533 
003 
ATCC 25525 
Bb12 
Bi-2 
BdBo 
Bf. species 420 
CI-7 
ATCC 17836 
ATCC 8260 
CI-3 
ATCC 19397 
Origin* 
human faeces 
human faeces 
oral isolate 
oral isolate 
human faeces 
RhonePoulenc 
RhonePoulenc 
swine faeces 
Christian 
Hanssen 
human faeces 
NIZO 
Wiesby 
human faeces 
human faeces 
Species 
CI. difficile 
CI. fallax 
CI. paraputrificium 
CI. perfringens 
CI. perfringens 
CI. ramosum 
CI. septicum 
CI. sordelli 
CI. sporogenes 
CI. tertium 
Ec. faecalis 
Ec. faecium 
Ec. hirae 
E. coli 
Eu. aerofaciens 
F. mortiferum 
F. necrogenes 
F. necrophorum 
Kl. pneumoniae 
L. lactis ssp. lactis 
Lb. acidophilus 
Lb. acidophilus 
Lb. acidophilus 
Lb. acidophilus 
Lb. casei 
Lb. casei 
Lb. delbrueckii ssp. 
bulgaricus 
Lb. fermentum 
Lb. helveticus 
Lb. plantarum 
Me. elsdenii 
mixed starter 
P. prevotii 
Ft. productus 
Salmonella infantis 
Shigella 
dysenteriae 
St. thermophilus 
Yersinia 
enterocolitica 
Strains 
CI-14 
ATCC 19400 
CI-2 
NCTC 8239 
CI-35 and 657 
CI-12 
ATCC 6008 
ATCC 9714 
ATCC 19404 
CI-15 
ATCC 19433 
Ec-5 and Ec-6 
ATCC 9790 
114, E-22andE-23 
ATCC 25986 
ATCC 9817 
ATCC 25556 
DSM 20698 
119 
ATCC 19435, DSM 
20661 
126 and 128 
Lacid 
La-5 
Shirota 
LC-10 
DSM 20080 
123 
NCIMB 8652, NCFB 
860 
ATCC 8014 
Meg-1 
NCFM 
ATCC 9321 
ATCC 35244 
E-7 
E-29 
DSM 20259.NCFB 
2075 
E-25 
Origin* 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
human faeces 
swine faeces 
Rhone-
Poulenc 
NIZO 
Christian 
Hanssen 
Yakult 
RhonePoulenc 
swine faeces 
swine faeces 
RhonePoulenc 
human faeces 
human faeces 
human faeces 
* The starter cultures were obtained through the following distributors : Christian Hanssen, Houten, The 
Netherlands ; NIZO, Netherlands Institute for Dairy Research, Ede, The Netherlands; Rhone Poulenc, 
Vellinga Food Ingredients, Oudewater, The Netherlands; Wiesby, Niebiill, Germany and Yakult BV, 
Almere, The Netherlands 
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cultures and used as controls. Growth was determined by optical density 
measurements at 620 nm (OD620, EAR 400, SLT Instruments, Groedig, Austria) and 
final pH was determined (pH PocketFet, Sentron, Roden, The Netherlands). For three 
media, BiBI, CB and RB only final pH was determined, for one medium, prop, only 
OD620 was determined. Growth was considered positive when either the OD620 was 
> 0.2 units higher than the non-inoculated medium or the pH was > 1.0 units lower than 
the non-inoculated control. 
Solid media (AL, BiBI, BIM-25, CB, GL, LCL, LP, NPNL, prop and RB) were 
prepared according to the literature (Table 7.1). Thioglycollate agar was used as the 
control medium. A selection of 4 bifidobacteria and 11 non-bifidobacteria were pre-
cultured in thioglycollate broth for 24-48 h anaerobically at 37°C. Plates were inoculated 
with these cultures and incubated 72 h anaerobically at 37°C. Growth and colony 
morphology were determined visually. 
RB modifications 
Several modifications of RB-medium were tested to increase the selectivity. The media 
were prepared as broths. Propionate concentrations were changed to 10 g/l (RB-9), 20 
g/l (RB-11), 25 g/l (RB-12) or 30 g/l (RB-13). Propionate was replaced by butyrate (RB-
17) or valerate (RB-18). Sodium caseinate was reduced to 2.5 g/l (RB-14) or replaced 
by acid casein hydrolysate (RB-8) and ammonium-iron sulfate (RB15), and raffinose 
was replaced by TOS (RB-5). TOS was free of glucose, lactose and galactose (Borculo 
Whey Products, Borculo, The Netherlands). The strains tested showed possible false 
positive results on RB agar (one actinomyces, one Clostridium and four lactobacilli). In 
addition some bifidobacteria (two type strains, one isolate from swine faeces and one 
'wild' strain from human faeces) were used. For RB-5, replacing raffinose with TOS, 
only 15 bifidobacteria were tested, among these all Bi. bifidum strains. 
RESULTS 
Growth on RB medium 
Most bifidobacteria grew well on RB agar. Growth was defined as visible colonies of 
over 1 mm diameter. Visible colonies with smaller diameter were considered pin-point 
colonies. Of 27 strains, representing 18 species, six failed to show characteristic 
growth. Characteristic growth was defined as a yellow colony over 3 mm diameter with 
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a yellow opaque halo, due to acid formation and casein precipitation. Of these six 
strains only the type strain of Bi. asteroides failed to grow completely. The type strain of 
Bi. pullorum and four of the Bi. bifidum strains did grow, but failed to produce acid and 
thus showed no yellow halo or precipitation. Two other strains, Bi. gallicum and Bi. 
animalis, did show some acid formation, but no clear halo or precipitation zone. All 
other strains, including one Bi. bifidum (NCIMB 8810) showed the characteristic 
reactions. 
Most non-bifidobacteria failed to grow on RB-medium. Only four out of 48 
identified strains (representing 40 species) showed characteristic growth. These strains 
were CI. perfringens 657 (a human isolate) and three lactobacilli, Lb. fermentum 123 
and Lb. acidophilus 126 and 128. These last three strains were isolated from pigs. 
Three out of five actinomycetes, Ac. naeslundii Ac-2 and 041 and Ac. viscosus 040, 
showed growth, but with limited acid production. Casein precipitation was sometimes 
observed. The four Bacteroides species, 12 other Clostridia, 6 enterobacteria, 3 
enterococci, 4 lactobacilli, 2 streptococci, 2 lactococci, 3 fusobacteria, Pe. prevotii, Eu. 
limosum and Me. elsdenii showed either no growth or pin-point colonies. All Lb. 
acidophilus or Lb. casei containing starter cultures did either not grow at all, or showed 
pin-point colonies. Four out of six starters containing bifidobacteria showed 
characteristic colonies. Bf. species 420 and the Bi. infantis from the MSK B2 mixture 
failed to grow. The failure to recover bifidobacteria from the starter MSK B2 is probably 
due to the pre-culturing conditions. It is possible that the two other species (Lb. 
acidophilus and St. thermophilus) will outgrow bifidobacteria in thioglycollate broth. 
Subsequent plating on RB will therefore fail to show bifidobacteria. Preculturing in RB 
broth instead of thioglycollate and subsequent plating on RB agar did result in 
characteristic colonies, indicating that the Bi. infantis strain does grow on RB medium. 
Of the unidentified faecal isolates all strains with a typical bifidobacterium 
morphology grew well on the medium and showed the characteristic reactions. None of 
the cocci showed characteristic reactions, neither did most of the lactobacilli. Only 
lactobacilli isolated from swine faeces showed acid production, but no casein 
precipitation. 
121 
< ° 
c + 
o _ 
O 3 
s 1 
s 
co CD 
V -
3 
• * -» 
3 
O 
JZ 
•5 
_C 
CO 
c 
'to 
0) 
"cO 
0 
CD 
CO 
H — 
• 0 
c 
CO 
.2 
*^ -CD 
*^  O CO 
J3 
O 
2 
*— JD 
O 
. C 
5 0 1 _ 
O ) 
*— O 
c 
0 
.52 
* i _ 
CO 
Q. 
E 
0 
O 
CO 
r^  
CD 
CO 
H 
E 
3 
TJ 
CD 
2 
m 
cc 
0 
1= 
w 
O 
H 
> 
Q-
O 
H 
a 
0 
t _ 
Q. 
Q. 
- 1 
O 
- 1 
- 1 
O 
m O 
m 
m 
< 
0 
!c 
c 
'fC 
to 
CO 
cu 
0 
CD 
CO 
+ + + + + + + + 
+ + + + + + + + + + + + + , + + + + + + + + + + + + + + + + + + 
+ + + + + + + I + + + + + + + + + + + + , + + + + + + + + + + + 
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
+ + + , + + + . , + + 
•D T3 
+ + + + + + + + + C + + + + , + + + + + + + + + + + C + + + + + 
+ + . + . . + , + + + , + + + + + + + + + + + + + + + + + + 
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
+ + + + + + + + + + + + + + + 
*= + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + 
co 1 - o 
O CM O 
S K I N m o m 
1 ^ t ^ co m - i -
a> o co 00 co • * c\i 
CD r~- m CM 00 h- co 
i n i n 1 ^ i n • * a> • * 
T - i - CM CM 00 CM CO 
o 
CO 
CM 
00 
CO 
co 
•* O) 
T -
CO 
O M f l 
05 1 - m 
t^- 00 10 
O) 05 CM 
• * 
•* CM 
i n 
CO 
0 0 0 0 0 0 0 0 0 0 o 0 0 0 
< < < 
0 0 0 • o 
^^g^^^^^pnoop?„„|p^S 
co o 3"o 
CO 
T CO 
C - o 
S ° 
o £ 
— CO 
1 * u 8 ° 
CO £ 
§ 1 
. * ; CO 
c .c 
o J= 
••- CM 
X <= 
® d 'E 
— c co 
*- CO "K 
•f I 
O J - Q c 
Z o 11 
i 2 c o - o 
c Q c 
=>o~ 
CO »= ~ 
ca 2L CO 
o 0 g 
<M - _ CO • = TJ 
o 2 s> 
0 C 0) 
— O S 
CO U CO 
•M»S 
£ s £ 
. co a> 
co £ S 
1 | I 
a> c a> 
> => to 
I; I 
"O C ' T 
CD CO § 
o m c 
l o o 
E c ~ 
O (0 r 
U CO £ 
SB'S 
Sag 
2 « co 
a g e 
(N 
RB MEDIUM 
Comparison of growth in broths 
The results of the comparison of the broth cultures are summarized in table 7.3. The six 
bifidobacteria were able to grow in all media except for Bi. bifidum ATCC 29521 (on 
LCL, prop and RB), Bi. adolescentis ATCC 15703 (on LCL and prop) and Bi. longum 
ATCC 15707 (on LCL and prop). Most non-bifidobacteria grew well in all media, except 
for the prop and RB media. 
Comparison of growth on solid media 
The results of the comparison of the solid media are summarized in table 7.4. Growth 
was defined as visible colonies of over 1 mm diameter. Visible colonies with smaller 
diameter were considered pin-point colonies. The four bifidobacteria were able to grow 
on all media, except for Bi. pseudolongum ssp pseudolongum ATCC 25526 on the 
prop medium. All other strains grew on thioglycollate medium (control), BiBI and BIM-25 
medium. On the latter medium bifidobacteria and lactic acid bacteria showed a 
characteristic pink color, whereas other species did not. 
Table 7.4 : Comparison of growth of bifidobacteria and other strains on agar plates. 
species 
Bi. adolescentis 
Bi. breve 
Bi. infantis 
Bi. pseudolongum 
ssp 
pseudolongum 
B. vulgatus 
CI. bifermentans 
CI. difficile 
CI. tertium 
Ec. faecalis 
Ec. faecium 
Ec. hirae 
Lb. acidophilus 
Lb. casei 
Lb. delbrueckii 
ssp bulgaricus 
St. thermophilus 
strain 
ATCC 15703 
ATCC 15700 
ATCC 25962 
ATCC 25526 
ATCC 8482 
ATCC 17836 
ATCC 19397 
CM 5 
ATCC 19433 
Ec-6 
ATCC 9790 
Lb. acid 
Shirota 
DSM 20080 
NCFB 2075 
thio 
+* 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
AL 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
BiBI 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
BIM 
4# 
+ 
+# 
+# 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+# 
+# 
CB 
+ 
+ 
+ 
+ 
+ 
n.d. 
n.d. 
n.d. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Medium 
GL 
+ 
+ 
+ 
+ 
+ 
n.d. 
n.d. 
n.d. 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
LCL 
+ 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
LP 
+ 
+ 
+ 
+ 
+ 
n.d. 
n.d. 
n.d. 
+ 
+ 
+ 
+ 
+ 
+ 
NPNL 
+ 
+ 
+ 
+ 
+ 
-
-
-
+ 
+ 
-
-
+ 
-
-
prop 
+ 
+ 
+ 
-
+ 
-
-
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
RB 
+ 
+ 
+ 
+ 
-
-
-
-
-
-
-
-
-
-
-
* + = good growth, colonies over 1 mm diameter, 
n.d. = not determined # = red colonies 
no growth or pin-point colonies (<1 mm diameter). 
The CB, GL and LP agars also supported growth of all strains tested. Bifidobacteria 
showed the characteristic brown color on CB agar, whereas other species showed blue 
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colonies. CI. tertium CI-15 failed to grow on AL agar and none of the Clostridia grew on 
LCL or prop agar. Seven strains failed on NPNL, among them all dairy strains. None of 
the non-bifidobacterial strains grew on RB agar. 
RB modifications 
The results of RB with different propionate concentrations are given in table 7.5. The 
lower propionate concentrations (10 and 15 g/l) enhanced the growth of Lb. 
acidophilus. Increasing the concentration to 20 or 25 g/l inhibited only the Lb. 
acidophilus strains from dairy products. With 30 g/l propionate some bifidobacteria were 
inhibited, whereas other strains were not inhibited. 
Addition of butyrate did not increase the selectivity. All 10 strains showed the 
same growth in the medium with propionate as in the medium with butyrate. Addition of 
valerate resulted in inhibition of two out of six bifidobacteria, whereas other bacteria 
showed the same growth as with propionate. 
Replacing casein by casein hydrolysate did not affect the growth of any of the 
bacteria tested. The precipitation of casein, one of the main characteristics of RB 
medium, however, was not visible with casein hydrolysate. Addition of ammonium-iron 
sulfate (RB-15) resulted in decreased growth of bifidobacteria (lower final OD values) 
and no growth of some lactobacilli. The Actinomyces species were not inhibited. 
Replacing raffinose by TOS resulted in increased growth of Bi. bifidum strains, 
none of the other bifidobacteria were inhibited. 
Table 7.5: Effect of propionate concentration on the growth of selected bacteria, 
species strain medium 
RB-9* RB-10 RB-11 RB-12 RB-13 
Bifidobacterium sp. 
Bi. infantis 
Bi. longum 
Bi. suis 
Ac. naeslundii 
CI. bifermentans 
Lb. acidophilus 
Lb. acidophilus 
Lb. fermentum 
Lb. fermentum 
Bi-2 
ATCC15697 
ATCC15707 
003 
Ac-2 
ATCC 17836 
126 
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124 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
-
+ 
+ 
-
+ 
-
+ 
-
-
+ 
-
+ 
+ 
* RB-9 10 g/l propionate, RB-10 15 g/l, RB-11 20 g/l, RB-12 25 g/l and RB-13 30 g/l 
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DISCUSSION 
As most bifidobacteria possess the enzyme oc-galactosidase we used raffinose as a 
selective carbon source. The same principle has been used previously, based on the 
detection of the enzyme a-galactosidase (Chevalier et ai, 1991). However, the 
chromogenic substrate used by these authors is expensive and difficult to obtain. 
Replacing raffinose by other carbohydrates as lactulose, fructooligosaccharides (FOS) 
and TOS did not result in increased selectivity. Many non-bifidobacteria strains did grow 
on the FOS and lactulose media (data not shown). TOS showed similar results as 
raffinose, but with increased growth of Bi. bifidum. However, TOS is as yet not available 
commercially in large quantities and high purity. Use of commercial TOS (with 10-15% 
lactose and galactose) showed good growth of a large number of other bacteria (data 
not shown), due to the mono-and disaccharides present. When TOS is available in high 
purity and large quantities, it has to be established whether replacing raffinose with 
TOS increases the selectivity. 
Propionate was added in a high concentration. Bifidobacteria are stimulated by 
short-chain fatty acids, like propionate and butyrate (Kaneko et ai, 1994), whereas many 
other species are inhibited. Increasing the propionate concentration to 25 or 30 g/l did 
not improve the selectivity, the three lactobacilli showing false positive results were not 
inhibited. As propionate is cheaper, available as an (odorless) salt and as effective as 
butyrate, it was decided not to use butyrate. 
Casein was added as bifidobacteria may be stimulated by casein fractions 
(Bezkorovainy and Milier-Catchpole, 1989). The fermentation of raffinose, and subsequent 
decrease in pH, resulted in casein precipitation. Although not intended, this precipitation 
was useful in characterizing bifidobacteria on RB agar. Replacing casein with casein 
hydrolysate or ammoniumsulfate resulted in loss of a precipitation zone. Increased 
selectivity was not observed by these replacements. 
Finally bromocresolpurple was added as a pH indicator. Unexpectedly, some 
Clostridia, which only showed pin-point colonies, did show a clear halo. However, this 
halo was neither yellow, nor was a precipitate present. Other experiments showed that 
this was due to degradation of the bromocresolpurple. Degradation of this indicator has 
not been demonstrated in the literature. This degradation will not yield in false-positive 
results, as the characteristic reactions are not present. 
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Growth of bifidobacteria on RB-medium was characteristic, due to acid formation 
from raffinose. This resulted in a yellow colony and halo and a precipitation of casein, 
due to the drop in pH. Twenty-one strains, out of 27 (75%) as well as four out of six 
(67%) starter cultures showed the characteristic reactions. Except for Bi. bifidum, these 
strains represent all major human species as well as the species used as probiotics. 
Raffinose fermentation by Bi. bifidum is strain specific (Scardovi, 1986; Bezkorovainy and 
Miller-Catchpole, 1989; Holdeman and Moore, 1977), which may result in a lower isolation of 
this species. From the bifidobacteria that did not show characteristic growth on RB-
agar, Bi. asteroides and Bi. pullorum have so far only be isolated from honeybees and 
poultry respectively, Bi. animalis has been isolated from a number of animal species, 
whereas Bi. gallicum is a rare human species (only one strain has been described until 
1996). The failure to recover bifidobacteria from the starter MSK B2 was due to the pre-
culturing conditions as described above. 
Growth of non-bifidobacterial strains on RB agar was restricted to actinomycetes, 
one CI. perfringens and several lactobacilli. Actinomycetes are closely related to 
bifidobacteria and it is therefore not surprising that some growth will occur (Cross and 
Goodfeilow, 1973). All lactobacilli that showed characteristic growth on RB agar were all 
isolated from pigs. As none of the lactobacilli from humans or dairy products showed 
any growth, the characteristic growth of these strains may be due to porcine origin. The 
reason for this difference remains unknown. 
From the results it can be concluded that most antibiotic-free media tested do 
support the growth of bifidobacteria as well as many non-bifidobacteria. This was 
confirmed both in broth cultures as well on agar plates. Media with antibiotics (NPNL, 
BIM-25) supported the growth of bifidobacteria, but also of several other species. RB-
broth and RB-agar support the growth of most bifidobacteria but only very few non-
bifidobacteria. 
RB-medium is therefore a more selective medium for the detection of bifidobacteria 
than the other media tested. 
However, as with all media for bifidobacteria, all colonies showing doubtful 
characteristics should be confirmed as bifidobacteria by enzymatic or DNA-based 
methods (Scardovi, 1986; Bezkorovainy and Miller-Catchpole, 1989). 
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SUMMARY 
The development of a new selective medium, LAMVAB, for the isolation of Lactobacillus 
species from faeces is described. The medium is highly selective due to a low pH and the 
presence of vancomycin (20 mg L"1). In addition the medium contains cysteine.HCI to enhance 
anaerobic conditions, and bromocresol green as a pH indicator. 
Competing faecal flora is inhibited by the low pH (enterobacteria, bacteroides and other 
Gram-negative anaerobes, Clostridia) and the vancomycin (enterococci, bifidobacteria, 
Clostridia). 
Characterization of the strains isolated on LAMVAB from human faeces included all 
common faecal lactobacilli and no other lactic acid bacteria. In one sample vancomycin-
resistant cocci were present and in another sample yeasts were isolated. 
It can be concluded that the new medium is highly selective and permits the growth of all 
common faecal lactobacilli. 
The new medium can also be applied as a selective medium for lactobacilli in probiotics, 
which contain mixed populations of lactobacilli, bifidobacteria and enterococci. 
INTRODUCTION 
Lactobacilli are Gram-positive anaerobic or facultative aerobic rods, which can be 
isolated from a large number of sources. Lactobacilli can be isolated from the human 
and animal body (oral cavity, stomach, intestines, vagina), plants and material of plant 
origin, sewage and fermented products. Lactobacilli are strictly fermentative and acid-
resistant. Growth is enhanced by acidic conditions. Final pH in broth cultures is 
generally below 4.5 (Hammes and Vogel, 1995). 
Lactobacilli are considered to have beneficial effects on human and animal health. 
Therefore several species of lactobacilli are used as probiotics. Worldwide many 
products with probiotic lactobacilli are marketed (Fuller, 1992; Sanders, 1993). To have a 
beneficial effect on the health of the host, it is necessary that the probiotic strain is able 
to survive in the gastrointestinal tract (Fuller, 1992). It is therefore necessary to determine 
the number of lactobacilli in faeces and, if possible, to identify the different species 
directly. This can be done using specific selective media, DNA probes or immunological 
techniques. 
Lactobacilli are generally isolated on rich, slightly acidic media, such as MRS, LBS 
and Rogosa agars (Mitsuoka et al., 1973; Kleessen et al., 1995; Minelli era/., 1993). For most 
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(fermented) food products these media allow selective isolation of lactobacilli, as they 
are generally the most abundant group of bacteria present. In faeces, however, 
lactobacilli are present in relatively low numbers (Mitsuoka and Ohno, 1977; Finegoid et ai., 
1977). In faecal samples several lactobacilli have been isolated (Table 8.1), in humans 
the main lactobacilli are Lb. acidophilus, Lb. casei and Lb. paracasei (Hammes and Vogei, 
1995). The counts of lactobacilli in faeces are highly variable between species and 
persons, even within a single person (Mitsuoka et ai., 1973; Mitsuoka and Ohno, 1977; Finegoid et 
ai, 1977). The media mentioned above are not selective as growth of other acid-resistant 
bacteria is not restricted and in particular bifidobacteria, streptococci and enterococci 
are able to grow on these media (Cole and Fuller, 1989; Nelson and George, 1995). 
Growth of other intestinal bacteria is restricted, but not negligible. It is therefore 
necessary to have a highly selective medium, which allows the isolation of low numbers 
of lactobacilli in the presence of high numbers of bifidobacteria, streptococci and/or 
enterococci. 
In this report we describe the development of a new selective medium for the isolation 
of faecal lactobacilli. 
Table 8.1 : Species of lactobacilli isolated from human or animal faeces (Hammes and Vogel, 
1995) 
Species 
Lb. acidophilus 
Lb. amylovorus 
Lb. aviarius 
Lb. brevis 
Lb. casei 
Lb. coryniformis 
Lb. crispatus 
Lb. curvatus 
Lb. fermentum 
Lb. gallinarium 
Lb. gasseri 
Isolated from 
human, 
pig 
chicken 
human, 
human 
cow 
human 
cow 
human 
chicken 
human 
animals 
cow, rat 
Species 
Lb. hamsteri 
Lb. intestinalis 
Lb. johnsonii 
Lb. murinus 
Lb. paracasei 
Lb. plantarum 
Lb. reuteri 
Lb. rhamnosus 
Lb. salivarius 
Lb. vaccinostercus 
Isolated from 
hamster 
mouse, rat 
chicken, calf, mouse, pig 
mouse, rat 
human 
human 
human, animals 
human 
human, hamster, chicken 
cow 
Lactobacilli are highly acid resistant, growth is possible at an initial pH of 5.0 
(Hammes and Vogei, 1995). Most other intestinal bacteria are not able to grow at this acidic 
pH. Bifidobacteria, enterococci and streptococci are not inhibited (Hardie et al., 1995; 
Sgorbati et ai, 1995; Devriese and Pot, 1995). Contrary to other Gram-positive bacteria, most 
lactobacilli are resistant to the antibiotic vancomycin, while Gram-negative bacteria are 
129 
LAMVAB 
generally resistant (Swenson etal., 1990; Holliman and Bone, 1988; Lentsner etal., 1981; Chow and 
Cheng, 1988). Vancomycin has already been applied previously for the selective isolation 
of lactobacilli from brewery products (Simpson et ai, 1988). It is not useful as a selective 
agent in dairy products containing Leuconostoc or Pediococcus species, as these are 
vancomycin resistant (Swenson ef a/., 1990; Bille et ai., 1992; Tsakri and Maniatis, 1991). 
Enterococci, streptococci and bifidobacteria are susceptible to vancomycin (Potgieter et 
ai, 1992; Lim etal., 1993; Green etal., 1991). Furthermore resistance to vancomycin is not 
inducible and only few vancomycin resistant enterococci have been isolated (Huygens, 
1995). Vancomycin resistant bifidobacteria have not been reported. 
Although lactobacilli are aerotolerant, anaerobic conditions favor their isolation 
and growth. It was decided to add cystein as a reducing agent to improve the isolation 
of lactobacilli. 
The final medium consisted of MRS agar, with vancomycin, low pH (5.0) and 
cystein as selective and elective agents, and was named Lactobacillus Anaerobic MRS 
with Vancomycin and Bromocresol green, or LAMVAB. 
MATERIALS AND METHODS 
LAMVAB 
The medium consists of three different components: 
Solution A: MRS broth (Merck 1.10661) 104.4 g/l, with cystein.HCI 0.5 g/l and 
bromocresol green 0.05 g/l. The pH of this solution was adjusted to 5.0 +/- 0.1 using 4M 
HCI before autoclaving. Solution B: Agar 40 g/l. Solution C: Vancomycin hydrochloride 
(local pharmacy, >95% purity) 2 mg/ml in water. Solution C should be kept at 0-4 °C 
and was found to be stable at least three months. 
Solutions A and B are sterilized at 121°C for 15 min. Solution C is sterilized by 
filtration using a 0.2 urn filter. 
Preparation of the medium involves sterilization of equal volumes of solutions A 
and B. Solution B is cooled down to 50 °C in a water bath. Solution A is cooled down to 
room temperature. To 500 ml solution A 10 ml of solution C is added aseptically. Finally 
solution B is added to the MRS-vancomycin (A+C) mixture. Plates have to be poured 
immediately after mixing. This procedure results in a final vancomycin concentration of 
20 mg/l. 
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Growth of different intestinal bacteria on LAMVAB 
Selected intestinal bacteria from stock cultures were pre-cultured anaerobically in 
thioglycollate broth for 24-48h at 37°C. From these cultures a streak was made, using a 
sterile cotton swab, on LAMVAB and RCA (Reinforced Clostridial Agar, Oxoid) plates. 
RCA was used as a control medium. 
The following strains were used: lactobacilli (150 strains, >10 species), 
bacteroides (10 strains, 5 species), Clostridia (15 strains, 13 species), bifidobacteria (25 
strains, >12 species), eubacteria (2 strains, 2 species), streptococci, lactococci and 
enterococci (50 strains, >10 species), anaerobic cocci (5 strains, 3 species), 
fusobacteria (5 strains, 3 species), enterobacteria (15 strains, 7 species), actinomyces 
(4 strains, 3 species) and two strains of Megasphaera elsdenii. 
Inhibition of intestinal bacteria by LAMVAB 
To determine which component of the LAMVAB medium inhibits different groups of 
intestinal bacteria, a selection of isolates (Table 8.2) was tested for growth on LAMVAB, 
LAMVAB with pH 6.5 (L65), and LAMVAB without vancomycin (L-). The inoculation was 
carried out as described above. 
Comparison of LAMVAB with MRS 
To compare the growth of intestinal lactobacilli and possible competing flora on MRS 
and LAMVAB, 71 strains of lactobacilli, bifidobacteria, Actinomyces species, 
streptococci and lactococci (Table 8.3) were grown in MRS broth. From these broths 
decimal dilutions were prepared as described above, and inoculated on MRS and 
LAMVAB agars. The plates were incubated anaerobically at 37°C for 72 h . 
Isolation of lactobacilli from faeces 
To determine the selectivity of LAMVAB as a medium for the isolation of lactobacilli, 
faecal samples (from humans and animals) were taken and dilutions were plated on 
MRS and LAMVAB agars. Fecal samples were taken as fresh as possible and an 
aliquot was transferred into a pre-weighed bottle with buffered medium. This medium 
consisted of Buffered Peptone Water (Oxoid ) with cystein.HCI 0.5 g/l and Tween 80 1 
ml/I. The pH was adjusted to 6.5 +/- 0.1 before autoclaving at 121°C for 15 min. After 
sampling the bottles were imported into an anaerobic chamber, with an atmosphere of 
80% nitrogen, 10% hydrogen and 10% carbon dioxide (HoekLoos SHK 050H, 
HoekLoos, Rotterdam, The Netherlands). The samples were mixed thoroughly using an 
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Ultra Turrax mixer. A decimal dilution series was prepared of the homogenates using 
RPS. RPS consisted of Neutralized Bacterial Peptone (Oxoid), 0.5 g/l, NaCI (Merck) 8.0 
g/l and cystein.HCI 0.5 g/l. The pH was adjusted to 6.7 +/- 0.1 before autoclaving at 121 
°C for 15 min. The tubes were kept anaerobically at least 16h before use. Finally 30 uJ 
of the 3rd, 5th and 7th dilutions was pipetted on LAMVAB or MRS plates. The plates 
were incubated anaerobically at 37 °C for 72 h. 
RESULTS 
Growth of different intestinal bacteria on LAMVAB 
None of the intestinal strains, except for the lactobacilli and one strain of St. gordonii 
were able to grow on LAMVAB. All lactobacilli from all origins were able to grow on 
LAMVAB. Growth was determined as colonies over 1 mm diameter and a yellow 
discoloration of the medium, due to acid production. Most colonies were green or blue, 
due to the uptake of bromocresol green into the cell. As not all lactobacilli showed this 
color and remained white, the color of the colonies was not considered characteristic. 
Several isolates from fish failed to grow on LAMVAB. Further identification showed that 
these isolates were camobacteria and not lactobacilli (M. Dapkevicius, Wageningen 
Agricultural University, personal communication). Camobacteria fail to grow at pH 5.0. 
Table 8.2 : Growth of selected bacteria on LAMVAB, LAMVAB at pH 6.5 (L65) or LAMVAB 
without vancomycin (L-). 
Species 
Ac. naeslundii 
Aeromonas hydrophila 
Bacillus cereus 
Bacillus megatherium 
B. fragilis 
B. ovatus 
Bi. adolescentis 
Bi. dentium 
Bi. infantis 
Bi. longum 
Enterobacter cloacae 
Ec. faecalis 
Ec. species 
L65 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
Yes 
Yes 
No 
L-
Yes 
No 
No 
No 
No 
No 
Yes 
Yes 
Yes 
Yes 
No 
No 
Yes 
LAMVAB 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
Species 
E. coll 
Lactococcus lactis 
Listeria innocua 
Proteus mirabilis 
Proteus vulgaris 
Pseudomonas tragi 
Pseudomonas sp. 
Salmonella infantis 
Salmonella montevideo 
Staphylococcus aureus 
St. mutans 
St. oralis 
Yersinia enterocolitica 
L65 
Yes 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
Yes 
L-
No 
Yes 
No 
No 
No 
No 
No 
No 
No 
Yes 
Yes 
Yes 
No 
LAMVAB 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
Growth was considered positive if colonies were visible. This included pinpoint colonies. 
132 
CO 
5 
CO 
CO 
T3 
<D 
CO 
CO 
CD 
i_ 
Q . 
X 
CD 
CO 
£ 
c 
3 
O 
O 
CD 
< 
> 
•a 
c 
CO 
CD 
E 
c 
o 
CO 
DC 
c 
o 
CO 
o 
CD 
Q L 
E 
o 
o 
.g 
'co 
CO 
o 
Q . 
T3 
c 
CO o 
CO 
JD 
O 
O 
T3 
CD 
t3 
.2? 
CD 
CO 
«, co O 
c ® 
o E 
O 3 
c 
o 
CO ^ 
c m 
o < 
, o > 
2 
raco 
o < 
o —l 
O)C0 
Set 
O O - i - C O C O O J C O O O O O O O O O O O O O O O O O O O O O O O O O r - . 
C O O O C M O C O C O O I O O J C O O C O C M T - O ^ - C O O 
^ i f l r ( O i - c o o o ) 0 ) o q ' t o | h ; c q N P ) i n i ^ 
o o c o c o N N c d o o s o o c o c d s o d o o c o c o o o c o c o 
CO 
CO 
o CO 
CO 
c-
co b 
(D 
o 
<D 
CO 
(-m 
b 
<u 
<> CD CO 
r 
m 
fc 
> 
u 
m 
o m t ^ . c n c o c M c o c \ i c o 
L O c q c p p c q c n o o c o c M 
c o c o c o c d c r i r ^ r ^ r ^ c r i c o 
co co co 
E E 
3 3 3 3 3 
— Q) CD CD Q 0) CD CD 
< JO < CO Q . Q . O . Q . Q . Q . O . 
1) 1) » «l F 
0 . 0 . 0 . 0 . " -
CO O P O 
> • £ - . £ • . £ • £ • . & . & £ &£•&£•£ 
o_ p !>i rg 
£• < Z Z 
o N 
^ 
F F 
z z 
£•£• 
> > CO CO 
o u 
o o 
CM CO O Tf Tt r- T 
N t - CM O O W 9 
CO (O CO CO CM CO < 
O) m (/) id iq «) 
qj qj Q) Q) ^ „3 . 3 o) 
75 "75 "?5 "75 n \ i»i". ri\ f* 
cj) 
Ql 
Q 
0) 
Ql 
Q 
CJ) 
Ql 
Q 
0) 
U 
Ql 
Q CO 
l 
CJ 
Ql 
Q 
Ql 
O 
Q> 
Q 
», m N w en r- r-. o co co ^ -*. #« 
^ C O C O ^ t C O T t c O ' - C f t ^ t C O C O c O o O l O i - T T v i— O O CO • — • — • — • — • — CM -— i— - — • — • — 00 CM CD T - O o '*> 
^ - < ^ - 0 0 C Q C Q C Q C Q C Q C M C D c \ j C Q C Q C Q c O ( O C D C \ j U J J 
E 
•S 
... -. £ i 
8 
* 
3 
- I _l t •* 
Ql 
CO 
T l 
C 
3 
CO 
Ql 
01 
c 
T> 
IT 
3 
CO 
<1) 
01 
c o x; .9 -a 
3 -a E E 
O •£ 3 3 
XJ £ D) O) 
O . 2 C C 
.C j 5 . 9 t5i s .a -a d o . 
E 
? 
s 3 
Q. 
iP 
CD 
CJ 
Q l 
* 
CO 
.0) 
CJ 
Q l 
& 
CO 
CO 
b 
Q l 
* 
.CO 
3 
CO 
• 2 
to 
Q> 
-S 
3 
8 
o 
s 
.CO 
CJ 
OS 
.CO 
CJ 
CO 
£ 
s 
D) 
.V> 
6 -O Cj t> 
3 3 3 3 3 3 ^ ^ ^ ^ i S S i S i S c S c Q S c Q S c Q m c Q C Q ( S i S c 5 u j 
C O O 3 C O C D C 0 C O N C O N 
i - c o m r ^ o o ) c o o o c o c o i o o c M o o o o 
O l f l O ) r ; W r : r ; ' t T ) ; r ; C O T ) : q r - ( N j 0 j 
C O N S C O c d o O N N S S N O O N N V V 
0 ) 0 0 0 
o s i o o o m o i - ' t ^ O ' t o i n i n m o o m s n c o m N - ™ 
^ © o c o » - ^ o w © i - ^ , o ) c \ i w i - c » » n c o r ; w ^ q ^ N W N 
—^  —
=
 ^" --^  —
r
 —^  —
r
 —^  ^" —
r
 ^" ^" oo oc5 cxi co f—^  i—^  r—^  i—I oo i—I r—I r-^  oc5 co i—^  ( D O J C O C C i c O S C O N N 
CO CO y- o -<t 
- • - " '
 —
 h-
T- •>- in 
CM p CD 
CO 00 s 
» S 8 g 
W aj to to 
11} • 
'to co 5 '5 5 <0 "co 
"a "o to to — "D "o 
5 » 8 8 
~ t (D Q) 
.$3 . 2 co to 
^ ^ £ £ 
5 5 
CD O) CD CD 
CJ CD O CJ 
CD O CD CD 
C C 
CO 
(0 
CO CO CO CD 
CD O CD O 
O O O CD 
0 CD CD tO 
CO CO CO M — 
<D Z Z 
_ c O © t O C O Q ) C D C D 
a> a> © O E £ E E .£ .£ .£ P - ^ - 9 - ^ = 5 § 3 5 5 5 to ^ ^ to to to £•£ ' .£ '< 
— c o c o c o c O c o c O C ^ 
C O C D U O U O U O C O d c — — — — — c 
E ' > ( D c o c a n i c d i 9 ^ 
- C C 0 O O O O O O . C 
CO Q. CO 
o S~ 6 
CD 
1
 O CO V CO T - ^-
T- O O C o V c O C O T f C O T v V . S H - C O C O C D C O C j T - O l i C C ^ r . ^ 
O 1 - T - - I - _ I o o , - T - j j j j c o » i - ' - c o c o c o s o h C O t o r o i - l - ( 0 * n ^ 
It •c -c .o 5 5 S1 
•Q -Q -Q ^ i ^ i -O 
—I —I —I —I —I -~J 
cn CJ 
X ) 
- J 
F 
E 
J! 
X I 
- 4 
F 
3 
E 
a 
X I 
—1 
CO 
3 
s Ql 
• t : 
X I 
- j 
E 2 
•S 
c 
J5 
u. 
X I 
- j 
<u 
3 
s 
X I 
- J 
Ql 
* • 
01 
CO 
X I 
- J 
Q) 
G 
<l> 
o CO 
XJ 
~ J 
Ql 
CJ 
Ql 
Q CO 
XJ 
- 1 
<1) 
8 Q CO 
XJ 
~J 
Ql 
<3 
Ql 
Q (0 
XJ 
~J 
Ql 
CJ 
Ql 
Q CO 
X ) 
~ J 
Ql 
CJ 
Ql 
Q CO 
X I 
- J 
Ql 
CJ 
Ql 
Q CO 
X I 
- 4 
Ql 
CJ 
Ql 
CJ 
CO 
X> 
- 4 
Q> 
CJ 
Ql 
U CO 
X I 
- J 
Cll 
cj 
Ql 
U 
X I 
- J 
Ql 
cj 
Q) 
O 
X I 
- J 
Ql 
cj 
Ql 
U 
X ) 
- J 
Ql 
cj 
Q) 
O 
X I 
- J 
CO 
Ql 
cj 
Ql 
Q 
XJ 
- J 
CO 
Ql 
CI 
Q> 
a 
XJ 
- J 
U) 
C) 
Q) 
Q CO 
XJ 
—1 
CO 
c 
fc ^J 
U j 
CO 
c 
fc * J 
UJ 
CO 
F> 
o 
* J 
U j 
CO 
« 
LAMVAB 
Legend to Table 8.3 
"These strains were obtained from : type : type strains, obtained from DSM, Braunsweig, Germany; MA = Maastricht 
University, The Netherlands; NIZO = Netherlands Institute for Dairy Research, Ede, The Netherlands; ATO = Agro 
Technological Institute, Wageningen, The Netherlands, IM = Dept. Industrial Microbiology, Wageningen Agricultural 
University, The Netherlands; Nijm = Dept. Oral Microbiology, Nijmegen University, The Netherlands 
Inhibition of intestinal bacteria by LAMVAB 
Comparing the growth on LAMVAB with LAMVAB at pH 6.5 (L65) and LAMVAB without 
vancomycin (L-) showed that Gram-negative bacteria were mainly inhibited by the low 
pH (Table 8.2) and Gram-positive bacteria by the vancomycin. 
Comparison of LAMVAB with MRS 
Comparing the new LAMVAB medium with MRS as a reference medium showed that 
only two out of 38 lactobacilli failed to grow on LAMVAB (Table 8.3). These two strains 
were both isolated from the oral cavity. All other lactobacilli showed no reduction in 
counts on LAMVAB. None of the bifidobacteria, Actinomyces species and cocci grew 
on LAMVAB, with the exception of St. gordonii, a strain isolated from the oral cavity. 
Isolation of lactobacilli from faeces 
Lactobacilli could be selectively isolated from samples of human faeces. Out of 20 
samples of human faeces, lactobacilli could be detected in 15 samples. The counts 
ranged from (logN) 2.5 to 9.0. With the exception of enterococci in one sample and 
yeasts in another sample, no other bacteria were observed. 
Fecal samples from 19 different animals were plated on MRS and LAMVAB 
(Table 8.4). Growth on MRS was observed in all samples. Bifidobacteria, cocci and 
spore-forming organisms were observed in 17 samples. In only two samples (from 3 
and 34) only lactobacilli were detected on MRS. Growth on LAMVAB was observed in 
13 samples. Lactobacilli were present in all 13 samples. Only in one sample some cocci 
were observed. Bifidobacteria, yeasts or spore-forming organisms were not observed. 
In only two samples presumptive lactobacilli were observed on MRS, but no growth was 
observed on LAMVAB. 
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Table 8.4: Morphology of bacteria isolated from animal faeces. 
Animal 
Gravy's Zebra 
{Equus grevyi) 
Capybara 
{Hydrochaeris hydrochaeris) 
Giant Bat 
(Pteropus vampyrus) 
Bongo 
(Boocercus euryceros) 
White rhinoceros 
{Cerathoterium simum) 
Gorilla 
(Gorilla gorilla) 
Chimpanzee 
{Pan troglodytes) 
Chimpanzee 
Chimpanzee 
Three-toed sloth 
(Bradipus tridactylus) 
Celebes Hornbill 
(Aceros cassidix) 
Giraffe 
{Giraffa camelopardalis) 
Mouse deer 
(Tragulus javanicus) 
Llama 
{Lama glama) 
Elephant 
(Loxodonta africana) 
Yak 
(Bos grunniens) 
Cheetah 
(Acinonyx jubatus) 
Watussi 
(Bos taurus) 
Bactrian Camel 
(Camelus bactrianus) 
Medium 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
MRS 
LAMVAB 
Colonies 
on plate1 
9 
5 
8 
8 
8 
n.g. 
36 
12 
52 
33 
14 
3 
9 
6 
17 
4 
15 
50 
9 
6 
61 
22 
31 
n.g. 
8 
4 
8 
n.g. 
214 
25 
9 
n.g. 
12 
n.g. 
19 
n.g. 
37 
3 
Colonies 
tested2 
8 
5 
8 
4 
8 
8 
6 
8 
8 
8 
3 
8 
6 
8 
4 
8 
8 
8 
5 
8 
4 
8 
8 
3 
8 
8 
8 
8 
8 
8 
8 
2 
possible 
lactobacilli3 
7 
5 
4 
4 
0 
3 
6 
8 
8 
5 
3 
6 
6 
3 
4 
5 
8 
8 
5 
3 
4 
2 
0 
3 
0 
1 
6 
0 
0 
1 
3 
2 
Cocci4 
1 
0 
4 
0 
8 
5 
0 
0 
0 
1 
0 
1 
0 
0 
0 
0 
0 
0 
0 
4 
0 
6 
1 
0 
8 
1 
2 
6 
0 
6 
3 
0 
Bifid5 
0 
0 
0 
0 
0 
0 
0 
0 
0 
2 
0 
1 
0 
5 
0 
3 
0 
0 
0 
1 
0 
0 
1 
0 
0 
6 
0 
2 
0 
0 
2 
0 
Other6 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
6 (spores) 
0 
0 
0 
0 
0 
8 (spores) 
1 (spores) 
0 
0 
1
 Total number of colonies on the plate tested;2 The number of colonies tested, preferably of the same 
dilution for both media, the colonies taken were mainly selected on differences in colony morphology, not 
incidence; 3 Possible lactobacilli were rod shaped straight or slightly curved, not branched bacteria and 
showed no spores; 4 Cocci were all coccal-shaped bacteria, mono-, duplo-, or streptococci; 5 Bifid were 
rod shaped bacteria with branches, included possible Bifidobacterium, Actinomyces and 
Propionibacterium species; 6 Others included spore-forming rods, yeasts and moulds, n.g. = no visible 
growth 
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DISCUSSION 
The isolation of lactobacilli from faeces is generally difficult, due to the presence of 
competing micro-organisms, like bifidobacteria, streptococci and enterococci, which 
may be present in higher numbers than lactobacilli. Most media used for the isolation of 
lactobacilli, also support growth of these competing micro-organisms (Nelson and George, 
1995; Cole and Fuller; 1989). The results presented above indicate that LAMVAB does not 
support the growth of these bacteria, whereas growth of lactobacilli is unaffected. 
LAMVAB is easy to prepare, even though the three different components have to 
be sterilized separately. Due to the low pH of the medium, it is impossible to add the 
agar to the MRS broth directly. The medium does not require expensive chemicals or 
antibiotics. Vancomycin is widely used, relatively inexpensive and easy to obtain from 
pharmacies. 
The medium is selective due to the low pH, which inhibits the most common 
Gram-negative bacteria in faeces, as well as the presence of vancomycin, which 
inhibits the competing Gram-positive flora (Table 8.2). This is in accordance with the 
literature. 
Vancomycin inhibits Gram-positive bacteria, except lactobacilli. Several studies 
have shown that faecal lactobacilli are not inhibited by vancomycin (Swenson era/., 1990; 
Holliman and Bone, 1988; Lentsner era/., 1981; Chow and Cheng, 1988). Only one Study indicated 
susceptibility of faecal lactobacilli towards vancomycin (Pacher and Kneifel, 1996). 
Susceptibility was reported for Lb. acidophilus and Lb. bulgaricus towards very low 
concentrations of vancomycin (1 and 4 mg/l). Our results show that most lactobacilli are 
not affected by the vancomycin, as there is no significant reduction in logarithmic 
counts between MRS and LAMVAB. Only two unidentified oral isolates failed to grow on 
LAMVAB. These results are in accordance with the literature (Swenson era/., 1990; Holliman 
and Bone, 1988; Lentsner era/., 1981; Chow and Cheng, 1988). 
On only a few occasions other bacteria could be isolated on LAMVAB. These 
were cocci, probably enterococci or streptococci and it is known that a small percentage 
of enterococci are vancomycin resistant (Potgieter et al., 1992; Lim et ai, 1993; Green et al., 
1991). Also, we observed growth of St. gordonii, an oral species, which may be present 
in small numbers in faeces. 
Comparison of LAMVAB with MRS indicated a low selectivity of MRS, whereas 
LAMVAB was highly selective for lactobacilli. Even though we did not compare 
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LAMVAB with other common media, such as Rogosa and LBS agar, it is known that the 
growth of the bacteria tested on these media is similar to MRS (Nelson and George, 1995; 
Cole and Fuller; 1989). 
LAMVAB was successfully applied to isolate lactobacilli from faeces from humans 
and a number of animals. Lactobacilli were present in most of the animals tested (Table 
8.4), with the exception of the giant bat, giraffe, llama, yak, cheetah and watussi. In 
those samples other bacteria were isolated on MRS medium, indicating lower selectivity 
for this medium. 
In only two samples (from the giraffe and watussi) presumptive lactobacilli were 
isolated on MRS, whereas no colonies were visible on LAMVAB. It is not known 
whether these isolates were true lactobacilli or other non-sporeforming non-branched 
rods. 
LAMVAB may also be a suitable medium for the isolation of lactobacilli from 
probiotics. These products often contain lactobacilli and bifidobacteria. As bifidobacteria 
fail to grow on LAMVAB selective isolation of the lactobacilli is possible. We have 
successfully used LAMVAB to isolate different species of lactobacilli from dairy 
products in the presence of streptococci and bifidobacteria (data not shown). 
It can be concluded that LAMVAB is highly selective for lactobacilli. It allows 
growth of all faecal lactobacilli tested and suppresses all other bacteria encountered in 
faecal material, with an occasional exception of cocci and yeasts. The medium is more 
selective than the media commonly used for the isolation of lactobacilli from faeces and 
probiotics. 
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SUMMARY 
The interest in functional foods, probiotics and prebiotics requires a proper method to determine 
specific bacterial groups in the intestinal flora, especially bifidobacteria and lactobacilli. Three 
media for lactobacilli (MRS, Rogosa, LAMVAB), three media for bifidobacteria (RB, NPNL, 
Beerens medium) and nine media for total anaerobes have been tested for selectivity and 
recovery. For total anaerobes Faecal Reinforced Clostridial Agar (FRCA) showed the highest 
cfu/g, followed by Columbia Blood Agar and BHI Blood agar. There were no significant 
differences between the media tested. Reduced physiological salt solution was found to be the 
best dilution medium. For bifidobacteria and lactobacilli samples of human faeces, cat faeces 
and pig ileal contents were used. Bifidobacteria could reliably be determined on all three media 
tested in human faeces, but not on pig ileal contents or cat faeces. Absolute counts were 
highest in human samples. No lactobacilli could be isolated on MRS in either sample, none of 
the colonies in the countable plates were lactobacilli. For Rogosa over 90% of the colony types 
observed in human samples were not lactobacilli. For cat faeces this was 58%, but no false 
positives were observed in the pig ileal samples. For LAMVAB the percentages of false positive 
colony types were 9, 14 and 0% for human, cat and pig samples. 
It can be concluded that for bifidobacteria RB and Beerens medium show comparable 
results, and can be used to quantify bifidobacteria in human faeces, but none of the media 
tested is suitable for reliably counting bifidobacteria from pig and cat samples. For lactobacilli 
LAMVAB shows the highest sensitivity. 
INTRODUCTION 
In the last decade there has been an increasing interest in the effect of live bacteria (as 
probiotics) and non-digestible oligosaccharides (as prebiotics) on the intestinal 
microflora. It is claimed that both probiotics and prebiotics may have an effect on the 
composition and/or the metabolic activity of the intestinal flora, both in humans and in 
animals (Gibson and MacCartney, 1998). As probiotics mainly members of the genera 
Lactobacillus and Bifidobacterium are being used. Several types of non-digestible 
oligosaccharides, such as fructooligosaccharides and galactooligosaccharides, are 
commercially available as prebiotics (Gibson and MacCartney, 1998; Playne and Crittenden, 
1996). In addition to these two categories much research is being carried out on the 
effect of antibiotics and polysaccharides (fibres) on the composition of the intestinal 
flora (Finegold era/., 1983; Sugawara etal., 1992; Bourquin etal., 1996). 
One major prerequisite for studying the effect of a certain compound on the flora, 
is the ability to quantify the different groups of intestinal bacteria accurately. For this 
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there are several methods, based on plate counts, molecular techniques, fluorescence 
and immunological techniques. Of these the first method is the most widely used. 
Molecular techniques are increasingly being used, but the other methods are so far 
used very rarely in applied studies. For all techniques it is necessary to know the 
accuracy, selectivity and possible problems and drawbacks (Charteris etai., 1997). 
The intestinal flora of humans and animals is a very complex microbial ecosystem, 
in which several hundred bacterial species have been isolated and identified. Detection 
of a single group of bacteria will always involve elimination of most of the other bacteria. 
It is thus obvious that contamination (plate counts) or cross-hybridization (DNA-
techniques) is a serious problem, especially in the detection of groups or species that 
are not among the numerically dominant groups. Unfortunately data on selectivity are 
often not available or, for many media, only described for other purposes than faecal 
flora Studies (Rasic, 1990; Pacherand Kneifel, 1996). 
The bacterial groups studied most extensively are total anaerobes, bifidobacteria, 
lactobacilli and Escherichia coli. For none of these groups there seems to be a standard 
medium available, as a large number of media have been used for the detection of 
these bacteria from faeces. Some of the media used for the detection of these groups 
are combined in Tables 9.1 (total anaerobes), 9.2 (bifidobacteria) and 9.3 (lactobacilli). 
For E. coli mainly MacConkey and Eosine Methylene Blue agars are used, both of 
which seem selective for faecal COliforms (Baron etai, 1992; Adami and Cavazzoni, 1996). 
Table 9.1 : Media used for the detection of total anaerobes from faeces 
Medium 
BB-Agar 
Brain Heart Infusion Blood Agar 
Columbia Blood Agar 
Eggert Gagnon Agar 
RCA 
Wensinck Agar 
Wilkins Chalgren Agar 
Class* 
1 
1 
1 
1 
2 
1 
1 
Reference 
Summanen etai, 1993 
Roberts etai, 1992 
Bartram etai, 1994 
Mitsuoka et ai, 1973 
Venketeshwer Rao etai, 1994 
Wensinck etai, 1981 
Bearneefa/., 1990 
* class : 1 = with blood, 2 = without additional ingredients 
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Total counts in faeces normally do not exceed 10 /g wet faeces. Counts can 
reach as high as 11.3 (logN/g wet weight), but higher counts are physically impossible. 
Combining the results of 65 studies in healthy human adults the average count was 
determined as 10.7 (Fig 9.1.). 
Media used for the detection of bifidobacteria can be classified in 5 different 
groups; known non selective media (MRS, Rogosa), media with elective carbohydrates, 
media with antibiotics, media with propionate and media with elective substance and/or 
low pH (Table 9.2). 
Table 9.2 : Media used for the detection of bifidobacteria from faeces 
Medium Group* Reference 
Acetylglucosamine - Lactose Agar (AL-agar) 
Bifidobacterium selective agar (BS-Agar) 
Bifidobacterium selective medium (BBM-agar) 
Bifidus Blood Agar 
Bifidobacterium lodoacetate Medium (BIM-25 Agar) 
China Blue Agar 
Liver Cystine Lactose Agar (LCL-agar) 
Modified Rogosa Agar 
MPN-agar 
MRS 
MRS Agar with LiCI and antibiotics (MRS-NN) 
Neomycin Paromomycin Lithium Nalidixic acid Agar (NPNL) 
Propionate agar (Beerens-Agar) 
Raffinose - Bifidobacterium Agar 
Reinforced Clostridial Agar with Cephalothin and Blood (RCB) 
Rogosa agar 
Tomato Casein Peptone Yeast Agar (TCPY) 
Tomato Casein Peptone Yeast Agar (TCPY) with azide 
Tomato Casein Peptone Yeast Agar (TCPY) with sorbic acid 
Tomato Casein Peptone Yeast Agar (TCPY) with antibiotics 
Transgalactosyloligosaccharide Agar (TOS-agar) 
TTC-agar 
x-Gal medium 
YN-6 Agar 
2 
3,5 
2,3 
5 
3 
5 
2 
3,5 
2,3 
1 
3,5 
3,4 
4 
2,4 
3 
1 
5 
5 
5 
3 
2 
5 
5 
2,3,5 
Yazawaefa/., 1984 
Mitsuokaefa/., 1973 
Cole and Fuller, 1989 
Rasig, 1984 
Munoa and Pares, 1988 
Mevissen-Verhage et al. 
1987 
Rasic, 1990 
Rasig, 1990 
Tanaka and Mutai, 1980 
Venketeshwer Rao et al. 
1994 
Norinefa/., 1991 
Teraguchi era/. ,1978 
Beerens, 1990 
Hartemink et al., 1996 
Yaeshimaefa/., 1997 
Rasic, 1990 
Rasic, 1990 
Rasic, 1990 
Rasic, 1990 
Roberts era/., 1992 
Sonoikeefa/., 1986 
Gyllenberg and Niemela 
1958 
Chevalier et al., 1991 
Resnick and Levin, 1981 
* group : 1 = non selective medium, 2 = medium without antibiotics but with elective carbohydrate, 3 = medium with 
antibiotics, 4 = medium with propionate, 5 = medium with elective substance and/or low pH 
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Combinations, media belonging to more than one group, are also used. From the 
large number of media used it can be concluded that there is no standard medium for 
the detection of bifidobacteria. Bifidobacteria are, in humans, normally present in 
numbers between (log) 9.0 and 10.5 per gram wet weight as can be seen in Figure 9.2., 
which has been derived from data of 65 studies. 
13 
12 -
^ l i -
ra 
® 10 -
9 
on 
O 7 
Study 
Fig. 9.1 : Total anaerobic counts as derived from 65 studies. All data were reported from fresh 
faeces obtained from healthy adult volunteers and expressed as log10 cfu/g wet weight. 
The number of media used for the detection of lactobacilli is limited. Most media 
are not claimed to be selective for faecal lactobacilli, with the exception of the LAMVAB 
medium (Hartemink era/., 1997). Lactobacilli are mainly inhabitants of the small intestine in 
humans and animals. Logarithmic counts in (human) faeces vary considerably between 
persons and even within a single person, as can be seen in Figure 9.2 (Mitsuoka and 
Ohno, 1977; Ogata et a/.,1997). 
In this study we examined the selectivity of different media for the quantification of 
total anaerobes, bifidobacteria and lactobacilli. Media were chosen on the basis of 
selectivity (from literature data) and usage in different studies. All media were tested 
with fresh human faeces, ileal samples of pigs (for small intestinal flora) and faecal 
samples of cats (a carnivorous animal), to obtain three types of samples, which may be 
markedly different in bacterial composition. 
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Table 9.3 : Media used for the detection of lactobacilli from faeces 
Medium 
LAB Agar 
LAMVAB 
LBS Agar 
LBS Agar with Tomato Juice 
MRS 
Rogosa 
Group* 
2,4 
3,4 
4 
4 
1 
4 
Reference 
Norin etal., 1991 
Harteminke/a/., 1997 
Mitsuokaefa/., 1973 
Summanen etal., 1993 
Mitsuokaefa/., 1973 
Mitsuokaefa/., 1973 
*group : 1 = non selective medium, 2 = medium without antibiotics, with elective carbohydrate, 3 = 
medium with antibiotics, 4 = medium with elective substance and/or low pH 
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Fig. 9.2 : Counts of lactobacilli (triangles) and bifidobacteria (circles) as derived from 65 studies. 
All data were reported from fresh faeces obtained from healthy adult volunteers and expressed 
as logio cfu/g wet weight. 
MATERIAL AND METHODS 
Faecal samples 
Human faecal samples were collected from healthy human volunteers, who had not 
used antibiotics for the last 6 months prior to the sampling date, and had no recent 
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history of gastrointestinal complaints. Volunteers defaecated in a plastic bag and 
immediately the sample was homogenized by kneading the bag and a sub sample of 
approximately 10 grams was put in a pre-weighed glass container with 90 ml anaerobic 
buffered peptone water (Oxoid) with 0.5 g/l cysteine.HCI. The container was then 
closed, weighed to determine the actual sample size and immediately imported into an 
anaerobic cabinet (atmosphere : nitrogen 80%, carbon dioxide 10% and hydrogen 10%, 
HoekLoos SHK 050H, Rotterdam, the Netherlands). The whole procedure between 
defaecation and importing in the cabinet generally took less than 5 minutes. The 
samples were further homogenized using an Ultra Turrax blender inside the cabinet. 
Mixed samples were diluted further using reduced physiological salt solution (rps, 
peptone 1 g/l, cysteine.HCI 0.5 g/l and NaCI 8 g/l) or test media (see below). Finally the 
samples were plated on the appropriate media and incubated at 37°C. Unless 
otherwise stated, mixing, diluting, plating and incubation was carried out anaerobically. 
Samples from pigs were obtained during a trial at the Department of Animal 
Nutrition. The trial conditions were not intended to affect the intestinal flora composition. 
Pigs were slaughtered and intestinal contents were sampled. For this study samples 
taken at the terminal ileum were used. Samples were collected and kept in a glass 
container with anaerobic buffered peptone water, flushed with nitrogen to remove 
oxygen from the headspace and imported into the anaerobic cabinet. Total time 
between sampling and importing took less than one hour. Samples were further treated 
as described above. 
Samples from cats were taken at the local animal shelter. Samples were taken 
immediately after defaecation and placed in a glass container with anaerobic peptone 
water. Samples were imported into an anaerobic cabinet within 2 hours. Samples were 
further treated as described above. 
Determination of total anaerobic counts 
To determine the best medium for the determination of total anaerobic counts the 
following 9 media were compared : 1) Brucella Blood Agar (Summanen et ai., 1993), 2) 
CDC Anaerobe Blood Agar (Dowell et ai., 1981), 3) Reinforced Clostridial Agar (RCA, 
Oxoid, CM 151), 4) FRCA (see below), 5) RCA with 5 g/l bile salts (Oxoid L55), 6) 
Columbia Blood Agar (CAB, Oxoid CM 331), 7) Schaedler Blood Agar (Oxoid CM 437), 
8) BHI Blood Agar (Difco 0037-17-8 with 1.6% agar and 50 ml sheep blood/l) and 9) 
Thioglycollate Agar (Oxoid CM 173). Faecal Reinforced Clostridial Agar (FRCA) was 
prepared from RCA with the following additions per liter medium : faecal extract (swine 
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faeces diluted 1:1 with buffered peptone water and sterilized 20 min 121°C) 50 ml, PY 
salts solution (Holdeman and Moore, 1977) 30 ml, hemin solution (Summanen era/., 1993) 10 
ml, vitamin K solution 0,2 ml. All media were poured inside an anaerobic cabinet to 
avoid exposure to oxygen. Media were kept in the anaerobic cabinet 24h before use. A 
total of 5 fresh human faecal samples were plated on all media. Plates were incubated 
anaerobically for 4 days at 37 °C. 
Effect of dilution medium 
The effect of dilution medium was tested with 9 different dilution media; 1) physiological 
salt solution (ps), 2) reduced physiological salt solution (ps with 0.5 g/l cysteine.HCI, pH 
6.7), 3) dilution medium according to McCann era/. (McCann etai., 1996), 4) thioglycollate 
broth (Oxoid CM 173), 5) Reinforced Clostridial Medium (RCM), 6) reduced transport 
medium (Atlas and Parks, 1993), 7) reduced salt solution medium (Atlas and Parks, 1993), 8) 
rps with 0.1% Tween 80 and 9) reduced salt solution medium at pH 6.7. All media were 
kept in an anaerobic cabinet for at least 24 h before use. Two different samples were 
diluted in all 9 media. Samples were plated on FRCA plates and incubated 
anaerobically for 4 days at 37°C. 
The effect of diluting under aerobic and anaerobic conditions was tested for ps 
and rps. When diluting aerobically no vortex mixer was used, but samples were diluted 
by gently mixing with a pipette. Vortex mixing under aerobic conditions will result in 
rapid reduction of viable anaerobes (data not shown). 
Media for bifidobacteria 
The following media for bifidobacteria were tested : Beerens propionic acid medium 
(PROP (Beerens, 1990)), Raffinose-Bifidobacterium medium (RB, (Hartemink ef a/., 1996)) 
and Neomycin-Paromomycin-Nalidixic acid-Lithium chloride agar (NPNL (Teraguchi et 
a/.,1978)). PROP and NPNL were made according to the instructions by the authors, RB 
was kindly prepared by Merck (Darmstadt, Germany). In total 10 fresh human faecal 
samples, 7 samples of ileal contents of pigs and 9 faecal samples of cats were tested. 
Samples were treated and diluted in rps as described above. All diluting and plating 
procedures were carried out anaerobically. Plates were poured under aerobic 
conditions and stored in the anaerobic cabinet at least 20h prior to use. All plates were 
incubated anaerobically at 37 °C for 5 days. Total and typical colonies were counted. 
For RB medium, where bifidobacteria are supposed to form yellow-green colonies with 
a yellow halo, morphologies of typical and non-typical colonies were compared 
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(Hartemink et ai, 1996). No typical colonies have been described for PROP or NPNL. All 
colonies with different morphologies were examined microscopically. All bifid-shaped 
rods were tentatively considered bifidobacteria. 
Media for lactobacilli 
The following media for lactobacilli were tested : de Man, Rogosa and Sharpe Agar 
(MRS, Merck 1.10661), Rogosa Agar (Oxoid CM 627) and LAMVAB agar (Hartemink et 
ai, 1997). MRS and Rogosa were prepared according to the manufacturer's instructions, 
LAMVAB according to the instructions by the authors. 
Samples and procedures for plating were the same as for the bifidobacteria. All 
plates were incubated anaerobically at 37 °C for 3 days. Total and typical colonies were 
counted. Typical colonies could not be defined for MRS and Rogosa, but all green to 
blue colonies on LAMVAB were considered typical (Hartemink era/., 1997). Yellow or large 
white colonies were considered non-typical. All colonies with different morphologies 
were examined microscopically. All non-spore forming straight rods were tentatively 
considered lactobacilli. 
RESULTS 
Determination of total anaerobic counts 
From Table 9.4 it can be concluded that total anaerobic counts on different media do 
not differ much from each other. Still each medium was assigned a rank number for 
each sample, based on absolute counts. Highest counts received a rank number of 1, 
lowest counts of 9. In general FRCA, BHI-blood agar and CAB show the highest counts, 
resulting in the lowest rank numbers. The average rank numbers for samples 2-5 are : 
FRCA 2.0; CAB and BHI 2.5; RCA 4.75; CDC 5.25; Schaedler 6.0; Thioglycollate 6.25; 
RCA/bile 7.25 and Brucella 7.5. Due to a heavily spreading species, no proper rank 
numbers could be assigned for sample 1. Total counts were in agreement with other 
studies (Fig 9.1), only sample 4 showed relatively low counts, which was mainly due to 
the high moisture content of the sample itself (relatively loose stools). 
Colony morphologies were determined visually. On each medium different colony 
morphologies could be distinguished. On Schaedler, CDC, BHI and FRCA 5 different 
colony morphologies could be seen on the countable dilutions (10-100 colonies/plate), 
on CAB, Brucella and Thioglycollate 4, on RCA 3 and on RCA/bile only 2 different 
morphologies. Microscopic evaluation showed that in most cases the colonies consisted 
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of small pleomorphic rods or (duplo)cocci, only 3 colonies with bifid-shaped bacteria 
were observed (on FRCA, BHI and RCA). 
Colony size was the largest on FRCA where 73% of the colonies on the countable 
plates had a diameter of 3 mm or more. Corresponding percentages for the other 
media were RCA 42, RCA/bile 33, BHI 29, CAB 21, CDC 9, Schaedler 6, Thioglycollate 
5 and Brucella 1 %. 
Table 9.4 : Anaerobic counts in human faeces using 9 different media. Counts are expressed 
as logio cfu/g wet weight and relative rank. 
Medium 
1 Brucella 
2 CDC 
3 RCA 
4 FRCA 
5 RCA/bile 
6 CAB 
7 Schaedler 
8 BHI 
9 Thioglycollate 
Sample 
logN/g 
9.87 
>10.5 
>10.5 
>10.5 
>10.5 
>10.5 
>10.5 
10.21 
>10.5 
1* 
rank 
9 
1 
1 
1 
1 
1 
1 
8 
1 
Sample 
logN/g 
10.06 
10.31 
10.32 
10.33 
9.52 
10.34 
10.02 
10.25 
10.05 
2 
rank 
6 
4 
3 
2 
9 
1 
8 
5 
7 
Sample 3 
logN/g 
9.72 
9.90 
10.35 
10.71 
9.93 
10.30 
10.15 
10.77 
10.10 
rank 
9 
8 
3 
2 
7 
4 
5 
1 
6 
Sample 4 
logN/g 
9.65 
9.92 
9.75 
10.15 
9.07 
9.96 
9.83 
10.04 
9.97 
rank 
8 
5 
7 
1 
9 
4 
6 
2 
3 
Sample 5 
logN/g 
9.92 
9.82 
10.00 
10.12 
10.07 
10.34 
10.00 
10.18 
9.52 
rank 
7 
8 
5 
3 
4 
1 
5 
2 
9 
* counts could not accurately be determined, due to spreading of one of the species present 
Effect of dilution medium 
The effect of the dilution medium on the total plate counts is shown in Table 9.5. With 
the exception of the salt solution medium at pH 6.7 (medium 9) or 9.2 (medium 7) there 
were no differences between the different dilution media. Physiological salt and 
reduced physiological salt showed the highest results. These two media were further 
tested on the effect of anaerobic or aerobic conditions. No significant differences were 
observed between diluting and plating the samples aerobically or anaerobically. Nor 
were the results between ps and rps significantly different. 
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Table 9.5 : Effect of dilution medium. Counts are expressed as log™ cfu/g wet weight on FRCA 
plating medium. 
Dilution medium 
1 physiological salt 
2 reduced physiological salt (rps) 
3 salt solution ace. McCann 
4 thioglycollate broth 
5RCM 
6 reduced transport medium 
7 reduced salt solution pH 9.2 
8 rps with Tween 80 
9 reduced salt solution pH 6.7 
Sample 1 
10.3 
10.2 
10.1 
10.1 
10.0 
9.8 
9.9 
10.0 
9.5 
Sample 2 
10.4 
10.3 
10.4 
9.9 
10.0 
10.3 
9.7 
10.2 
9.8 
Media for bifidobacteria 
The three media for bifidobacteria tested, showed a large variation in counts for the 
different samples (Fig. 9.3). Absolute counts were highest for the human faecal 
samples, followed by cat faeces and pig ileal contents. Variations were highest for the 
pig ileal samples, where, within the same sample, differences of two log units were 
observed between the three different media. NPNL always showed the highest counts, 
followed by RB in 8 of 9 samples. PROP showed the lowest counts. For cat faecal 
samples the variations were generally very small between NPNL and RB, but in three 
samples PROP showed lower counts, up to two log units. For human faecal samples 
the differences between the three media were small, generally less than one log unit. 
Selectivity was determined by microscopic observations of all different colony 
morphologies on all countable (between 10 and 150 colonies/plate) plates (Table 9.6). 
Based on morphologies, selectivity was highest for human faeces with NPNL with 29% 
false positive colonies (growth, but no bifidobacteria! morphology). PROP showed 39% 
false positives and RB 50% false positives. For cat faeces the results were much 
worse, with PROP and RB both showing 61% false positives and NPNL even 77%. For 
the pig ileum, PROP showed no less than 90% false positive colonies, both other media 
showed around 70%. False negatives (non typical colonies, but bifid morphology) could 
only be determined on RB, as this is the only medium for which typical colonies were 
described, but no false negatives were observed. 
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Most false positive colonies were different cocci (mono-, duplo- or streptococci), 
spore-forming rods and short rods. Only one yeast was observed on PROP in a pig ileal 
sample. 
Based on actual counts, selectivity could only be determined for RB, as the 
colonies of bifidobacteria and non-bifidobacteria could not be determined for the other 
media and not all colonies were tested for morphology. Selectivity as a percentage of 
non-typical colonies ranged from around 5% for the human samples, to over 75% for 
some of the pig samples. Cat samples showed 10-50% non typical colonies per plate. 
Table 9.6 : Selectivity of media for bifidobacteria and lactobacilli. Colonies of different shapes 
were tested microscopically. Bacterial morphology was determined and typical and non-typical 
morphologies were determined. Typical morphology for bifidobacteria was branched or bifid-
shaped rods; for lactobacilli typical morphology was straight, non-sporeforming rods. 
Medium 
RB pos" 
RBneg 
PROP 
NPNL 
LAMVAB 
LAMVAB 
MRS 
Rogosa 
pos 
neg 
human faeces 
n 
24 
4 
18 
28 
24 
0 
33 
27 
morphology 
typical 
12 
0 
11 
20 
22 
0 
5 
1 
non-typ.* 
12(50) 
4(0) 
7(39) 
8(29) 
2(9) 
0 
28 (85) 
26 (96) 
cat faeces 
n 
23 
10 
23 
31 
14 
4 
29 
26 
morphology 
typical 
9 
0 
9 
7 
12 
0 
13 
11 
non-typ. 
14(61) 
10(0) 
14(61) 
24 (77) 
2 (14) 
4(0) 
16(55) 
15(58) 
pig 
n 
15 
13 
21 
33 
12 
10 
22 
6 
ileum 
morphology 
typical 
4 
0 
2 
11 
12 
0 
1 
6 
non-typ. 
9(73) 
13(0) 
19(90) 
22 (67) 
0(0) 
10(0) 
21 (95) 
0(0) 
* number in brackets is the percentage of false positive (typical colony, non typical morphology) or false 
negatives (non-typical colony, typical morphology) of the colonies tested. 
"pos = colonies showing characteristics for bifidobacteria or lactobacilli, neg = colonies not showing 
characteristics for bifidobacteria or lactobacilli. For bifidobacteria characteristics were defined as yellow-
green colonies with a yellow halo, for lactobacilli characteristics were defined as green to blue colonies 
and a yellow halo. These characteristics could only be determined on RB and LAMVAB, as no 
characteristics were defined for the other media. 
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Media for lactobacilli 
The three media for lactobacilli tested also showed a large variation in counts for the 
different samples (Fig 9.4). Absolute counts were highest for the human faecal 
samples, followed by cat faeces and pig ileal contents. Variations between the media 
were very high. In most samples LAMVAB showed the lowest counts, sometimes 5 log 
units lower than the counts on MRS. Rogosa showed similar or slightly lower counts 
than MRS, except for pig ileal samples, where the counts were comparable with 
LAMVAB. 
Selectivity was determined by microscopic observations of all colonies with 
different morphologies on all countable plates. Selectivity on MRS was really poor, 
85% of the different colony types for human faeces were not considered lactobacilli, for 
cat and pig samples these figures were 55 and 95% respectively. All straight, non 
spore-forming rods, were initially considered lactobacilli. Of the possible Lactobacillus 
colonies on MRS, 10 (3 from humans, 6 from cats and 1 from a pig sample) were 
tested for growth in MRS at pH 5.0. None of the strains grew at this pH, indicating that 
these strains were not lactobacilli (Hammes and Vogei, 1995). Other morphologies observed 
were bifid shaped bacteria, duplo- and streptococci, yeasts, spore forming anaerobes 
and Megasphaera species. 
The figures for Rogosa were slightly better for the cat samples (58% false 
positives) as compared to MRS, but similar for human samples (96% false positive). 
For pig ileal samples, all isolates were possible lactobacilli. As with MRS, bifid shaped 
bacteria and different cocci were commonly isolated, no yeasts were observed. Only 
one spore-forming rod and several Megasphaera colonies were observed. 
LAMVAB clearly was the most selective medium based on colony morphologies, 
no false positive colonies were observed for the pig samples, and only 9 and 14% in 
human and cat samples. No false negatives were observed on LAMVAB (non typical 
colonies, but possible lactobacilli). All non typical colonies (large white colonies, most 
often with a white halo) were found to be Megasphaera species. In addition to these, 
two isolates of duplococci were found. 
Based on actual counts, selectivity could only be determined for LAMVAB, as the 
colonies of lactobacilli and non-lactobacilli could not be determined for the other media 
and not all colonies were tested for morphology. Selectivity as a percentage of non-
typical colonies ranged from 0% for the pig samples, to around 5% for some of the cat 
samples. 
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MEDIA FOR FAECAL BACTERIA 
DISCUSSION 
The differences between the media for the determination of total anaerobic counts were 
relatively small, and not statistically different. The experimental medium RCA/bile 
clearly reduced the counts compared to RCA alone, most likely due to sensitivity of 
some of the more common species to the concentration of bile used. Addition of faecal 
extract instead of blood did result in slightly, but not significant, higher counts. Faecal 
extract was chosen as a substitute for blood as it would mimic the environment in the 
intestine more than blood. Growth on FRCA clearly was improved as compared to 
blood-based media, as could be seen from the size of the colonies, which were larger 
than on most other media. This makes counting colonies easier, and may reduce the 
incubation period. As with the blood-based media, counting is difficult as the media are 
not or poorly translucent. The major disadvantages of this medium are the smell and 
the difficulty in obtaining faecal extract. Taking these aspects into account, CAB or BHI 
with blood would be the medium of choice to use in daily practice. 
The effects of dilution media were relatively small as well. The dilution media 
commonly used are similar to rps or ps. These two simple solutions also gave the 
highest counts. Diluting aerobically or anaerobically did not affect the log counts 
significantly. Counts will decrease rapidly however, when the plates are kept aerobically 
for some time before incubation. In this study we only compared the effect of the 
dilution medium, therefore we did not use a vortex mixer and all plates were kept in the 
anaerobic cabinet prior to the plating procedure and immediately re-imported in the 
cabinet after plating. 
The three categories of samples, human faeces, pig ileum contents and cat 
faeces, were chosen as we expected large differences in competing flora in the three 
types. Human faeces was chosen as the reference, as most studies have been 
performed on human faeces. Cats, as most carnivorous animals, do not regularly 
consume carbohydrates. Both lactobacilli and bifidobacteria require carbohydrates for 
growth. For cats we thus expected a high number of protein-fermenting species 
(Clostridia, eubacteria) and relatively small numbers of lactobacilli and bifidobacteria. 
The pig ileum is a more aerobic environment, which will result in a different bacterial 
composition than present in faeces. Similarly, pigs generally consume large amounts of 
fibrous materials, which would also be beneficial for lactobacilli and bifidobacteria. 
For the determination of bifidobacteria none of the three media tested was very 
selective. In our studies we mainly determined the occurrence of false positive or false 
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negative colonies. The lowest occurrence of possible false positive colonies was 
observed on NPNL, but in all three media the number of non-bifidobacteria capable of 
growing on the selective media was very high. When many different species are 
capable of growing on the medium, an increase of one of these species may result in 
serious mistakes in calculating bifidobacteria. NPNL and RB gave slightly higher counts 
than PROP. The incidence of false positives, based on morphologies, on RB was 
comparable with that on PROP and somewhat higher than that on NPNL. In human 
faeces the incidence of competitive flora was relatively low (less than 10% of the total 
colonies on the plates) and bifidobacteria could reliably be counted. This was to be 
expected, as bifidobacteria are one of the main groups of intestinal bacteria in humans 
(Fig. 9.2). In cat and pig samples, where the incidence of bifidobacteria was expected 
to be lower than in human faeces, the number of false positives increased, both in 
incidence as in percentage of colony morphologies. The latter was observed for all 
three media tested, but the incidence could only be determined for RB. In these 
samples bifidobacteria could not be counted very reliably on either medium. The 
competitive flora consisted mainly of different cocci (cat, pig, human), Clostridia (cat, 
human) and lactobacilli (pig). 
PROP medium has been described as the best medium for the determination of 
bifidobacteria by Silvi et al. (1996), but they also concluded that the total bifidobacteria! 
counts were significantly lower on PROP than on the other media tested. Similarly 
Favier ef al. (1997) concluded that PROP underestimated bifidobacteria in several of 
their samples. Both studies used human faeces as the test substrate. Several other 
studies in which PROP agar is used, also show considerably lower bifidobacteria! 
counts than most other studies (Favier etal., 1997; Bouhnik ef al., 1996). The total counts in 
human faeces as determined in our study were comparable to counts observed by 
other groups and with studies using molecular techniques (Fig 9.2., Welling ef al., 1997; 
McCartney ef al., 1996). This was also true for the PROP medium, which did not show 
significantly lower counts. 
NPNL, which has been described as the medium of choice to determine 
bifidobacteria in dairy products (Teraguchi etal., 1978), was found to be insufficient for pig 
faeces. This was in accordance to Silvi et al. (1996), who observed, like in our studies, 
many cocci on this medium. In the same study BIM-25 was tested and this medium was 
also found to be non specific. 
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In conclusion, all three media performed reasonably well for human faeces and 
bifidobacteria can reliably be counted. For cat faeces none of the three media 
performed well. For pig ileal samples, bifidobacteria! colonies can be distinguished, but 
for reliable counts all different colonies should be identified. The results for lactobacilli 
indicated that both MRS and Rogosa, which are most often used, are highly non-
selective. On MRS more than 95% of the colonies from human or pig faeces were no 
tentative lactobacilli. Of the possible lactobacilli, none grew at pH 5.0, indicating that 
probably no lactobacilli were present on the countable plates (10-100 colonies/plate). 
This low selectivity also been observed previously (Cole and Fuller, 1989; Nelson and George, 
1995). The selectivity on Rogosa was clearly better than on MRS, but still considerable 
numbers of non-lactobacilli were determined. 
The selectivity of LAMVAB was very high, both based on colony morphology as on 
actual numbers. The total counts were sometimes very low, compared to the other two 
media. It is known that counts of lactobacilli vary considerably between persons (Table 
9.2) and within a single person (Mitsuoka and Ohno, 1977; Ogata et al., 1997). Very often not 
all persons in a test population harbor detectable numbers of lactobacilli, generally this 
figure is around 75% (Ogata et al., 1997). In our studies in 9 out of 10 samples lactobacilli 
could be determined in human faeces on LAMVAB. Similarly, there have been some 
reports that sensitivity towards vancomycin within the Lb. acidophilus group differs 
widely. This may result in underestimation of the Lactobacillus counts in some samples 
(Hamilton-Miller and Shah, 1998). 
Surprisingly, all cat samples contained relatively high numbers of lactobacilli. For 
pig ileal samples, lactobacilli could only be observed in 5 out of 7 samples on LAMVAB. 
Even though some lactobacilli do not grow on LAMVAB, the major advantage of 
LAMVAB is that very little false positive and no false negative colonies were observed. 
In most studies in which lactobacilli were determined accurately, laborious identification 
procedures were applied (either morphologically or biochemically). This is not 
necessary when LAMVAB is used. Still, there is no really better alternative to LAMVAB, 
as MRS and Rogosa are clearly unreliable media. Similarly, LBS, another medium, 
which has sometimes been used, was shown to be non-selective (Nelson and George, 
1995). 
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INTRODUCTION 
This thesis describes studies related to the microbial effects of Non-Digestible 
Oligosaccharides (NDOs) on the intestinal microflora. The studies can be divided in 
three separate themes : effects on the oral microflora, fermentation of plant 
polysaccharides, as parent compounds for certain NDOs, and development of new 
isolation media for intestinal micro-organisms. 
In this chapter the results of these studies are summarized and compared with 
other studies. Results obtained after the publication of some of the chapters by other 
groups will be discussed. Finally recommendations for further research are given at the 
end of this chapter. 
ORAL MICROFLORA 
Several NDOs are used commercially as prebiotics and/or bifidogenic factors in 
functional foods. Functional foods are defined as new foods, that are specially designed 
with additional health promoting ingredients. At present, most functional foods are 
regular foods with additional ingredients (fortified foods) or foods in which normal 
ingredients have been replaced by other, comparable, but health-promoting, ingredients 
(e.g. polyunsaturated fatty acids instead of saturated fatty acids). Foods, that are aimed 
to enhance the beneficial effects of the intestinal flora in general, or bifidobacteria in 
particular, are either fortified with NDOs or contain NDO-rich ingredients as 
replacement of regular ingredients. 
As NDOs are added for their health promoting effects, they should not have any 
negative effect on the host health. This includes no negative effects in the oral cavity. 
NDOs, being carbohydrates, are a potential risk for caries and tooth decay. In Chapters 
2 and 3 the in vitro effects of NDOs on the oral flora are described. 
The effects of FOS on the oral microflora are described in Chapter 2. It is 
concluded that FOS are fermented by the oral microflora, and that plaque formation is 
initiated in vitro. This has been confirmed by other studies (Ziesenitz and Sieber, 1987) for 
nystose, one of the components in FOS. Japanese studies on the other hand, did not 
observe any degradation of this compound by oral streptococci (Hirasawa etai., 1984). No 
recent studies have been published, in which FOS is tested for its potential 
cariogenicity, neither in vivo nor in vitro (Moynihan, 1998). 
The effects of TOS and lactulose are described in Chapter 3. It is concluded that 
TOS and lactulose can be degraded by the oral microflora, but the rate of acid and 
plaque formation is relatively slow. The risk of caries due to TOS is thus considered 
low. These studies have been confirmed for lactose and lactulose, both in vivo and in 
vitro. Moynihan et al. (1998) confirm the degradation and fermentation of lactulose by 
the oral microflora. Like in our studies they observed a relatively slow acidification rate. 
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In in vivo studies they also confirmed degradation and fermentation, but the oral pH did 
not reach values low enough to be a risk for dental caries (Moynihan et ai, 1998). To our 
knowledge, no other studies on TOS and cariogenicity, either in vitro nor in vivo have 
been published prior to 1999. 
Overall it can be concluded that FOS are cariogenic, but TOS are not. The actual 
risk of caries due to ingestion of FOS, however, is low as compared to sucrose, starch 
or other highly cariogenic carbohydrates. The total production of FOS in 1995 was 
limited to 12000 tonnes (Playne and Crittenden, 1996), which is just a fraction of the 
production of saccharose (over 100 million tonnes annually), glucose syrup (7 million 
tonnes) and starch (Beiitz and Grosch, 1987). Daily intake of FOS from natural sources 
ranges from 2-10 g/day (Roberfroid et ai, 1993; Campbell et ai, 1997). FOS from functional 
foods will increase this amount, although it is difficult to estimate how much, as the 
number of foods with added FOS is still low and limited to a few food categories (product 
information Orafti, Tienen, Belgium). 
In Chapter 5 the fermentation of guar gum is described (see below). Surprisingly, 
we observed that one of the few strains capable of degrading guar, was an oral 
species, Bi. dentium. This species has been isolated regularly from the oral cavity, but 
only from carious lesions. Using guar as a substrate, we have been able to 
demonstrate that Bi. dentium was present in the saliva of 19 out of 20 volunteers. Final 
pH of guar degradation was below pH 5.0, and guar can thus be considered cariogenic. 
The amount of guar consumed, as well as the low numbers of Bi. dentium reported, 
however, indicate that the risk of caries from guar can be considered to be low. 
Guar can also be used in an easy and rapid procedure to isolate Bi. dentium from 
the oral flora. Quantitative counting of this species using guar-containing isolation 
media was tested, but this turned out to be non-reliable. Enrichment studies using guar 
tubes clearly showed the presence of Bi. dentium, but plating of the same samples did 
not result in the isolation of this species in around 50% of the samples (unpublished 
data). 
DEGRADATION OF PLANT CELL WALL OLIGO- AND POLYSACCHARIDES 
A large part of the human diet consists of vegetable material. Part of this vegetable 
material consists of non-digestible cell wall components, mainly polysaccharides. 
Therefore it can be expected that oligosaccharides, derived from plant (cell wall) 
polysaccharides are also (partly) non-digestible. Since plant cell wall polysaccharides 
are completely or partly degraded by the intestinal microflora these compounds may be 
a new source for NDOs. Oligosaccharides from plant cell walls can be produced 
enzymatically, using specific endo-glycanases (Van Laere, 1997). Oligosaccharides from 
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different plant cell walls were prepared (Fig. 10.1) and the fermentation of these 
oligosaccharides were tested. 
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Figure 10.1 : Production of oligosaccharides by enzymatic hydrolases of plant polysaccharides ( Van 
Laereefa/., 1997). 
Arabinoxylan oligosaccharides were prepared from arabinoxylan by incubation of 
arabinoxylan with endo-xylanase III from Aspergillus awamori. Of the 25 bacterial 
strains of intestinal origin tested, only 4 were able to degrade these oligosaccharides. 
These were Bi. adolescentis, B. vulgatus, B. ovatus and CI. sporogenes (Van Laere era/., 
1995a). 
Other oligosaccharides were prepared from pectins. Pectins are a complex class 
of plant cell wall polysaccharides. They comprise a family of acidic polymers like 
homogalacturonans and rhamnogalacturonans. These polysaccharides are often 
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associated with neutral polymers like arabans, galactans and arabinogalactans. Three 
types of oligosaccharides were produced by incubating polygalacturonan with a 
polygalacturonidase (galacturonooligosaccharides); methoxylated pectin with pectate 
lyase (pectic oligosaccharides) and rhamnogalacturonan with rhamnogalacturonidase 
(rhamnogalacturonooligosaccharides). 
The galacturonooligosaccharides were fermented by CI. clostridioforme, CI. 
ramosum and B. ovatus, while the pectic oligosaccharides were fermented by Bi. 
bifidum, CI. clostridioforme, CI. novyi, CI. beijerinckii, B. thetaiotaomicron and B. ovatus. 
The rhamnogalacturonooligosaccharides were only fermented by B. fragilis, B. ovatus, 
B. thetaiotaomicron and B. vulgatus. The oligosaccharides were completely fermented, 
which was determined using high performance anion exchange chromatography (Van 
Laere etal., 1995b). 
As preparation of oligosaccharides from polysaccharides is time-consuming, 
expensive and laboratory preparation results in only small quantities of pure 
oligosaccharides, it was decided to determine the fermentation of interesting 
polysaccharides. Two different polysaccharides were chosen, xyloglucan and 
galactomannan (guar gum). Xyloglucan is present in the cell wall of most plants, 
whereas galactomannan, which is present in most edible plants in small quantities only, 
is used regularly as a food additive (guar gum). The results of these studies is 
described in Chapter 4 and 5. 
From the studies on oligo- and polysaccharides described above, it can be 
concluded that mainly Clostridium and Bacteroides species are capable of degrading 
and fermenting plant cell wall oligo-and polysaccharides. Some strains of bifidobacteria 
were also capable of degrading some components. Fermentation of polysaccharides by 
Bacteroides species has been described previously in many studies (Saiyers etal., 1977; 
Saiyersetal, 1978). Fermentation by intestinal Clostridia has been observed previously, but 
this has not been studied in detail. In our studies we observed that both xyloglucan and 
guar are fermented mainly by clostridial species in vitro. Fermentation of the plant cell 
wall poly- and oligosaccharides by bifidobacteria was limited. That is why the substrates 
tested may not be very effective to increase the number of intestinal bifidobacteria. 
In Chapter 6 fermentation of guar and xyloglucan was studied using faecal 
inocula. A third polysaccharide, inulin, was also included. Inulin, or polyfructose, is used 
as a bifidogenic factor (see Chapter 1). Inulin is a plant polysaccharide, not a cell wall 
polysaccharide, but rather an energy storage compound. 
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From the results described in Chapter 6, it can be concluded that xyloglucan and 
guar gum are degraded to a large extent by gas- and butyrate forming bacteria. 
Combining these results with those from chapters 4 and 5, it can be concluded that 
Clostridia also play a major role in guar and xyloglucan degradation and fermentation in 
complex batch fermentations. This is further confirmed for guar in studies using human 
volunteers. In all cases an increase in breath hydrogen was observed, and sometimes 
an increased flatulence was reported. 
No evidence was found that fermentation of inulin can be attributed mainly to a 
single group of bacteria. As with the other polysaccharides, butyrate was produced, but 
less than from the other polysaccharides. Also, more lactate and acetate and less gas 
was produced from inulin than from guar or xyloglucan. As it is known that 
bifidobacteria are capable of fermenting inulin, it is suggested that inulin is fermented by 
several bacterial groups, which is reflected in a mixture of fermentation end-products. 
In conclusion it can be stated that the polysaccharides and plant cell wall 
oligosaccharides tested, are not primarily fermented by bifidobacteria. Degradation and 
fermentation of these substrates in vitro is mainly due to Clostridia and bacteroides. In 
vivo other bacteria may benefit from the initial degradation of the polysaccharides into 
oligosaccharides. This has to be confirmed with studies using human volunteers. Only 
one such study has been performed with one of the substrates tested in our studies. 
Japanese researchers observed a bifidogenic effect of ingested hydrolyzed guar gum. 
They did not observe in vitro degradation by bifidobacteria, but an increased number of 
bifidobacteria in faeces (Okubo et ai, 1994). It is thus likely that bifidobacteria may benefit 
from degradation products from the oligosaccharides tested, produced by other 
species, such as Clostridia. 
ANALYSIS OF FAECAL FLORA 
Ingestion of NDOs has been reported to influence the composition of the intestinal 
microflora (Chapter 1). Most often an increase in bifidobacteria is reported. Changes in 
the number of bifidobacteria, and other bacteria, are thus to be determined accurately. 
The two main methods used for determining the number of (intestinal) bacterial groups 
are plate counts on selective media and molecular techniques. The plate count method 
is more often used, although the last few years more studies have made use of 
molecular techniques. In our studies on the faecal flora of humans and animals, we 
analysed many different bacterial groups (Alles et ai, 1999; Houdijk etai., 1997; Houdijk etal., 
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1999), using plate count techniques. Although molecular techniques are becoming 
increasingly popular, we used selective plating techniques, since availability of, and 
experience with molecular techniques was rather limited. We also wanted to use 
selective media to isolate and further characterize bacteria capable of fermenting 
oligosaccharides. 
The main bacterial groups investigated were the bifidobacteria, lactobacilli, 
Clostridia and E. coli as specific genera, as well as total aerobic and anaerobic bacteria. 
As the media generally used for the first three groups turned out to be unreliable, we 
developed new selective media for bifidobacteria and lactobacilli. The results of these 
studies are described in Chapters 7, 8 and 9. 
The medium for bifidobacteria, RB, is suitable as a selective medium to isolate 
bifidobacteria from human faeces. Its selectivity was observed to be equal or better 
than other media used. As described in Chapter 9, it is also suitable for pig faeces, but 
not suitable for cat faeces. It is also not suitable for many other animal samples, such 
as samples from camels, elephants and seals. On the other hand it was a suitable 
medium for the isolation of bifidobacteria from gorillas and chimpanzees (Winsemius, 
1996). For cats and pigs the medium, however, still performed better than the two other 
media tested. 
RB medium has also successfully been tested in a multi-laboratory ring test using 
dairy bifidobacteria and lactobacilli. In the dairy industry viable bifidobacteria are to be 
determined in lyophilized starter cultures as well as in consumer products. In both 
products bifidobacteria are stressed, and thus are more susceptible for the acids or 
antibiotics used in most media (Table 7.1). Using RB, the recovery of bifidobacteria did 
not exceed 5% as compared with a non-selective medium. Still, this number was higher 
than obtained on Beerens medium (Beerens, 1990), with a high concentration of 
propionate at a relatively low pH. Using a double-layer technique and a four hour 
resuscitation period on non-selective medium, the recovery of bifidobacteria from 
starter cultures was increased to 90% or more. In the ring test most laboratories 
reported better results with RB than with the media used so far in their laboratory 
(unpublished results). 
RB medium has also successfully been applied by the Swiss Office for Public 
Health (Grand and Baumgartner, 1997). The same authors report the effect of different agar 
bases on the recovery of bifidobacteria using the RB formula. Over 10 percent 
differences were observed in counts of the same product using different agar bases. As 
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most of the media used for the detection of intestinal micro-organisms are not available 
commercially, results from different groups may vary due to the use of different medium 
ingredients. 
The development of a new selective medium for lactobacilli is described in 
Chapter 8. This medium was observed to be more selective than the other two media 
generally used (Chapter 9). We have used LAMVAB medium for the isolation of human 
and animal lactobacilli. We have isolated lactobacilli from over 50 species of animals, 
with none or very few non Lactobacillus isolates. LAMVAB has also successfully been 
used by other research groups (pers. comm, unpublished results). 
The search for a new medium for Clostridia was not successful. Combinations of 
different selective agents have been tried, but no selective medium could be developed. 
Clostridia are a very heterogeneous group, it is likely that in the near future, genetic 
information will make it possible to divide this group in several new genera. It may be 
possible to develop selective media, or specific probes, for these new genera. 
The methodology used for the determination of the total aerobic and anaerobic 
counts has been evaluated in Chapter 9. It was observed that the procedures used by 
our group were reliable and the total (anaerobic) counts observed are of the same order 
of magnitude as obtained by other groups. 
In conclusion it can be stated that the methodology used for the analysis of the 
(human) faecal flora, including the use of the two newly developed media, is reliable 
and the results obtained are comparable with other techniques. The main drawback of 
our methodology, however, is that the samples are to be treated fresh. Freezing the 
samples for later analysis was shown to cause unreliable and non-reproducible results 
(unpublished data). This drawback causes several methodological and logistic 
problems, when a large number of samples has to be processed. Similarly, due to 
oxygen stress, the samples have to be treated completely under anaerobic conditions. 
This may also cause problems in larger trials. 
Molecular techniques may overcome part of these problems. For analysis with 
molecular techniques samples may be frozen and do not have to be kept anaerobically. 
On the other hand, when specific strains have to be isolated, molecular techniques 
cannot be used. A major drawback of molecular techniques, especially in frozen 
samples, is that it is not possible to distinguish between living and dead cells. At 
present, quantitative analysis of specific groups using molecular techniques is still very 
difficult as most probes have a high detection limit (over 107 cells/g) and there are no 
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probes for all groups available. Quantification of lactobacilli, which are often present in 
relatively small numbers, or total aerobic bacteria, using molecular techniques is not 
possible at present. 
Molecular techniques may be used for specific purposes, but for each study it has 
to be determined on scientific and economic grounds which method is the most suitable 
for the purpose. 
CHANGES IN THE INTESTINAL MICROFLORA 
Prebiotics are defined as : non digestible food ingredients, that beneficially affect the 
host by selectively stimulating the growth and/or activity of one or a limited number of 
bacteria in the colon, and thus improve host health (Gibson and Roberfroid, 1995). Most 
compounds that at present are used or marketed as prebiotics, are oligosaccharides. 
Even though the definition does not mention any bacterial group specifically, most 
studies with prebiotics aim for an increase in the number of faecal bifidobacteria. 
Subsequently, many studies are performed to determine whether bifidobacteria are 
capable of degrading and fermenting new oligosaccharides. At present (Table 1.3) no 
carbohydrates are known that are selectively fermented by bifidobacteria. FOS, the 
best studied oligosaccharide mixture, for example, can be partly or completely 
fermented by all major groups of intestinal bacteria (Chapter 1). 
An increase in bifidobacteria is used as an aim, as high numbers of bifidobacteria 
are considered positive for human health. This theory has its origins in Japan in the 
1970s (Mitsuoka, 1990) are is based on the observations that infants receiving breastmilk 
had higher number of bifidobacteria than infants receiving artificial milk. A high number 
of bifidobacteria is thus considered the natural state. Many health aspects have been 
attributed to bifidobacteria (Mitsuoka, 1990), and as yet no negative effects have been 
attributed to bifidobacteria. On the other hand, there is no proof that people without 
bifidobacteria are less healthy or have intestinal disorders, as no such people have ever 
been reported (Fig. 9.2). Similarly, there is no proof, nor indication, that increased 
numbers of bifidobacteria make a person more healthy. 
From the definition it can be concluded that any change in bacterial numbers or 
bacterial metabolism, which is beneficial for the host, can be used as a parameter for 
the effect of presumptive prebiotics. An increase of the number of faecal bifidobacteria 
may be considered as one of the possible parameters. Similarly, a decrease in possible 
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pathogenic bacteria or a decrease in putrefactive products, can be used as parameters. 
As many characteristics of the intestinal microflora are host-specific (Chapter 6), 
and many different internal or external factors influence the intestinal flora or its 
metabolism (Chapter 1), large inter- and intrapersonal variations occur for each 
parameter. To determine the effect of prebiotics, these variations should be determined 
and taken into account. This problem may partly be overcome, by using a set of 
metabolic and microbial parameters combined in a health index. 
Table 10.1 : Possible health parameters to be included in a health index. 
a) microbiological parameters 
bifidobacteria 
total anaerobes 
total aerobes 
lactobacilli 
conforms 
ratios between these groups to minimize intrapersonal variations 
b) chemical parameters 
gases 
pH 
ammonia 
bile salts 
c) enzyme activities 
glycosidases 
proteases 
tryptophanase 
d) physiological parameters 
gastrointestinal complaints 
flatulence 
diarrhoea 
A health index may consist of a defined set of reliable parameters. Average values 
and standard deviations of each of these parameters have to be determined in a 
specific population, similar to the test population. Changes due to a dietary intervention 
will be expressed as percentages above or below the average. From the changes in 
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individual parameters an overall average can be determined, the health index number. 
The deviation of this number from the health index number obtained from control 
subjects, determines the overall effect of the test compound. If the deviation correlates 
with an overall beneficial effect, the test compound can be considered a prebiotic. 
To determine which parameters have to be included, it has to be established first 
what the importance of a specific parameter is for general health. Secondly, parameters 
should be quantifyable and with a high degree of reproducibility. Finally, inter- and 
intrapersonal variations should be determined and, when too high for practical 
purposes, a parameter should be excluded. Some possible parameters are described 
below. These parameters have been described in the literature, but other, as yet 
undetermined, parameters may be included. Neither the actual effect on the host 
health, nor the inter- and intrapersonal variations of these parameters are well 
established as yet. 
A health index consisting of several of the parameters described above, or new 
parameters, may thus be more reliable to predict effects of presumptive prebiotics than 
the studies used so far. 
RECOMMENDATIONS 
Taking into account the considerations in the previous paragraphs, the following topics 
for future research can be recommended : 
1. Determining the fermentation of other plant cell wall polysaccharides, as possible 
prebiotics. 
2. Development of reliable parameters to determine gastrointestinal health. 
3. Studies towards the changes of the intestinal flora within single individuals to 
determine inter- and intrapersonal variations. 
4. Development of a health index. 
5. Well controlled studies to the effect of presumptive prebiotics, using the health index 
concept. 
6. Development of traditional or modern methods for the quantitative determination of 
intestinal bacteria. 
7. More studies to the effect of genetic (host) factors on the composition and 
metabolism of the intestinal flora. 
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SUMMARY 
This thesis is the result of work carried out within a four-year multi-disciplined program, 
entitled ' Non-digestible oligosaccharides in foods and feed'. Within the project, four 
Ph.D. students were employed at the Food Chemistry, Food Microbiology, Human 
Nutrition and Animal Nutrition groups of the Wageningen Agricultural University. This 
thesis describes the studies carried out at the Food Microbiology group. 
Oligosaccharides are carbohydrates, with an average chain length of 2-10 sugar 
residues. Most oligosaccharides cannot be digested by the enzymes in the upper gut, 
nor can these compounds be absorbed. These oligosaccharides are considered non-
digestible, and reach the large intestine unaltered. Non-digestible oligosaccharides 
(NDOs) are mainly of vegetable origin and are a normal part of the human diet. Some 
of the natural NDOs are now produced commercially using enzymatic methods. 
Most NDOs are completely or partially degraded and fermented by the bacterial 
populations in the large intestine. Some of the NDOs are considered to have a 
beneficial effect on the health of the host, due to the specific fermentation by two 
groups of intestinal bacteria, the bifidobacteria and lactobacilli. Commercial NDOs are 
marketed as a healthy ingredient, due to this selective fermentation, in several Western 
countries. 
Chapter 1 describes the gastrointestinal tract and the bacterial composition in 
each part thereof. The same chapter gives an overview of the current knowledge of 
the fermentation of NDOs by intestinal bacteria and the effects on the host health, as 
far as known. 
Chapters 2 and 3 describe the effect of the two types of NDOs, currently 
available on the Dutch market, on the etiology of dental caries. When consumed, 
residues of NDOs in foods may remain in the oral cavity. In the oral cavity many 
different bacteria are capable of degrading and fermenting carbohydrates, which results 
in the formation of acid and, possibly, dental lesions and caries. NDOs, being 
carbohydrates, may thus be fermented and are, in theory, a risk factor for dental 
caries. 
In Chapter 2 the degradation and fermentation of fructooligosaccharides (FOS) by 
the oral microflora is described. It can be concluded that this class of NDOs can be 
fermented by the most common bacterial species. These NDOs can be considered 
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cariogenic, in vitro, but in vivo studies have to be carried out to determine the actual risk 
for dental caries. 
In Chapter 3, the degradation and fermentation of transgalactosyl-
oligosaccharides (TOS) by the oral microflora is described. It was concluded that this 
class of NDOs is not, or very slowly, degraded and fermented. These NDOs are not 
considered a risk factor for dental caries. 
Within the framework of the project, the Food Chemistry group synthesized and 
purified a large number of oligosaccharide mixtures from plant cell walls. As these 
purifications are laborious and the total quantities of pure oligosaccharides are very 
small, it was decided to determine the fermentation of plant cell wall compounds by 
intestinal bacteria. These plant cell wall compounds are available in large quantities and 
thus could be used for screening studies. 
Chapter 4 describes the degradation and fermentation of such a plant cell wall 
polysaccharide, xyloglucan. Xyloglucan is present in many edible plants, but it is 
commercially prepared from tamarind seeds. The more (chemically) complex the 
compound the more enzymes are necessary for degradation, and the less bacteria are 
capable of fermenting the compound. Xyloglucan has a relatively simple chemical 
structure, but, surprisingly, only very few intestinal bacteria were capable of degrading 
this compound. The second remarkable conclusion was that most of the bacteria 
capable of degrading xyloglucan, belonged to the genus Clostridium. Previously, this 
genus has not been considered of major importance for polysaccharide degradation in 
the intestine. 
Chapter 5 describes the degradation of a second plant cell wall polysaccharide, 
guar gum, a galactomannan. Like xyloglucan, galactomannans are part of the cell wall 
of many plants. Guar is commercially produced from the seeds of the Cyamopsis 
tetragonoloba tree and used as a thickening agent in many foods. Guar also has a 
relatively simple structure. Nevertheless, only three different bacterial species, capable 
of degrading guar, could be isolated from human and animal faeces. One of these, 
Bifidobacterium dentium was considered to be mainly an oral species, but, using guar, 
could also be isolated from faeces. The same species could also be isolated from 
samples of saliva from 19 out of 20 volunteers. A second species, Streptococcus bovis 
could only be isolated from animal faeces, whereas the third species, Clostridium 
butyricum was present in human and animal faeces. The latter species produced large 
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amounts of gas, and can thus be considered responsible for the increased flatulence 
observed after the ingestion of guar. 
Chapter 6 describes the differences in the fermentation of different 
oligosaccharides by human faecal inocula. In addition three polysaccharides were used 
in these studies. All donors had received the same diet and four samples were taken 
from each volunteer. The results show large differences between test compounds 
within the same volunteer, and large differences between volunteers on the same test 
compound. It can be concluded that the fermentation is largely dependent on host 
(genetic) factors, and not on dietary factors. It was also concluded that formation of gas 
is correlated with the formation of butyric acid. Butyric acid is considered to be 
important for the health of the intestinal wall. Gas production can thus be used as a 
simple screening method for butyrate production. 
Within the project the variations in the bacterial composition of human and pig 
faeces have been studied. It was concluded in the early stages of the project that no 
methods existed for the reliable quantification of two major intestinal bacterial groups, 
bifidobacteria and lactobacilli. Two new methods had to be developed for the 
quantification of these bacterial groups. 
Chapter 7 describes the development of a new medium for bifidobacteria, the RB 
medium. Selectivity is based on raffinose, propionate and lithiumchloride. The medium 
is not yet an ideal medium for the isolation and quantification for bifidobacteria but, 
compared with media currently used, it is more selective. 
Chapter 8 describes the development of a new medium for lactobacilli, the 
LAMVAB medium. Selectivity is based on vancomycin and a low pH (5.0). The 
combination of vancomycin and low pH inhibits practically all other intestinal bacteria. 
LAMVAB has successfully been employed to isolate lactobacilli from faeces from a 
large number of animals. 
The two newly developed media were compared with two other media, that are 
used regularly. The results of this comparison is described in Chapter 9. The media 
were used to isolate bifidobacteria and lactobacilli in human and cat faeces and pig 
small intestinal contents. The three media for bifidobacteria performed equally well for 
human faeces, but for the other two kinds of samples, the RB medium performed 
better. For lactobacilli, LAMVAB performed better for all three types of samples tested. 
Chapter 10 discusses the results of this thesis and some recommendations for 
further research are given. 
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As conclusion it can be stated that very few NDOs are degraded and fermented 
selectively by bifidobacteria. This was confirmed in Chapters 2 and 6, in which 
degradation and fermentation of FOS by other bacterial groups is described. 
Although FOS and TOS are found to be possibly cariogenic, it is not likely that 
either oligosaccharide will cause caries under normal conditions. 
Xyloglucan and guar are degraded only by a limited number of bacteria. 
Unexpectedly, Clostridia played a major role in the degradation of both substrates. Both 
substrates may be a good substrate for the production of new NDOs, but considering 
the results it is unlikely that these oligosaccharides are a good substrate for lactobacilli 
or bifidobacteria. 
RB and LAMVAB are new media, which are suitable for the quantitative isolation 
of bifidobacteria and lactobacilli from human faeces. LAMVAB is also suitable for 
animal faeces. Both media are more selective than the media used at present. 
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Dit proefschrift is tot stand gekomen binnen een vierjarig programma getiteld 'Niet 
verteerbare oligosacchariden in voeding en voeder'. Binnen dit project hebben vier 
AlO's gewerkt, gedetacheerd bij de vakgroepen Levensmiddelenchemie, 
Levensmiddelenmicrobiologie, Humane Voeding en Veevoeding. Dit proefschrift 
beschrijft de resultaten op het gebied van de microbiologie. 
Oligosacchariden zijn koolhydraten met een gemiddelde ketenlengte van 2-10 
suikerresiduen. De meeste oligosacchariden kunnen in de dunne darm van mens en 
dier niet opgenomen of verteerd worden. Deze oligosacchariden worden derhalve niet-
verteerbare oligosacchariden genoemd. Deze komen van nature voor in de voeding van 
mens en dier, met name in plantaardig materiaal. Tevens zijn er tegenwoordig 
enzymatisch vervaardigde mengsels van oligosacchariden verkrijgbaar. 
Deze niet-verteerbare oligosacchariden (in het vervolg NDOs genoemd, naar de 
Engelse afkorting Non-Digestible Oligosaccharides) worden door de bacterien in het 
maagdarmkanaal gefermenteerd. Van een aantal van deze NDOs wordt gezegd dat ze 
de gezondheid van de gastheer zouden bevorderen. Dat zou gebeuren door selectieve 
fermentatie door twee groepen darmbacterien, namelijk de bifidobacterien en de 
lactobacillen. Om deze reden worden NDOs tegenwoordig geproduceerd in een aantal 
landen en als specifiek gezondheidsbevorderend ingredient aan levensmiddelen 
toegevoegd. 
In Hoofdstuk 1 wordt een overzicht gegeven van het maagdarmkanaal en de 
daarin voorkomende bacterien. Ook worden hier de NDOs beschreven, waarvan op dit 
moment informatie beschikbaar is. Voor zover bekend is ook aangegeven door welke 
darmbacterien deze NDOs gefermenteerd kunnen worden, en of een 
gezondheidseffect te verwachten is. 
In de volgende twee Hoofdstukken (Hoofdstuk 2 en 3) worden de mogelijke 
effecten van de twee in Nederland verkrijgbare commerciele NDOs op de vorming van 
caries ('gaatjes') beschreven. Als NDOs aan levensmiddelen worden toegevoegd, dan 
bestaat er het risico dat een deel in de mondholte achterblijft. In de mondholte komen 
vele bacterien voor, en afbraak van de achtergebleven NDOs kan leiden tot zuur- en 
plaquevorming en daarna tot gaatjes. In Hoofdstuk 2 is beschreven welke bacterien uit 
de mondholte fructooligosacchariden, FOS, kunnen afbreken en fermenteren. 
Geconcludeerd kan worden dat dit type oligosacchariden goed afgebroken en 
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gefermenteerd kan worden. Er bestaat dus een theoretisch risico dat deze 
oligosaccharide!! tot caries kunnen leiden. Dit dient nog in vivo verder onderzocht te 
worden. 
De in Hoofdstuk 3 beschreven transgalactosyl-oligosacchariden, TOS, en 
aanverwante verbindingen, zijn veel moeilijker of zelfs niet af te breken door de 
bacterien uit de mondholte. Er kan dan ook geconcludeerd worden dat deze NDOs 
geen risico vormen voor caries. 
Binnen het project zijn door de groep van Levensmiddelenchemie een groot 
aantal mengsels van oligosacchariden gemaakt uit plantencelwanden. Het maken en 
zuiveren van dergelijke mengsels is bijzonder arbeidsintensief en bovendien zijn de 
opbrengsten erg laag, honderden milligrammen zuivere stof. Dit is te weinig om 
uitgebreide studies met darmbacterien mee uit te voeren. Daarom is besloten om eerst 
een aantal polysacchariden te bestuderen, waaruit, bij gunstige resultaten, later 
oligosacchariden bereid zouden kunnen worden. De polysacchariden, van plantaardige 
oorsprong, zijn wel in grote hoeveelheden voorhanden. 
In Hoofdstuk 4 wordt beschreven hoe xyloglucaan, een polysaccharide aanwezig 
in vele (eetbare) planten, maar commercieel gewonnen uit tamarindezaad, afgebroken 
wordt door darmbacterien. Opvallend was dat maar een zeer beperkt aantal 
darmbacterien in staat was om dit polysaccharide af te breken. Opvallend, omdat de 
chemische structuur vrij simpel is en het dus de verwachting was dat veel bacterien in 
staat zouden zijn dit polysaccharide af te breken. Een tweede opvallende conclusie is 
dat van de bacterien, die xyloglucaan konden afbreken, een groot deel behoorde tot het 
geslacht Clostridium. Hoewel bekend is dat dit geslacht in staat is plantencelwanden af 
te breken, worden ze meestal niet in verband gebracht met de afbraak van plantaardig 
materiaal in de darm. 
In Hoofdstuk 5 wordt de afbraak van een tweede polysaccharide, guar gum, een 
galactomanaan, beschreven. Guar wordt veel in levensmiddelen toegepast als 
verdikkingsmiddel, en vergelijkbare structuren komen voor in veel plantaardig materiaal. 
Ook dit polysaccharide heeft een vrij eenvoudige structuur. Desondanks blijkt guar 
maar door een drietal soorten darmbacterien afgebroken te worden. Een daarvan, 
Bifidobacterium dentium was eigenlijk alleen bekend als een mondbacterie, maar blijkt 
ook in de darm voor te komen. Door de unieke eigenschap van guar afbraak is ook 
aangetoond dat deze bacterie in de mond van 19 van de 20 geteste personen 
voorkwam. Een tweede bacterie, Streptococcus bovis, werd alleen uit dierlijke 
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faecesmonsters geTsoleerd, terwijl de derde soort Clostridium butyricum zowel bij 
mensen als bij dieren het meeste geTsoleerd werd. Deze laatste bacterie is 
waarschijnlijk ook verantwoordelijk voor de gasvorming die bij veel personen wordt 
waargenomen na het eten van (te grote) hoeveelheden guar. 
Hoofdstuk 6 beschrijft de verschillen in fermentatie van verschillende 
oligosacchariden en de hierboven beschreven polysacchariden. Er is gebruik gemaakt 
van faecale monsters van proefpersonen, die meededen aan een grote voedingsproef. 
Alle deelnemers kregen hetzelfde dieet, hierdoor werden mogelijke dieetinvloeden 
uitgesloten. De resultaten laten zien dat er grote verschillen bestaan tussen de 
monsters van verschillende proefpersonen, ook al gebruiken ze hetzelfde dieet. 
Geconcludeerd kon worden dat de fermentatieve capaciteit van de flora meer afhangt 
van gastheer-factoren dan van het dieet. Ook bleek er een goede correlatie te zijn 
tussen de hoeveelheid gevormd gas en boterzuur. Het meten van gas kan dus gebruikt 
worden als een makkelijke manier om te selecteren op boterzuurproductie. Boterzuur is 
een belangrijk eindproduct, omdat het mogelijk darmkanker kan tegengaan. 
Binnen het project is ook veel onderzoek verricht naar de effecten van NDOs op 
de darmflora van mensen en biggen. Al vroeg bleek dat er geen betrouwbare methoden 
beschikbaar waren om de belangrijkste bacteriegroepen, de bifidobacterien en de 
lactobacillen, betrouwbaar aan te tonen. Daarom werd het noodzakelijk om nieuwe 
methodieken te ontwikkelen voor het aantonen van deze twee bacteriegroepen. 
In Hoofdstuk 7 wordt de ontwikkeling van een nieuw medium voor bifidobacterien 
beschreven. Dit medium is selectief door het gebruik van een NDO, raffinose, as 
koolstofbron en propionaat en lithiumchloride als remstoffen. Het medium is nog niet 
ideaal, maar het is een selectiever medium, dan de tot nu toe beschreven media. Het 
blijkt ook zeer bruikbaar te zijn voor het tellen en isoleren van bifidobacterien uit 
humane faeces. 
In Hoofdstuk 8 wordt vervolgens een medium voor lactobacillen in faeces 
beschreven. De selectiviteit van dit medium is gebaseerd op een antibioticum, 
vancomycine, en een pH van 5.0. Door een combinatie van deze twee factoren worden 
de meeste andere in de darm voorkomende bacterien geremd. Het blijkt ook zeer 
geschikt voor de isolatie van lactobacillen uit dierlijke faeces. 
In Hoofdstuk 9 worden de twee bovenstaande media vervolgens vergeleken met 
een aantal media, zoals die tot nu toe veelvuldig worden gebruikt. Uit de vergelijking 
blijkt dat de nieuwe media beter zijn dan de andere geteste media voor humane 
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monsters. Bij varkens zijn geen van de drie geteste media voor bifidobacterien ideaal te 
noemen, maar het in Hoofdstuk 7 beschreven RB medium was wel het meest geschikt, 
omdat er goed onderscheid te maken was tussen bifidobacterien en ongewenste 
bacterien. Bij monsters van katten, die maar weinig bifidobacterien in hun darm 
hebben, bleken de drie media niet geschikt. In varkens en katten bleken de twee oude 
media voor lactobacillen bijzonder ongeschikt, het in Hoofdstuk 8 beschreven LAMVAB 
werd echter zeer geschikt bevonden. 
Tenslotte worden in Hoofdstuk 10 de resultaten kritisch belicht en wordt ook een 
vergelijking gemaakt met de andere resultaten in het gehele NDO-project. 
Concreet kan afgeleid worden uit Hoofdstuk 1 dat er maar weinig NDOs zijn, die 
selectief door bifidobacterien of lactobacillen worden afgebroken. Dit werd ook 
bevestigd in Hoofdstuk 2, waarin FOS door de meeste mondbacterien werd 
afgebroken, en Hoofdstuk 6, waarin faecale fermentaties nader zijn bestudeerd. 
FOS en TOS blijken in de praktijk niet tot een risico op caries te leiden, hoewel 
FOS, in tegenstelling tot TOS wel potentieel cariogeen zijn. 
Xyloglucaan en guar blijken moeilijk afbreekbaar te zijn, ondanks de relatief 
eenvoudige structuur. Opvallend is de rol van Clostridia in de afbraak. Beide 
polysacchariden zijn misschien een goede bron voor NDOs, maar door de moeizame 
fermentatie, is niet te verwachten dat bifidobacterien en/of lactobacillen gestimuleerd 
zullen worden. 
RB en LAMVAB zijn media die zeer goed te gebruiken zijn voor humaan faecaal 
onderzoek. RB is minder geschikt voor dierlijke monsters, terwijl LAMVAB geschikt is 
voor zeer diverse diersoorten. De media zijn beter geschikt dan de tot nu toe 
gebruikelijke media. 
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Het in dit proefschrift beschreven onderzoek is hoofdzakelijk uitgevoerd bij de 
leerstoelgroep Levensmiddelenmicrobiologie van het Departement Levensmiddelen-
technologie en Voedingswetenschappen, van de Landbouwuniversiteit Wageningen. 
Terminologie die anders was aan het begin van het onderzoek en over een jaar zullen 
zowel de universiteit als de leerstoelgroep wel weer anders heten. Een situatie 
vergelijkbaar met de wereld van de darmflora; de namen van de verschillende bacterien 
veranderen ook, lijkt het, iedere paar jaar, wat het interpreteren van de resultaten soms 
sterk bemoeilijkt. 
In ieder geval heb ik met veel plezier aan het onderwerp gewerkt, een onderwerp 
waarvan ik dacht toen ik begon, dat het een (letterlijk) uitgekauwd onderwerp zou zijn. 
Niets bleek minder waar, het grootste deel van wat zich in de darm afspeelt is ook nu 
nog en groot raadsel, en het meeste onderzoek roept weer nieuwe vragen op. Maar dat 
is typisch voor onderzoek. 
Uiteraard doe je nooit alleen onderzoek. Ik wil dan ook iedereen bedanken die in 
de loop van deze vijf jaar een bijdrage heeft geleverd aan dit boekje, of aan de 
algemene werksfeer. 
Allereerst mijn directe collega's van levensmiddelenmicrobiologie. Het was, en is, 
nog steeds een van de gezelligste groepen in het Biotechnion en ik hoop dat dat ook zo 
blijft. En ik wil jullie alien bedanken voor het bereidwillig afstaan van allerlei 
'lichaamseigen producten', jullie weten wel wat ik allemaal bedoel... 
Verder natuurlijk mijn promotor, Frans Rombouts, en co-promotor, Rob Nout, die 
mij in het begin enthousiast gemaakt hebben voor het poeponderzoek. Met name in 
het begin van het onderzoek, toen er een anaerobe kast bleek te zijn, maar niemand 
die wist hoe het ding werkte, heb ik veel steun gehad om op gang te komen. Later 
natuurlijk de discussies over het onderzoek, waarvan ik zeer veel heb geleerd. Hiervoor 
mijn grote dank. 
Het onderzoek heeft deel uitgemaakt van een grater samenwerkingsverband met 
Humane Voeding, Veevoeding en Levensmiddelenchemie. Hierdoor heeft het 
onderzoek een grotere dimensie gekregen. Het duurde even voor we elkaars 
terminologie begrepen; 'HPAEC, 'ileal pouch-anal anastomosis' en de 'lleale en 
caecale' parameters in biggen, zijn voor mij geen onbekende begrippen meer. En ons 
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aller Vlaams is er ook op vooruitgegaan (of achteruitgegaan ?). Hierbij mijn dank aan 
alle NDO-ers en in net speciaal de AlO's : 
Katrien, we hebben heel wat tegenstrijdig onderzoek verricht; jij maakte met heel 
veel moeite diverse oligo's, waarna ik keek hoe ze zo snel mogelijk weer afgebroken 
konden worden. Desondanks hebben we samen veel plezier gehad en ook veel bereikt. 
Martine, ook met jou heb ik zeer plezierig samengewerkt, uiteraard met als 
hoogtepunt de Platos proef. 
Jos, ik wist niets van varkens en dank zij jou ken ik ze van binnen en van buiten I 
Dankzij jou heb ik de weg naar het Zodiac weer kunnen vinden. 
Dit proefschrift zou nooit tot stand zijn gekomen, zonder het enthousiasme van de 
studenten, die met mij 'in de poep geroerd' hebben. Dank zij jullie inzet hebben we een 
groot aantal zijwegen kunnen bewandelen en hebben we een aantal hypotheses 
kunnen bevestigen of verwerken. 
In willekeurige volgorde : Yvonne, Riku, Andrea, Angenietje, Heidi, Anja, Sonja, 
Siemen, Olga, Ellis, Henriette, Henriet, Cecile, Anne-Marie, Annemieke, Victor, Rob, 
Miriam en Barend, ik heb aan jullie zeer goede herinneringen; zoals het lab-503 uitje 
(de 'partnerkijkdag'), de dierentuin(en), het ovemachten in het Biotechnion, het 
ijsmaken, de Usland Anders, en de andere gezellige uren in lab 503. Een aantal van 
jullie zijn vereeuwigd; hetzij als bacteriestam in de vriezer van de vakgroep, hetzij als 
RB (de oorspronkelijke afkorting wel te verstaan) of op diverse foto's van de anaerobe 
kast. 
Tenslotte wil ik nog iedereen bedanken, die 'in de periferie' meegeholpen heeft om de 
afgelopen vijf jaar tot een succes te maken; mijn kamergenoten Maria, Jeroen en 
Siemen, Hans Hoekstra, zonder wie ik geen appelsap meer kan drinken zonder aan 
hem te denken, de mensen van Askja, Margaret Bosveld, de mensen van de Platos 
proef, de medewerkers van de dierentuinen en natuurlijk iedereen in de privesfeer. 
Als laatste wil ik mijn ouders bedanken voor de steun en interesse gedurende mijn 
gehele studie, het verblijf in Usland en het promotieonderzoek. Aan jullie draag ik dan 
ook dit proefschrift op. 
200 
CURRICULUM VITAE 
CURRICULUM VITAE 
Ralf Hartemink werd geboren op 22 januari 1966 in Hilversum. In 1984 behaalde hij 
het VWO diploma aan net Gemeentelijk Gymnasium aldaar. In hetzelfde jaar werd 
begonnen aan de studie Levensmiddelentechnologie aan de toenmalige 
Landbouwhogeschool Wageningen. Hij studeerde af in September 1989 met als 
gecombineerde afstudeerrichting Levensmiddelenchemie en Levensmiddelen-
microbiologie. Afstudeervakken en stages vonden plaats bij het RIKILT te Wageningen, 
de sectie Levensmiddelenmicrobiologie, Coberco Research in Deventer en 
Hollustuvernd Rfkisins in Reykjavfk, Usland. Tijdens zijn studie was hij actief in de 
studentenbadmintonvereniging De Lobbers, waarin hij vier jaar in het bestuur zat en de 
NSK Badminton 1989 organiseerde. 
Na afstuderen vertrok hij opnieuw naar Usland, waar hij twee jaar werkte bij het 
Uslands Visserijinstituut en anderhalf jaar bij de Universiteit van Usland, als 
wetenschappelijk onderzoeker. In januari 1993 keerde hij terug naar Wageningen om 
te beginnen aan het in dit proefschrift beschreven promotieonderzoek, dat tot juni 1997 
duurde. In 1998 was hij tevens de organisator van het op 4 en 5 december gehouden 
internationale symposium, ter gelegenheid het einde van het NDO-project. Sinds maart 
1998 is hij aangesteld bij de sectie levensmiddelenmicrobiologie als tijdelijk 
wetenschappelijk medewerker, en bij het OWI Technologie en Voeding als een van de 
drie studiecoordinatoren Levensmiddelentechnologie, met als hoofdtaak de voorlichting 
en PR van de studierichting., alsmede als secretaris van de Richtings Onderwijs 
Commissie. 
Sinds 1993 is hij tevens 's zomers reisleider van Nederlandse groepen in Usland en 
Groenland en gedurende 1993-1996 is hij lid geweest van de AlO-raad van de 
onderzoeksschool VLAG, waarvan in 1995 als voorzitter. 
201 
LIST OF PUBLICA TIONS 
LIST OF PUBLICATIONS 
FULL PAPERS 
1. Hartemink, R. and Georgsson, F.: Incidence of Listeria species in seafood and seafood salads. Int. J. Fd. 
Micr. 12(1991)189-196. 
2. Asgeirsson, B.; Hartemink, R. and Chlebowski, J. : Alkaline phosphatase from Atlantic cod (Gadus 
morhua). Kinetic and structural properties which indicate adaptation to low temperatures. Comp. Biochem. 
Physiol. B 110(1995)315-330. 
3. Hoekstra, J.H.; Aker, J.H.L. van den; Ghoos, Y.F.; Hartemink, R. and Kneepkens, C.M.F. :Fluid intake 
and industrial processing in apple juice induced chronic non-specific diarrhoea. Arch. Dis. Childhood 
73(1995)126-130. 
4. Hartemink, R.; Quataert, M.C.J.; Van Laere, K.M.J., Nout, M.J.R. and Rombouts, F.M. :Degradation 
and fermentation of fructo-oligosaccharides by oral streptococci. J. Appl. Bact.79(1995)551-557. 
5. Hoekstra, J.H.; Aker, J.H.L. van den; Hartemink, R. and Kneepkens, C.M.F.: Fruit juice malabsorption: 
not only fructose. Acta Paediatrica 84(1995)1241-1244. 
6. Alles, M.S.; Hautvast, H.G.A.J.; Nagengast, F.M.; Hartemink, R.; Van Laere, K.M.J. andJansen, 
J.B.M.J.: Fate of fructo-oligosaccharides in the human intestine. Br. J. Nutr.76(1996)211-221. 
7. Hartemink, R.; Van Laere, K.M.J.; Mertens, A.K.C. and Rombouts, F.M. : Fermentation of xyloglucan 
by intestinal bacteria. Anaerobe 2(1996)223-230. 
8. Hartemink, R.; Kok, B.J.; Weenk, G.H. and Rombouts, F.M. : Raffinose-Bifidobacterium (RB) agar, a 
new selective medium for bifidobacteria. J. Micr. Meth. 27(1996)33-43. 
9. Hartemink, R. ; Van Laere, K.M.J.; Peeters, C.C.K.M.; Nout, M.J.R. and Rombouts, F.M. : In vitro 
cariogenicity of trans-galactosyl oligosaccharides. Lett. Appl. Bact. 25(1997)38-42 
lO.Hartemink, R.; Van Laere, K.M.J, and Rombouts, F.M. : Growth of enterobacteria on fructo-
oligosaccharides. J. Appl. Micr. 83(1997)367-374. 
11.Hartemink, R.; Domenech, V.R. and Rombouts, F.M. : LAMVAB - a new selective medium for the 
isolation of lactobacilli from faeces. J. Micr. Meth. 29(1997)77-84. 
12.Hartemink, R.; Nout, M.J.R. and Rombouts, F.M. : Fermentation of oligosaccharides by human 
intestinal bacteria and possible effects on protein fermentation. Med. Fac.Landbouww. Univ. Gent 
62/4a(1997)1289-1296. 
13.Hartemink, R.; Schoustra, S.E. and Rombouts, F.M. : Degradation of guar gum by intestinal bacteria. 
Bioscience and Microflora. In press. 
202 
LIST OF PUBLICATIONS 
14.Laere, K.M.J, van; Hartemink, Ft.; Bosveld, M.; Schols, H.A. and Voragen, A.G.J. : Fermentation of 
plant cell wall derived oligosaccharides by intestinal bacteria. J. Appl. Bact. Submitted. 
15.Hartemink, R. and Rombouts, F.M. : Comparison of media for the detection of bifidobacteria, 
lactobacilli and total anaerobes from faecal samples. J. Appl. Bact. In press. 
l6.Alles, M.S. , Hartemink, R. ; Meyboom, S.; Harryvan JL ; Laer, K.M.J, van; Nagengast, F.M. and 
Hautvast, J.G.A.J.: Effect of transgalacto-oligosaccharides on composition and activity of the intestinal 
microflora. In press. 
l7.Houdijk, J.G.M. ; Hartemink, R.; Verstegen, M.W.A. and Bosch, M.W. : Dietary non-digestible 
oligosaccharides affect microbial characteristics of ileal- and caecal digesta, and faeces of weaner 
pigs. Br. J. Nut. Submitted. 
lS.Laere, K.M.J, van ; Hartemink, R. ; Beldman, G.; Pitson, S.; Dijkema, C; Schols, H.A. and Voragen, 
A.G.J. : Bifidobacterium adolescentis <x-galactosidase:hydrolase and transglycosidase activities. 
Submitted. 
OTHER PAPERS 
1. Hartemink, R.; Nout, M.J.R. and Rombouts, F.M. : Effects of fructo-oligosaccharides on the human 
intestinal flora. In : Fuchs, A. (ed). Proceedings on the fourth seminar on inulin. Report of the Nationale 
Raad voor Landbouwkundig Onderzoek, 94/4,1994, pp 79-89. 
2. Hartemink, R.; Nout, M.J.R. en Rombouts, F.M. : Oligosacchariden als bifidogene factoren. 
Voedingsmiddelentechnologie 22 September 1994 biz 27-29. 
3. Hartemink, R.; Nout, M.J.R. and Romboutrs, F.M. : Fermentation of fructo-oligosaccharides by 
enterobacteria. Orafti conference, Brussels, January 17,1995. 
POSTERS AND ABSTRACTS 
1. Asgeirsson, B. and Hartemink, R. : Alkaline phosphatase from the intestines of Atlantic cod (Gadus 
morhua). Structural and enzymatic properties. 21st Annual meeting of the Federation of European 
Biochemical Societies, Dublin, Ireland, August 9-14,1992. 
2. Asgeirsson, B. and Hartemink, R. : Enhanced catalytic efficiency observed at low temperature with 
alkaline phosphatase from codfish can be related to a reduction in protein stability. 6th European Congress 
on biotechnology, Florence, Italy, June 13-17,1993. 
203 
LIST OF PUBLICATIONS 
3. Hartemink, R.; Mertens, A.K.C. and Rombouts, F.M. : Fermentation of xyloglucan by the intestinal 
microflora. Fifth Portuguese Congress on Zootechnics, Angra do Heroismo, Acores, Portugal, June 1-3, 
1995. Published in Revista Portuguesa de Zootechnica (poster and abstract) 
4. Hoekstra, J.H.; Aker, J.H.L. van den; Kneepkens, C.M.F. and Hartemink, R. : Apple juice induced chronic 
nonspecific diarrhea: the importance of industrial processing. International symposium on pediatric 
gastroenterology and nutrition, Montreal, Canada, June 22-23,1995. (poster) 
5. Hoekstra, J.H.; Aker, J.H.L. van den; Kneepkens, C.M.F. and Hartemink, R. : Fruit juice malabsorption: 
other factors than fructose. International symposium on pediatric gastroenterology and nutrition, Montreal, 
Canada, June 22-23, 1995. (poster) 
6. Hartemink, R.: Kok, B.J. and Rombouts, F.M. : RB-agar, a new selective medium for the enumeration of 
bifidobacteria from dairy products and faeces. World Congress on Anaerobic Bacteria and Infections, San 
Juan, Puerto Rico, November 5-8, 1995. (poster) 
7. Van Laere, K.M.J.; Hartemink, R.; Bosveld, M. and Voragen, A.G.J.: Degradation and fermentation of 
pectin-derived oligosaccharides by the intestinal microflora. World Congress on Anaerobic Bacteria and 
Infections, San Juan, Puerto Rico, November 5-8,1995. (poster) 
8. Van Laere, K.M.J.; Bosveld, M.; Hartemink, R. and Voragen, A.G.J.: Degradation and fermentation of 
arabinoxylan oligosaccharides by the intestinal microflora. World Congress on Anaerobic Bacteria and 
Infections, San Juan, Puerto Rico, November 5-8,1995. (poster) 
9. Hartemink, R.; Domenech, V.R. and Rombouts, F.M. : LAMVAB, a new selective medium for the isolation 
of Lactobacillus species from faeces. XXIst International congress on microbial ecology and disease, 
Paris, France, October 28-30, 1996. (poster) 
lO.Hartemink, R.; Schoustra, S.; Van Laere, K.M.J, and Rombouts, F.M. : Degradation of guar gum by 
intestinal and oral bacteria. XXIst International congress on microbial ecology and disease, Paris, France, 
October 28-30,1996. (poster) 
H.Houdijk, J.G.M.; Hartemink, R. and Verstegen, M.W.A.: Dietary non-digestible oligosaccharides affect ileal 
microbial microflora in young pigs. 48th Annual meeting of the EAAP 1997, Vienna, 25-28 August 1997. 
(poster) 
12.Alles, M.S.; Hartemink, R.; Meyboom, S.; Nagengast, F.M. and Hautvast, J.G.A.J. : Het effect van 
transgalacto-oligosacchariden op de bacteriele activiteit in het colon. Samenvattingen van lezingen en 
posters van het congres 'Trends in Voedingswetenschappen", 1997. (abstract) 
13.Houdijk, J.G.M. : Hartemink, R.; Hoving, J.; Hogenes, Y. and Verstegen, M.W.A. : Bacterial concentrations 
in porcine ileal chyme, caecal contents and faeces as affected by dietary non-digestible oligosaccharides. 
Symposium on gastrointestinal disorders in juveniles. ID-DLO, Lelystad, The Netherlands, 1997. (poster) 
204 
LIST OF PUBLICATIONS 
14.Hartemink, R. and Rombouts, F.M. : Gas formation from oligosaccharides by the intestinal microflora. In : 
Hartemink, R. (compiler) Non-digestible oligosaccharides - healthy food for the colon ?, Proceedings of a 
conference held in Wageningen, December 4-5,1997, p.57-66.(abstract) 
15.Houdijk, J.G.M.; Hartemink, R.; Laere, K.M.J, van; Williams, B.A.; Bosch, M.W.; Verstegen, M.W.A. and 
Tamminga, S. : Fructooligosaccharides and transgalactooligosaccharides in weaner pig's diet. In : 
Hartemink, R. (compiler) Non-digestible oligosaccharides - healthy food for the colon ?, Proceedings of a 
conference held in Wageningen, December 4-5,1997, p. 69-78 (abstract) 
205 
